
<html lang="en"     class="pb-page"  data-request-id="2d193795-dc33-4bad-a19e-47ab09d89ab8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2016.59.issue-2;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.5b01552;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery" /></meta><meta name="dc.Creator" content="Stephan G.  Zech" /></meta><meta name="dc.Creator" content="Anna  Kohlmann" /></meta><meta name="dc.Creator" content="Tianjun  Zhou" /></meta><meta name="dc.Creator" content="Feng  Li" /></meta><meta name="dc.Creator" content="Rachel M.  Squillace" /></meta><meta name="dc.Creator" content="Lois E.  Parillon" /></meta><meta name="dc.Creator" content="Matthew T.  Greenfield" /></meta><meta name="dc.Creator" content="David P.  Miller" /></meta><meta name="dc.Creator" content="Jiwei  Qi" /></meta><meta name="dc.Creator" content="R. Mathew  Thomas" /></meta><meta name="dc.Creator" content="Yihan  Wang" /></meta><meta name="dc.Creator" content="Yongjin  Xu" /></meta><meta name="dc.Creator" content="Juan J.  Miret" /></meta><meta name="dc.Creator" content="William C.  Shakespeare" /></meta><meta name="dc.Creator" content="Xiaotian  Zhu" /></meta><meta name="dc.Creator" content="David C.  Dalgarno" /></meta><meta name="dc.Description" content="Choline kinase α (ChoKα) is an enzyme involved in the synthesis of phospholipids and thereby plays key roles in regulation of cell proliferation, oncogenic transformation, and human carcinogenesis...." /></meta><meta name="Description" content="Choline kinase α (ChoKα) is an enzyme involved in the synthesis of phospholipids and thereby plays key roles in regulation of cell proliferation, oncogenic transformation, and human carcinogenesis...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 13, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01552" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01552" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01552" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01552" /></link>
        
    
    

<title>Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01552" /></meta><meta property="og:title" content="Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0019.jpeg" /></meta><meta property="og:description" content="Choline kinase α (ChoKα) is an enzyme involved in the synthesis of phospholipids and thereby plays key roles in regulation of cell proliferation, oncogenic transformation, and human carcinogenesis. Since several inhibitors of ChoKα display antiproliferative activity in both cellular and animal models, this novel oncogene has recently gained interest as a promising small molecule target for cancer therapy. Here we summarize our efforts to further validate ChoKα as an oncogenic target and explore the activity of novel small molecule inhibitors of ChoKα. Starting from weakly binding fragments, we describe a structure based lead discovery approach, which resulted in novel highly potent inhibitors of ChoKα. In cancer cell lines, our lead compounds exhibit a dose-dependent decrease of phosphocholine, inhibition of cell growth, and induction of apoptosis at low micromolar concentrations. The druglike lead series presented here is optimizable for improvements in cellular potency, drug target residence time, and pharmacokinetic parameters. These inhibitors may be utilized not only to further validate ChoKα as antioncogenic target but also as novel chemical matter that may lead to antitumor agents that specifically interfere with cancer cell metabolism." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01552"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01552">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01552&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01552&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01552&amp;href=/doi/10.1021/acs.jmedchem.5b01552" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 671-686</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01525" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01594" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephan+G.++Zech">Stephan G. Zech</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Kohlmann">Anna Kohlmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tianjun++Zhou">Tianjun Zhou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Li">Feng Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachel+M.++Squillace">Rachel M. Squillace</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lois+E.++Parillon">Lois E. Parillon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+T.++Greenfield">Matthew T. Greenfield</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+P.++Miller">David P. Miller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiwei++Qi">Jiwei Qi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R.+Mathew++Thomas">R. Mathew Thomas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihan++Wang">Yihan Wang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongjin++Xu">Yongjin Xu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan+J.++Miret">Juan J. Miret</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+C.++Shakespeare">William C. Shakespeare</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaotian++Zhu">Xiaotian Zhu</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Dalgarno">David C. Dalgarno</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-617-621-2363. E-mail: <a href="/cdn-cgi/l/email-protection#603314051008010e4e3a0503082001120901044e030f0d"><span class="__cf_email__" data-cfemail="96c5e2f3e6fef7f8b8ccf3f5fed6f7e4fff7f2b8f5f9fb">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01552&amp;href=/doi/10.1021%2Facs.jmedchem.5b01552" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 671–686</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 23, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 October 2015</li><li><span class="item_label"><b>Published</b> online</span>13 January 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 January 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01552" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01552</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D671%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStephan%2BG.%2BZech%252C%2BAnna%2BKohlmann%252C%2BTianjun%2BZhou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D2%26contentID%3Dacs.jmedchem.5b01552%26title%3DNovel%2BSmall%2BMolecule%2BInhibitors%2Bof%2BCholine%2BKinase%2BIdentified%2Bby%2BFragment-Based%2BDrug%2BDiscovery%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D686%26publicationDate%3DJanuary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01552"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2067</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01552" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stephan&quot;,&quot;last_name&quot;:&quot;G. Zech&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Kohlmann&quot;},{&quot;first_name&quot;:&quot;Tianjun&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;M. Squillace&quot;},{&quot;first_name&quot;:&quot;Lois&quot;,&quot;last_name&quot;:&quot;E. Parillon&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;T. Greenfield&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;P. Miller&quot;},{&quot;first_name&quot;:&quot;Jiwei&quot;,&quot;last_name&quot;:&quot;Qi&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Mathew Thomas&quot;},{&quot;first_name&quot;:&quot;Yihan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yongjin&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;J. Miret&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;C. Shakespeare&quot;},{&quot;first_name&quot;:&quot;Xiaotian&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Dalgarno&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;671-686&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01552&quot;},&quot;abstract&quot;:&quot;Choline kinase α (ChoKα) is an enzyme involved in the synthesis of phospholipids and thereby plays key roles in regulation of cell proliferation, oncogenic transformation, and human carcinogenesis. Since several inhibitors of ChoKα display antiproliferative activity in both cellular and animal models, this novel oncogene has recently gained interest as a promising small molecule target for cancer therapy. Here we summarize our efforts to further validate ChoKα as an oncogenic target and explore the activity of novel small molecule inhibitors of ChoKα. Starting from weakly binding fragments, we describe a structure based lead discovery approach, which resulted in novel highly potent inhibitors of ChoKα. In cancer cell lines, our lead compounds exhibit a dose-dependent decrease of phosphocholine, inhibition of cell growth, and induction of apoptosis at low micromolar concentrations. The druglike lead series presented here is optimizable for improvements in cellular potency, drug target residence time, and pharm&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01552&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01552" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01552&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01552" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01552&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01552" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01552&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01552&amp;href=/doi/10.1021/acs.jmedchem.5b01552" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01552" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01552" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01552%26sid%3Dliteratum%253Aachs%26pmid%3D26700752%26genre%3Darticle%26aulast%3DZech%26date%3D2016%26atitle%3DNovel%2BSmall%2BMolecule%2BInhibitors%2Bof%2BCholine%2BKinase%2BIdentified%2Bby%2BFragment-Based%2BDrug%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D2%26spage%3D671%26epage%3D686%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292101" title="Nutrition">Nutrition</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/jmcmar.2016.59.issue-2/20160128/jmcmar.2016.59.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Choline kinase α (ChoKα) is an enzyme involved in the synthesis of phospholipids and thereby plays key roles in regulation of cell proliferation, oncogenic transformation, and human carcinogenesis. Since several inhibitors of ChoKα display antiproliferative activity in both cellular and animal models, this novel oncogene has recently gained interest as a promising small molecule target for cancer therapy. Here we summarize our efforts to further validate ChoKα as an oncogenic target and explore the activity of novel small molecule inhibitors of ChoKα. Starting from weakly binding fragments, we describe a structure based lead discovery approach, which resulted in novel highly potent inhibitors of ChoKα. In cancer cell lines, our lead compounds exhibit a dose-dependent decrease of phosphocholine, inhibition of cell growth, and induction of apoptosis at low micromolar concentrations. The druglike lead series presented here is optimizable for improvements in cellular potency, drug target residence time, and pharmacokinetic parameters. These inhibitors may be utilized not only to further validate ChoKα as antioncogenic target but also as novel chemical matter that may lead to antitumor agents that specifically interfere with cancer cell metabolism.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Choline kinase (ChoK) is a cytosolic enzyme that catalyzes the MgATP-dependent phosphorylation of choline to phosphocholine (pCho) as the first step in the Kennedy pathway toward synthesis of the major membrane phospholipid, phosphatidylcholine (PtdCho). The mammalian choline kinase family is encoded by two distinct genes, ChoKα and ChoKβ, resulting in three different isoforms, namely, ChoKα1, ChoKα2, and ChoKβ. ChoKα1 (457 amino acids) and ChoKα2 (439 amino acids) are derived from a single gene (ChoKα) by alternative splicing. Apart from being a major structural component of mammalian cellular membranes, PtdCho serves as a precursor for the production of lipid second messengers that can activate growth and survival pathways.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> This implies that maintenance of PtdCho level is critical for cell growth because its oscillations would have implications not only in the structural homeostasis of the cell membranes but also in signaling processes involved in cell proliferation and apoptosis.</div><div class="NLM_p">Abnormal choline metabolism is characteristic of oncogenesis and cancer progression in an array of cancer types. Exogenous expression of ChoKα1, but not ChoKβ, is capable of driving tumor formation in nontransformed cells.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It is known that increased phosphorylation of choline is a hallmark of certain malignant phenotypes. ChoKα overexpression, primarily ChoKα1, has been associated with certain human cancers, including breast, liver, lung, colorectal, ovarian, and prostate.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> For example, ChoKα, pCho, and total choline were increased in breast carcinomas compared with normal breast tissue, and this was correlated with advanced tumor grades.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> This implies that elevated pCho or ChoKα itself may be a candidate biomarker for ChoKα inhibitor therapy across tumor types. Preclinical evidence suggests that inhibition of ChoKα expression in cell lines results in disruption of MAPK and AKT activity and decreased cell proliferation.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> It has also been found that cell lines expressing activated RAS exhibit sensitivity to ChoKα knockdown by siRNA or small molecule inhibition.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> More recently, ChoKα has been identified as a downstream mediator of EGFR/c-Src signaling in breast cancer cell lines.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These studies indicate that tumors demonstrating aberrant MAPK, PI3K/AKT, RAS, or EGFR/c-Src signaling may also be targetable by ChoKα inhibitors. Finally, recent studies have implicated that ChoKα inhibition triggers apoptosis in cancer cells by inducing exacerbated endoplasmic reticulum stress.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These observations have motivated efforts to develop anticancer agents targeting ChoKα.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">ChoKα inhibitors have been demonstrated to be potent antitumor agents both in vitro and in vivo. Hemicholinium-3 (<b>1</b>, HC-3),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S1 (Supporting Information</a>), is a known substrate site inhibitor that bears structural homology to choline, which contributes to its toxicity. A less toxic derivative of <b>1</b>, MN58b (<b>2</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> was reported to inhibit endogenous ChoKα activity and suppress breast cancer, colon cancer, and epidermoid carcinoma xenograft growth in vivo.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16-19)</a> Another ChoKα inhibitor, CK37 (<b>3</b>),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> identified through computational virtual screening, inhibited ChoKα activity both in enzymatic and in cellular assays. Compound <b>3</b> was also able to suppress pCho production and tumor growth in vivo.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Intriguingly, both <b>2</b> and <b>3</b> showed inconsistencies between their relatively weak enzymatic activities and more potent cellular and in vivo tumor suppression activities, which may indicate these inhibitors possess activities on targets additional to ChoKα. On the other hand, V-11-0711 (<b>4</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> also identified from a structure-directed approach, is a selective ChoKα inhibitor with an IC<sub>50</sub> of 20 nM against ChoKα which exhibited excellent selectivity against a panel of 50 kinases. Although treatment of HeLa cells and other cancer cells with <b>4</b> led to a substantial reduction in the pCho level, this treatment caused a reversible growth arrest but not cell death.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In addition, HeLa cells treated with <b>4</b> displayed only low levels of apoptotic markers. The precursor of this compound, VX-11-023907 (<b>5</b>),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> showed some unexpected properties with respect to its enzymatic mechanism of action. While the quinuclidine moiety binds to the choline site of ChoKα, the molecule has been found to be ATP competitive but not choline competitive.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Recently RSM-932A (<b>6</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S1</a>),<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> also known as TDC-717, became the first compound to enter phase I clinical trials as a potential cancer therapeutic agent targeting choline metabolism.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Compound <b>6</b> and its analogues<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> are symmetric bis-quinolinium derivatives that were derived from <b>1</b> and that demonstrated ChoKα enzyme inhibition activities similar to those of <b>1</b> and <b>2</b>. To overcome the toxicity problems associated with the <b>1</b> chemotype, pharmacophore-guided virtual screening has been used to identify novel chemical matter with binding affinities in the low μM range,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> starting from known choline site inhibitors. Alternatively, novel asymmetrical bispyridinium derivatives showed submicromolar enzyme activity, inhibited proliferation, and caused apoptosis in ChoK driven cancer cells.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In our hands, an enzyme-based screening of a library of commercially available kinase inhibitors failed to identify potent (IC<sub>50</sub> < 1 μM) ChoKα ATP site inhibitors. This is consistent with the low <i>K</i><sub>M</sub> of ATP (∼300 μM),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> indicating that subtle structural differences between the ATP binding pockets of protein kinases and ChoKα attenuate binding of known tyrosine kinase templates to ChoKα. With this knowledge, we turned to alternative methods to identify ChoKα inhibitors.</div><div class="NLM_p last">Here we describe a fragment-based approach to discovering novel and potent ChoKα inhibitors with the potential for a more favorable safety profile. We used NMR fragment screening as an unbiased hit-finding strategy followed by further biophysical validation and structure-driven chemical optimization. Novel symmetrical and nonsymmetrical ChoKα inhibitors were identified using an iterative structure-based approach with binding affinities against ChoKα of around 10 nM. Importantly, these inhibitors induced dose-dependent reduction of pCho and caused apoptotic cell death in breast cancer cell lines overexpressing ChoKα but not in control cell lines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53283" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53283" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Initial Hit Generation by Fragment Screening and Biophysical Validation</h3><div class="NLM_p">In the search for novel chemical matter targeting ChoKα1, we performed an unbiased screen of 1152 diverse rule-of-three compliant fragments using STD NMR as the primary screening technique.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> shows an example of the NMR screen. Panel A shows the NMR reference spectrum of compound <b>7</b> together with the STD NMR spectrum in the lower trace, indicating reversible binding of <b>7</b> to ChoKα. In contrast DMSO and buffer signals are not observed in the difference spectrum. Panel B shows the reference and STD NMR spectra of <b>8</b>. The resonances associated with the diazepane moiety are significantly more pronounced in the STD spectrum compared to the aromatic protons. The relative STD intensity can be used to deduce structural information,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> indicating that the diazepane is in close contact with the protein, thus facilitating more efficient magnetization transfer.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. STD NMR fragment screening. (A) Reference NMR spectrum of <b>7</b> and STD NMR spectrum (red) in the presence of 30 μM ChoK indicating reversible binding of <b>7</b>. (B) Reference spectrum and STD NMR spectrum of <b>8</b>. The stronger STD signals observed for the diazepane moiety compared to the aromatic signals imply a close contact of the diazepane with the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The NMR screen returned 55 hits (4.8% hit rate) comprising a diversity of chemotypes. On the basis of structural features of those fragments (e.g., binding capability to the kinase hinge region), some hits were likely ATP site binders, while others, lacking those features, were thought to bind to alternative binding sites of the protein. Fluorine NMR detected competition experiments (FAXS) can offer a sensitive way to monitor compounds binding to a specific binding site that is occupied by the “spy” molecule,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> as an alternative to more resource demanding technologies such as SAR by NMR.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In addition, FAXS competition experiments work well on larger proteins such as the homodimeric form of ChoKα1 (∼94 kDa) and require only weakly binding compounds as spy molecules (100–200 μM in this case). FAXS is therefore well suited for early stage discovery programs, where tight binding inhibitors may not be available. <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S2</a> exemplifies the competition experiments with either 2-fluoroadenosine (<b>9</b>, <i>K</i><sub>d</sub> = 165 μM) or fluorocholine chloride (<b>10</b>, <i>K</i><sub>d</sub> = 113 μM) which were used to monitor binding to ATP and substrate sites, respectively. <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S1 (Supporting Information</a>) includes a selection of fragment hits and their respective binding sites. Out of 55 fragment hits investigated, 13 showed competition with choline site binder <b>10</b>, while 21 compounds showed competition with ATP site binder <b>9</b>. NMR monitored competition experiments allowed us not only to validate initial hits from either fragment or enzyme-based screens (including high throughput and virtual screening campaigns) but also to locate screening hits to binding sites of interest. Compounds that did not compete with <b>9</b> or <b>10</b> were deprioritized because they may be very weak competitors, allosteric binders, or enzyme assay artifacts. Triaging primary screening hits using such competition assays results in both an increased confidence in the hits and improved success in downstream experiments, notably X-ray crystallography.</div><div class="NLM_p">Quantitative information on protein–ligand affinity was obtained by means of enzymatic assays and surface plasmon resonance (SPR). In the coupled choline kinase enzyme assay, most compounds showed only weak inhibition of the enzyme with IC<sub>50</sub> values larger than 0.3 mM, as are typically found for initial fragment hits. One exception was fragment <b>11</b>, which was confirmed as choline site binder by NMR competition experiments, with an IC<sub>50</sub> of 87 μM.</div><div class="NLM_p">Protein–ligand interaction studied by SPR also revealed that the majority of the fragment hits exhibited mostly weak binding affinities with <i>K</i><sub>d</sub> between 0.5 and 2 mM. We also observed rapid association and dissociation for all fragments hits, consistent with this weak affinity. In addition, many fragments showed nonspecific binding to the protein surface as monitored by the off-target affinity to carbonic anhydrase II (CA-II), a protein structurally and functionally unrelated to ChoK. An example is shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. Compound <b>12</b> showed significant selectivity for ChoK, with minor binding to CA-II. The other two compounds show affinity for both proteins. Nonspecific surface absorption of weakly binding fragments is often observed in early hit validation and gives rise to larger error margins for the <i>K</i><sub>d</sub> estimates and resulting derived ligand efficiencies. Ranking the hits based on SPR data alone would be difficult; however, taking data from NMR competition experiments into account enables a more confident prioritization for X-ray crystallography. In agreement with enzyme inhibition, compound <b>11</b> showed a strong affinity with <i>K</i><sub>d</sub> of 132 μM, despite some superstoichiometric binding at higher concentrations,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and was among the compounds selected for cocrystallization.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR validation of fragment hits. Sensograms for compounds <b>12</b>, <b>11</b>, and <b>13</b> binding to a surface with immobilized ChoKα (left) or the reference protein CA-II (right). The sensograms were obtained at 25 °C using a 2-fold dilution series with an upper concentration of 300 μM. <i>K</i><sub>d</sub> values were obtained by fitting the data to a 1:1 binding model (error margin of ∼2-fold, ∗ = injection artifact).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Structural Analysis of Fragment Hits</h3><div class="NLM_p">A selection of validated fragment hits was successfully soaked into ChoKα crystals, and crucial structural information was generated on both ATP and choline site binders. Surprisingly, during fragment optimization we found that the ATP site compounds were difficult to improve in potency, even though many of them were found to bind to the ATP site in typical ways (e.g., to the hinge region of the kinase ATP binding pocket). In contrast, we were able to progress the choline site binders rapidly using structure-guided approaches in hit-to-lead optimization.</div><div class="NLM_p"><a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> shows the cocrystal structure of <b>11</b> soaked into a crystal of N-terminally truncated ChoKα1 (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). The complex structure was determined at 2.4 Å by molecular replacement. As previously reported,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> ChoKα1 kinase adopts the typical eukaryotic protein kinase fold, including an N- and C-bilobal architecture with the ATP binding site located in a cleft between the two lobes and the choline substrate site in the lager C-lobe (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). There are two monomers in the crystallographic asymmetric unit, which assemble as a homodimer with the helix in the smaller N-lobe forming the major dimer interface. This is consistent with the findings that all the choline kinase isoforms exist either as dimers (homo- or hetero-) or as tetramers in solution and are not active in monomeric form.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of ChoKα bound by compound <b>11</b> at 2.4 Å (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQE">5EQE</a>). (A) Overview of the ChoKα complex structure. Compound <b>11</b>, binding in the choline site is shown as sticks and colored in green. The superimposed phosphochloline (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKQ">2CKQ</a>) in cyan is included for comparison. The ATP site of the enzyme is also indicated. Structural figures were prepared using PyMol unless noted otherwise. (B) Binding mode of compound <b>11</b> in the substrate site of ChoKα. The protein is shown as cartoon with amino acid side chains as sticks. The hydrophobic residues lining the “hydrophobic groove” are labeled. The purple dashed line denotes hydrogen bonding interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The electron density for <b>11</b> is well-defined in the structure despite its relatively low binding affinity (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S3</a>). As predicted by competitive NMR studies, the inhibitor binds in the choline site located in the mostly helical C-lobe. The methyldiazepane moiety sits deep at the base of choline site which is predominantly hydrophobic in nature. W420 serves as the “floor” of the binding site, while W423, Y333, Y354, and Y440 form three of the four sides of the pocket, with carbon-to-carbon contact distances of 3.5–5.0 Å. The fourth side consists of mostly polar residues including D306, Q308, and E349, all of which are conserved among either choline kinase or eukaryotic protein kinase families and perform critical structural and functional roles.<a onclick="showRef(event, 'ref11 ref32'); return false;" href="javascript:void(0);" class="ref ref11 ref32">(11, 32)</a> For example, D306 and Q308 were involved in the binding of the enzyme reaction product phosphocholine, and mutation D306A resulted in a total loss of activity.<a onclick="showRef(event, 'ref11 ref34'); return false;" href="javascript:void(0);" class="ref ref11 ref34">(11, 34)</a></div><div class="NLM_p">The diazepane methyl group is the most deeply bound portion of the inhibitor, filling a small hydrophobic pocket formed by Y333, W420, and W423 where it engages in strong aliphatic–aromatic edge-to-face contacts with the side chains of these residues (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). The importance of the methyl group is supported by the SAR of the des-methyl analogs which are typically less potent. Of interest, the 1′ N of the diazepane to which the methyl is attached is within hydrogen bond distance to the side chain of D306 (3.1 Å). This implies that the N is protonated under the crystallization conditions (pH 7.0) and carries a positive charge. Indeed, the protonation status of the 1′ N atom was confirmed by NMR titration experiments (data not shown). This polar interaction is reminiscent of that formed by the ChoK inhibitor <b>5</b> between its quinuclidine-N and D306.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">The phenyl group of <b>11</b> binds to part of a hydrophobic groove located between a helix and a loop (connecting two β strands) in the C-lobe (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B), where it forms favorable π–π interactions with the aromatic side chains of Y437 and Y354 (edge-to-face) and F435 (face-to-face). Finally, the benzylamino group is partially disordered in the structure, likely due to the lack of favorable interactions in the hydrophobic groove. This observation prompted us to explore lipophilic substitutions on the phenyl ring to enhance the contacts with the hydrophobic residues in this groove. Evaluation of the SAR (e.g., <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S1</a>) showed that compounds bearing a methylpiperazine headgroup (e.g., compound <b>22</b>) have weaker affinity than their diazepane analogs (compound <b>11</b>). This finding highlights the importance of the additional flexibility of diazepane which allows it to better fill the pocket and optimize the geometry of the hydrogen bonding interaction with D306.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure Guided Hit Exploration</h3><div class="NLM_p">Examination of the previously published X-ray crystal structure of ChoKα (3G15)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> revealed a choline site with a deep enclosed base widening toward the solvent front. Similarly, SiteMap analysis of the X-ray structure of compound <b>11</b> demonstrates a hydrophobic patch spanning the length of the pocket: a deeply buried hydrophobic tip flanked on one side by buried hydrogen bond acceptors and donors, with only scarce polar interactions at the solvent front (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S4</a>). This indicates that a potent inhibitor in the choline site must satisfy both the hydrophobic interactions and the precise arrangement of polar interactions in the pocket.</div><div class="NLM_p">To explore additional aspects of SAR around the initial fragment hits, commercially available analogs were selected based on docking studies into the binding site of ChoKα. Compounds exhibiting favorable interactions with the protein were purchased and tested for enzyme inhibition followed by SPR. Results for selected compounds are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S2</a>. Compound <b>27</b>, one of the purchased analogs, showed the highest potency (<i>K</i><sub>d</sub> = 7 μM, IC<sub>50</sub> = 17 μM) and confirmed our observation that more lipophilic bulk in the vicinity of the phenyl ring would be favorable for binding. Compound <b>27</b> was chosen as a starting point for chemical optimization.</div><div class="NLM_p"><a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> summarizes the key compounds in the hit-to-lead optimization process. Initially, the connectivity of the diazepane moiety was modified for ease of synthesis (compound <b>37</b>, <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S3</a>), with an insignificant change in potency. The cocrystal structure with this inhibitor showed that the second aromatic ring forms additional van der Waals contacts with residues lining the hydrophobic groove, specifically, a parallel-displaced π–π stacking interaction with F435 (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S5</a>). Subsequently, the quinoline moiety was modified to various fused bicyclic systems to probe the SAR in the solvent-front-directed part of the molecule. No significant improvement in potency was achieved (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S3</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Key SAR elements of the fragment hit-to-lead progression. Ligand efficiency was calculated as LE = −1.4 log(<i>K</i><sub>d</sub>)/(no. of heavy atoms).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then attempted to introduce flexibility into the solvent-directed part of the molecule. A library of compounds was designed with flexible linkers at the para position of the phenyl ring, bearing various polar substituents (data not shown). Although a modest decrease in enzymatic potency was observed, the <i>K</i><sub>d</sub> values remained unchanged, and this subseries was not pursued further. Finally, we substituted a biphenyl in place of a fused bicycle (compound <b>43</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) to retain hydrophobicity while introducing some flexibility into the aromatic system. Additionally, modifications at the para position of the second phenyl ring were introduced to probe polar interactions in the solvent front. An improvement in potency of <b>43</b> was observed when the second phenyl ring was substituted (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Addition of a heterocycle improved potency by 5- to 20-fold (compounds <b>44</b>, <b>48</b>, <b>49</b>), while small, polar, or hydrophobic substituents brought no improvement (compounds <b>46</b>, <b>47</b>)</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Modifications of the Biphenyl Moiety at the Para Position (Error Margins: 2- to 3-Fold)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0016.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p last">Modifications were then introduced into the diazepane moiety (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S4</a>). Consistent with our earlier analysis of SAR in the initial hit series, most changes resulted in a drastic loss of potency (50- to >100-fold) compared to compound <b>38</b>. This finding highlighted the methyldiazepane as a key pharmacophore feature for the binding of the inhibitor which is explained by the snug fit of the methyl group into the choline binding site observed in the cocrystal structure throughout fragment elaboration (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S6</a>). Even conservative modifications at the 1′ position caused a drastic reduction in potency. Interestingly, adding a second methyl group at the 1′ position (compound <b>52</b> bearing a positively charged ammonium ion) reduced the potency by 90-fold, indicating the importance of a hydrogen bonding donor at the 1′ position of the diazepane (see above). This suggests that methyldiazepane derivatives are better suited for the choline site binding site than quaternary ammonium ions present, e.g., in <b>1</b> and derivatives.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Optimization of the Biphenyl System</h3><div class="NLM_p">We proceeded to optimize the biphenyl linker of <b>49</b> with substitutions at various positions of one or both phenyl rings (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) finally obtaining compound <b>65</b> with <i>K</i><sub>d</sub> = 10 nM. Additional or alternative substitutions to the biphenyl linker were also tested to engage in additional contacts to the neighboring protein residues. However, these compounds did not display improved potency over <b>65</b>. As exemplified in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, simple substitutions of the biphenyl linker were able to significantly improve potency and ligand efficiency of the lead series, (e.g., a gain in potency of about 40-fold was observed by adding a CN group to <b>49</b>). The compound with the best potency, <b>65</b>, also showed the longest target residence time (τ > 2 min), indicating that further elaboration of the biphenyl part could potentially improve both potency and dissociation rate.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Linker Optimization and Kinetic Evaluation of the Leadlike Series<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Association kinetics <i>k</i><sub>on</sub>, protein–ligand residence time τ = 1/<i>k</i><sub>off</sub>, and dissociation constant <i>K</i><sub>D</sub> = 1/(<i>k</i><sub>on</sub>τ) were measured by surface plasmon resonance. IC<sub>50</sub> values were obtained from ChoKα enzyme inhibition assays. Error margins for <i>k</i><sub>on</sub> and τ are ∼2-fold, and error margins for <i>K</i><sub>d</sub> and IC<sub>50</sub> are 2- to 3-fold.</p></div></div><div></div></div><div class="NLM_p last">It is important to note that improving the affinity of compounds also led to better selectivity for ChoKα by reducing the nonspecific surface binding as monitored by SPR. In contrast to the early fragment hits (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S1</a>), the lead series did not show significant binding affinity to the reference protein CA-II (<i>K</i><sub>d</sub> > 100 μM). As outlined in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> and <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, ligand efficiency of ChoKα binding was maintained or even slightly improved throughout the hit-to-lead optimization process, indicating that all parts of the elaborated molecules contribute significantly to protein–ligand binding.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry</h3><div class="NLM_p">Compounds in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Tables S1 and S2</a> were purchased from vendors. Compounds <b>38</b>, <b>50</b>, <b>51</b>, and <b>53</b>–<b>64</b> were synthesized in a parallel fashion (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S5</a>) as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> by reductive amination of 2-naphthaldehyde (<b>71</b>) and substituted 1<i>H</i>-1,4-diazepines (<b>72</b>).</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>52</b> was synthesized by treating amine <b>38</b> with iodomethane at room temperature and isolated as a salt form according to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>37</b>, <b>39</b>–<b>43</b>, <b>46</b>, <b>47</b> were synthesized in a parallel fashion shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, by reductive amination of <i>N</i>-methyl-1<i>H</i>-1,4-diazepine (<b>72a</b>) and corresponding aromatic aldehydes (<b>73</b>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Reductive amination of <b>72a</b> and methyl 4′-formylbiphenyl-4-carboxylate (<b>74</b>) gave compound <b>45</b>, which was then treated with <b>72a</b> under Weinreb conditions to afford <b>48</b>. Amide <b>48</b> was reduced by LAH to give amine <b>49</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Boronic ester <b>76</b> was synthesized by treating of 4-(bromomethyl)benzeneboronic acid pinacol ester (<b>75</b>) with <b>72a</b>. Suzuki coupling of <b>76</b> with 1-(4-bromophenyl)-4-methylpiperazine (<b>77</b>) afforded <b>44</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>66</b>, <b>68</b>–<b>70</b> were synthesized in a parallel fashion. Suzuki coupling of 1-(4-bromobenzyl)-4-methylperhydro-1,4-diazepine (<b>79</b>) with subistitued 4-formylphenylboronic acids (<b>78a</b>–<b>d</b>) gave the corresponding intermediates (<b>80a</b>–<b>d</b>) followed by reductive amination with <b>72a</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">2-Bromo-5-(bromomethyl)benzonitrile (<b>81</b>) was treated with <b>72a</b> to give 2-bromo-5-[(hexahydro-4-methyl-1<i>H</i>-1,4-diazepin-1-yl)methyl]benzonitrile (<b>82</b>). Compound <b>65</b> was synthesized by Suzuki coupling of <b>82</b> with <b>79</b>. Compound <b>67</b> was synthesized by Suzuki coupling of <b>82</b> and 2-fluoro-4-formylbenzeneboronic acid pinacol ester (<b>83</b>) to give intermediate aldehyde <b>84</b> and followed by reductive amination with <b>72a</b> as shown in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>.</div><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structural and Kinetic Characterization of the Lead Series</h3><div class="NLM_p">To gain additional structural insights toward improved potency, we determined the crystal structure of ChoKα bound by <b>65</b> at 2.5 Å. The compound binds ChoKα vertically along the hydrophobic groove (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). While the bottom half of the inhibitor adopts a conformation similar to those of <b>11</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) and <b>37</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S5</a>), including a hydrogen bond to D306, it engages in additional molecular interactions. The biphenyl linker adopts a roughly perpendicular dihedral angle and optimally fills the hydrophobic groove. The second methyldiazepane group of <b>65</b> binds close to the solvent front but still makes favorable contacts with F361 and I433 and the aliphatic side chain of E434, thus contributing to the improved potency. Finally the CN group attached to one of the phenyl rings points to the polar side of the choline binding site and participates in a hydrogen-bonding network involving several water molecules and polar protein residues (E309, D215) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). There is a rotation of about 20° for the phenyl ring in <b>65</b> compared to those in <b>11</b> and <b>37</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Figure S6</a>). This conformational change seems necessary not only to prevent the attached nitrile group from clashing to the protein molecule (Y354 in particular) but also to engage in molecular interactions through water molecules.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of ChoKα bound by a lead compound <b>65</b> (2.5 Å, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQY">5EQY</a>). ChoKα is colored in green, and compound <b>65</b> is in orange. Red spheres are water molecules that bridge the interactions between the protein and inhibitor molecules. The purple dashed line denotes hydrogen bonding interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While some of our compounds display a high degree of symmetry, resembling the dimeric structures of <b>1</b> and analogues, the SAR outlined in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> proves that this symmetry is not strictly required to improve affinity, as the most potent compounds display a break in symmetry compared to <b>49</b>. The two diazepane moieties featured in our lead series serve a dual purpose: While one represents a novel pharmacophore with high affinity to the choline binding side, the other one is facing the solvent front. As shown in the cocrystal structure with compound <b>65</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), both diazepane moieties make significant interactions with the protein, thus favorably contributing to protein–ligand binding which is reflected in the gain in potency along with maintained ligand efficiency during fragment elaboration. The architecture of the choline binding site can be viewed as a deep and well-formed hydrophobic groove with a rim composed of a number of negatively charged residues.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These residues may function to guide the positively charged choline molecule into its binding site. The methyldiazepane of compound <b>65</b> that binds close to the solvent front is surrounded by E434 and E357 (<a class="ref internalNav" href="#fig5" aria-label="Figures 5">Figures 5</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">S6</a>); thus, electrostatic interactions also play a role in its binding and further contribute to potency gain. We arrived at these quasi-symmetric structures driven by the SAR (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) rather than derivatization of existing chemical matter. In addition, the lack of symmetry within the compound binding pocket (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) supports that there is no need for symmetry in the druglike compounds. Further optimization for potency or pharmacologic parameters will determine whether this quasi-symmetry is necessary or just an artifact as suggested by the SAR presented here or for other choline site inhibitors.<a onclick="showRef(event, 'ref20 ref21 ref25'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref25">(20, 21, 25)</a></div><div class="NLM_p last">In addition to potency, the understanding of the binding kinetics of a drug to its target can be essential to define a drug’s efficacy and duration of target suppression, as well as its safety due to mechanism based toxicity.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> Biosensor techniques, such as SPR, have been proven powerful in evaluating both association (<i>k</i><sub>on</sub>) and dissociation (<i>k</i><sub>off</sub>) kinetics in vitro.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a><a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> includes the <i>k</i><sub>on</sub> rates and the residence times τ (= 1/<i>k</i><sub>off</sub>) for a number of compounds from the lead series. In comparison to other drugs with known drug–target kinetics<a onclick="showRef(event, 'ref36 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref36 ref41 ref42">(36, 41, 42)</a> our lead series exhibits relatively fast association and dissociation kinetics for the given potency range. With target residence times between 0.5 and 2 min, these compounds could provide a balance between normal physiological function of ChoKα and inhibition of the target in ChoKα-overexpressed cancer cells, potentially reducing mechanism based toxicity. Further lead optimization for both potency and kinetics<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> should aim at residence times that provide signal suppression until apoptosis is induced in ChoKα dependent tumor cells,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> while healthy cells are still able to recover their growth kinetics once the drug is removed (e.g., by metabolism or excretion).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Cellular Activity of Leadlike Compounds</h3><div class="NLM_p">Representative members of this lead series, compounds <b>49</b> and <b>67</b>, were characterized in more detail and demonstrated potent enzyme inhibition against ChoKα as well as binding by SPR (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> summarizes the cell growth inhibition data for compounds <b>67</b> (panel A) and <b>49</b> (panel B). Compound <b>67</b> inhibited the growth of ChoKα-expressing breast cancer lines, MDA-MB-468 and MDA-MB-415, with GI<sub>50</sub> values of 7 and 2 μM, respectively. In contrast, compound <b>67</b> exhibited much lower activity against the nontransformed breast epithelial cell lines MCF-12A and MCF-10A, with a GI<sub>50</sub> of >40 and 18 μM, respectively. The activity of <b>49</b> against cancer cell lines was somewhat weaker, in agreement with weaker binding observed by SPR and in the ChoKα enzyme assay. However, in breast cancer cell lines <b>49</b> also resulted in cell death at low micromolar concentration, while nontransformed cells were not affected until concentrations of ∼30 μM were reached (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular activity of elaborated ChoK inhibitors. Growth inhibition of breast cancer cell lines by ChoK inhibitors <b>67</b> (A) and <b>49</b> (B). Both compounds selectively induced cell death of breast cancer but not breast epithelial lines. (C) Summary of GI<sub>50</sub> values and maximum growth inhibition. The markers identify the respective inhibition curves shown above. Numbers in red indicate cell death (>100% growth inhibition). Apoptosis signals measured for ChoK lead compounds <b>67</b> (D) and <b>49</b> (E) for cell lines MDA-MB-415 (top, solid red curves) and MCF-12A (bottom, solid blue curves).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Apoptosis signals were measured using the caspase-3/7 assay and are shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, panels D and E. The induction of apoptosis was consistent with the extent of proliferative inhibition. While <b>49</b> and <b>67</b> induced apoptosis at low μM concentrations in the ChoKα expressing cell line MDA-MB-415, the epithelial cell line MCF-12A did not undergo apoptosis at concentrations up to 40 μM.</div><div class="NLM_p">Intracellular choline and pCho levels were measured by NMR after extraction<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> of the nonmalignant cell line MCF-12A as well as the cancer cell lines MDA-MB-468 and MDA-MB-415. While the pCho levels of transformed cell lines were high and easily detectable by 1D proton NMR (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), the epithelial line MCF-12A showed very low levels of cellular choline and pCho (data not shown). After 24 h of treatment with <b>49</b>, complete inhibition of pCho was observed in the MDA-MB-468 cell line, in a dose dependent manner with an IC<sub>50</sub> of 2–3 μM. Similarly, 24 h treatment of MDA-MB-415 with <b>67</b> resulted in up to ∼80% inhibition of pCho with an IC<sub>50</sub> of ∼0.75 μM (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). In both cases, the cellular choline levels were too small to allow quantification. The dose-dependent inhibition of pCho in cells indicates that both compounds lead to inhibition of ChoKα in the cell lines MDA-MB-415 and MDA-MB-468. Consistent with cell growth, only minor effects on choline levels were observed in MCF-12A cell lines as result of compound treatment with <b>67</b>, while the pCho levels in this cell line were too small to be quantified by NMR (data not shown).</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. NMR detected reduction of cellular pCho levels as a function of compound treatment. (A) Overlay of NMR spectra of cell extracts from cell line MDA-MB-468 treated with increasing amounts of <b>49</b>. The level of pCho at ∼3.24 ppm shows a dose dependent inhibition. To account for slight variations in cell count and extraction efficiency, the spectral intensities have been calibrated to match the signals of lactate at ∼1.34 ppm. (B) NMR spectra of metabolites extracted from cell line MDA-MB-415 treated with <b>67</b>. Metabolites at 3.26–3.29 ppm have been used as internal reference. The pCho levels show a dose dependent decrease. Spectral positions for glycerolphosphocholine (GPC) and choline (Ch) are indicated. Table: Approximate cellular IC<sub>50</sub> of pCho inhibition evaluated from panels A and B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cellular activities in the low micromolar range have been previously reported for other ChoKα inhibitors.<a onclick="showRef(event, 'ref16 ref17 ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref20 ref22">(16, 17, 20, 22)</a> For our lead series, the potency for ChoKα driven cell lines and the selectivity over nontransformed cell lines represent a slight improvement over the current clinical compound <b>6</b>, with reported IC<sub>50</sub> values of 2.4 μM against MDA-MB-468 and 7.1 μM against the reference cell line MCF10-A.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This improvement was achieved at a significantly reduced molecular weight of our compounds (<b>49</b>, 407 Da; <b>67</b>, 450 Da) compared to <b>6</b> (878 Da) while also eliminating the permanent charges of the bis-quinolinium moieties.</div><div class="NLM_p">It is important to note that the breast cancer cell lines mentioned above were used solely because these or similar cell lines have been previously shown to be sensitive to ChoKα inhibition.<a onclick="showRef(event, 'ref3 ref12 ref22 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref3 ref12 ref22 ref44 ref45">(3, 12, 22, 44, 45)</a> This enables the comparison to other chemical matter, also on a cellular level. However, it does not imply that these cell lines are the most susceptible ones to ChoKα inhibition. Further evaluation and optimization of our lead series will encompass a broader screen of cancer cell lines<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> to help identify even more sensitive cell lines with improved potency and selectivity for our compounds. This in turn will also indicate which cancers are the most vulnerable to small molecule ChoKα inhibition and thereby assist in patient selection.</div><div class="NLM_p last">In summary, we demonstrated that small molecule inhibition of ChoKα resulted in a dose-dependent decrease of cellular pCho levels, inhibition of proliferation, and induction of apoptosis in ChoKα-expressing breast cancer cells at low micromolar concentrations. Taken together, these data further validate ChoKα as a potential therapeutic target in cancer and support the continued investigation into the utility of ChoKα inhibitors as antioncogenic agents.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We successfully applied fragment based approaches targeting ChoKα to generate novel chemical matter as starting point for medicinal chemistry optimization. Following an unbiased NMR fragment screen, initial hits were further validated by biophysical methods that gathered information on fragment binding sites, potency, and specificity. We identified both ATP and choline site binders and gained structural insights by X-ray crystallography on a significant number of initial hits, leading to ideas on how to improve and elaborate fragments hits. Surprisingly, for ATP site hits, improvements in potency proved difficult to achieve. In contrast, the choline site inhibitors progressed rapidly from weak fragments to a series of leadlike compounds with binding affinities of 10–50 nM. Our lead series is optimizable for further improvements in drug–target residence time, cellular potency, and pharmacokinetic parameters. We demonstrated inhibition of cell growth in a dose-dependent manner and induction of apoptosis in ChoKα-expressing breast cancer cell lines. Inhibition of ChoKα in cancer cells was directly shown by monitoring intracellular phosphocholine production.</div><div class="NLM_p">Interestingly, many of the ChoKα inhibitors in late preclinical or clinical development are dimeric structures featuring quaternary ammonium ions that, similar to choline, exhibit strong affinity for the substrate site. Unfortunately, these double positively charged chemotypes are associated with significant toxicity due to off-target activities, in part caused by their structural homology to choline. In contrast, the lead series identified in this paper uses basic amines present in methyldiazepanes as major driver for binding to the choline site. The protonated 1′ nitrogen adds a key hydrogen bond, resulting in significantly improved potency compared to, for example, <b>1</b> (IC<sub>50</sub> = 1.0 μM, <i>K</i><sub>d</sub> = 0.59 μM, LE = 0.29). It is important to note that the methyldiazepane moiety can be transiently protonated (i.e., charged) or be present as free base, depending on local conditions such as pH. Furthermore, diazepanes or piperazines are very commonly used in many approved drugs, mostly to improve solubility or ADME parameters. Usually those moieties do not give rise to major toxicity concerns.</div><div class="NLM_p last">This paper highlights the power of fragment based drug design approaches to quickly identify diverse hot spots on the protein target and to generate novel chemical starting points. Our fragment screen identified methyldiazepane as a novel key pharmacophore for choline site binding. Using structure-driven chemical optimization, we rapidly progressed toward a series of leadlike molecules with cellular potency and a novel mode of action. The thorough biophysical and biochemical evaluation of our lead series led to a clear correlation between enzyme activity (compound <b>67</b>: <i>K</i><sub>d</sub> ≈ IC<sub>50</sub> = 0.09–0.1 μM), cellular pCho inhibition (∼0.75 μM), growth inhibition of ChoK-driven cancer cell lines (2–7 μM) resulting in cell death and induction of apoptosis (5–10 μM). In contrast, nontransformed epithelial cell lines were much less affected and did not undergo apoptosis. These molecules, which specifically inhibit cellular metabolism, allow further optimization and may be utilized to validate ChoKα as an antioncogenic target and beyond. In turn, these molecules may open a new avenue for the development of antitumor drugs or provide novel treatment for noncancer conditions such as rheumatoid arthritis.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Protein Expression, Purification, and Crystallography</h3><div class="NLM_p">An N-terminal truncated form of human choline kinase α1 (ChoKα1) that includes residues 75–457 (accession no. NM_001277.2) was cloned into the pET28a expression vector (Novagene) with an N-terminal 6xHis affinity tag followed by a thrombin site. The recombinant protein was purified via affinity, ion-exchange, and size-exclusion chromatography with >95% purity. For crystallography, the purified ChoKα1 protein was concentrated to ∼30 mg/mL and crystallized as apo form in a condition containing 0.1 M sodium formate, 8–12% PEG 3350 at 18 °C.</div><div class="NLM_p last">The complex structures were obtained by soaking the inhibitors into the ChoKα1 crystals at a final concentration of 2–5 mM for 45–60 min before freezing in liquid nitrogen. Diffraction data were collected at 100 K on a Rigaku rotating anode and R-AXIS IV++ imaging system. The data were indexed and scaled using the HKL2000 package. The structures were determined by molecular replacement with CNX using published structures (e.g., PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G15">3G15</a>) as search models. The structures were refined with CNX combined with model building in Quanta (Accelrys Inc.). The inhibitor molecules were built into the density after several cycles of refinement and model building. Refinement parameters are given in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S6</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Enzyme Assay</h3><div class="NLM_p last">Enzyme inhibition measurements to obtain IC<sub>50</sub> values were made using a coupled ATP regeneration assay<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> with LDH/PK (5U/4U), choline chloride (200 μM), ATP (200 μM), PEP (500 μM), and NADH (250 μM) in MOPS buffer (100 mM MOPS, pH = 7.0, 150 mM NaCl, 10 mM MgCl<sub>2</sub>, 0.1% Triton X-100). The reaction was initiated by adding between 10 and 50 nM human ChoKα1 (monomeric concentration). Absorbance of NADH at 340 nm was measured over 10–30 min using a SpectraMax M5 (Molecular Devices). Initial reaction velocity (Δ<i>A</i><sub>340</sub>/Δ<i>t</i>) was calculated and plotted as a function of inhibitor concentration in a 2-fold dilution series. IC<sub>50</sub> values were obtained by fitting the relative velocities to a dose–response model.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> NMR Fragment Screening and Competition Experiments</h3><div class="NLM_p">NMR fragment screening experiments were performed at a temperature of 300 K on a Bruker Avance DRX 600 MHz spectrometer (Bruker Biospin Corp.), equipped with a <i>z</i>-gradient 1.0 mm TXI microprobe and a Bruker SampleJet autosampler. STD NMR experiments were recorded with 2 s saturation time, applying 50 ms Gaussian shaped pulses with a nominal flip angle of 720°. The frequency of the on-resonance irradiation was set to 0.8 ppm, and the off-resonance pulse was at 30 ppm. The residual water signal was suppressed using excitation sculpting. For the primary screen, ChoKα1 (homodimeric form, 94 kDa) was dissolved at 30 μM monomer concentration in D<sub>2</sub>O based buffer containing 50 mM d-MOPS, 100 mM NaCl, pH 7.4, and 0.33 mM TSP as chemical shift reference. After addition of fragments from concentrated DMSO-<i>d</i><sub>6</sub> stock solution in pools of five compounds at a final concentration of ∼3 mM per compound, about 10 μL of solution was transferred to 1.0 mm NMR tubes using a Gilson liquid handler. Samples contained up to 7% DMSO-<i>d</i><sub>6</sub> and were kept at room temperature until measured. Data sets shown are the average of 320 scans. All data processing was performed using the Bruker TopSpin 2.0 software.</div><div class="NLM_p last"><sup>19</sup>F-detected NMR competition experiments (FAXS<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>) were conducted on a 600 MHz Bruker Avance-III instrument using a 5 mm BBFO probe. The NMR samples (3 mm tubes, 170 μL) contained 10 μM ChoKα1 in D<sub>2</sub>O based buffer (50 mM d-MOPS, 100 mM NaCl, pH 7.4), with each 50 μM of reporter molecules <b>9</b> (Sigma-Aldrich) and <b>10</b> (SynQuest Laboratories). Compounds were added at 1 mM final concentration from DMSO-<i>d</i><sub>6</sub> stock. <i>T</i><sub>2</sub> relaxation weighted spectra were acquired using a CPMG pulse sequence with 20 ms echo delay and a total spin lock time of 160–200 ms to eliminate <i>J</i>-couplings and suppress <sup>19</sup>F background signals. The transmitter frequency was placed close to the resonances of <b>9</b> (−52 ppm) or <b>10</b> (−193 ppm). Proton decoupling was applied only during acquisition. For each sample, 800 scans were acquired with 2 s relaxation delay. After magnitude Fourier transformation, the intensities of the <b>9</b> and <b>10</b><sup>19</sup>F signals were analyzed by integration. In addition, a 1D proton reference spectrum with water suppression was acquired for every sample to ensure compound integrity, concentration, and proper shimming of the NMR magnet.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Surface Plasmon Resonance Assay</h3><div class="NLM_p last">Protein–ligand affinity (<i>K</i><sub>d</sub>) and kinetic rates were measured by surface plasmon resonance technology using either Biacore T100 (GE Healthcare) or SensiQ Pioneer (SensiQ Technologies) system. ChoKα1 protein was immobilized by standard amine coupling methods on a CM5 sensor chip (Biacore) or a COOH5 sensor chip installed in a SensiQ Pioneer system. ChoKα1 was diluted into 10 mM sodium acetate buffer (pH 4.0) with 10 mM MgCl<sub>2</sub> and 1 mM ADP for the coupling step. As the reference protein, carbonic anhydrase II at a similar density was used. Surfaces were blocked with a 1:1 mixture of 1 M ethanolamine in the running buffer. Sensograms were measured using either the single step kinetics (Biacore) or FastStep screen method (SensiQ). Fragment hits were tested at 300 μM as the highest concentration in a 2-fold dilution series. The running buffer contained 100 mM Tris (pH 7.5), 100 mM NaCl, 10 mM MgCl<sub>2</sub>, 0.05% Tween-20, and 5% DMSO. All data were collected at 25 °C. Kinetics and affinity were obtained from fits to a 1:1 binding model.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Molecular Modeling</h3><div class="NLM_p last">The X-ray crystal structure of ChoKα reported here was used in modeling studies. To explore the binding cavity, SiteMap<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> was applied to the crystal structure with default settings; cofactor and substrate were used to define binding site regions. An initial minimization and a molecular dynamics simulation were run for 9 ns on a solvated protein system in the absence of the ligand. The preparation of the protein for docking was performed with PrepWizard using the standard protocol, including the addition of hydrogens, and the assignment of bond order and protonation states. The hydrogen bonding network of the protein was optimized. Docking experiments were performed using Glide XP.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The fragments and ligands were treated with LigPrep<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> to obtain 3D structures, and protonation states were assigned using Epik. MM-GB/SA in Prime<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> was performed on top scoring ligand poses, with default settings. Commercially available reagents were utilized to create virtual compounds according to a chemical synthesis scheme, and then compounds were docked and scored with Glide XP. Compounds with undesirable physicochemical properties were removed.</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cellular Assays. Cell Lines</h3><div class="NLM_p last">Cell lines MDA-MB-468, MDA-MB-415, MCF12A, and MCF10A were obtained from American Type Culture Collection (Manassus, VA) and were used within 6 months without further cell line authentication. Cells were maintained and cultured using medium recommended by the supplier.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cell Growth Assay</h3><div class="NLM_p last">Vehicle or compound treated cells were assessed for cell growth after 72 h of treatment using the CyQuant cell proliferation kit (Promega). To differentiate between a cytostatic and cytotoxic drug effect, the concentration that causes 50% growth inhibition (GI<sub>50</sub>) was determined by correcting for the cell count at time zero (time of treatment) and plotting data as percent growth relative to vehicle-treated cells. Data are shown as mean (±SD) from ≥2 separate experiments.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Apoptosis Assay</h3><div class="NLM_p last">Cells were treated with compounds for 24 h, then assessed for caspase activity using the Apo-ONE homogeneous caspase-3/7 assay (Promega). A representative experiment is shown with apoptosis plotted as a percentage relative to vehicle-treated cells.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> NMR Detected pCho Assay</h3><div class="NLM_p last">5 ×10<sup>6</sup> cells of each line were grown in the presence of increasing concentrations of the test compound or vehicle (DMSO) for 24 h, then were counted and assessed for viability using Trypan blue exclusion protocol. 5 ×10<sup>6</sup> viable cells were washed twice in ice cold d-PBS, then solubilized by vortexing for 30 s in 6 mL of ice-cold 100% methanol. 6 mL of chloroform and 6 mL of water were added, and the mixture was vortexed again. After centrifugation for 10 min at 5220 rpms, 10 mL of the aqueous phase was removed and lyophilized. The samples were redissolved in 50 μL of D<sub>2</sub>O, transferred into 1.7 mm NMR tubes, and analyzed by <sup>1</sup>H NMR to determine phosphocholine levels. NMR measurements were performed at 600 MHz on a Bruker Avance III spectrometer equipped with a 1.7 mm PATXI probe using presaturation as water suppression and composite pulses for excitation (zgcppr). The relative spectral intensity was adjusted to match metabolites unrelated to choline metabolism, such as lactate.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p last">Commercially available chemicals and solvents were purchased and used without further purification. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance-III 400 spectrometer. Chemical shifts (δ) are reported relative to CDCl<sub>3</sub> at 7.26 ppm or DMSO-<i>d</i><sub>6</sub> at 2.50 ppm as an internal standard. MS spectra were recorded on a Waters Micromass ZQ spectrometer. HPLC was performed on an Agilent 1100 HPLC system. All tested compounds were purified to >95% purity as determined by <sup>1</sup>H NMR and HPLC (C-18 column, MeCN/H<sub>2</sub>O with 0.1% TFA as the mobile phase).</div></div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure 1 for Reductive Amination</h3><div class="NLM_p last">A mixture of aldehyde (1.0 mmol) and amine (1.0 mmol) in DCM (3.0 mL) was treated overnight with sodium triacetoxyborohydride (2.0 mmol) and molecular sieves (0.3 g) at room temperature. The mixture was diluted with aqueous NaHCO<sub>3</sub> and extracted with DCM. Solvent was evaporated and the residue was purified by TLC plate (DCM/MeOH = 100/(5–10)) or preparative HPLC to give products.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure 2 for Suzuki Coupling</h3><div class="NLM_p">A mixture of aryl bromide (0.50 mmol) and boronic acid or boronic ester (0.50 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (50 mg), K<sub>2</sub>CO<sub>3</sub> (1.0 mmol) in dioxane (1.5 mL) and water (0.8 mL) was degassed and heated to reflux in sealed tube for 5 min. The mixture was extracted with DCM, and product was purified by TLC plate (DCM/MeOH = 100/(10–20)) or by preparative HPLC.</div><div class="NLM_p">Compounds <b>1</b>–<b>3</b>, <b>7</b>–<b>36</b>, <b>72</b>–<b>75</b>, <b>77</b>–<b>79</b>, <b>81</b>, and <b>83</b> were obtained from commercial vendors and used without further purification. The following compounds were synthesized in a parallel fashion (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">Table S5</a>) by utilizing general procedure 1.</div><div class="NLM_p"><b>37</b>: 7-((4-methyl-1,4-diazepan-1-yl)methyl)quinolone, C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>, yellow oil, yield 63%. LCMS <i>m</i>/<i>z</i> 256 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.88 (dd, <i>J</i> = 1.76, 4.27 Hz, 1H), 8.13 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 8.07 (d, <i>J</i> = 8.7 Hz, 1H), 7.78 (dd, <i>J</i> = 2.0, 8.8 Hz, 1H), 7.73 (s, 1H), 7.40 (dd, <i>J</i> = 4.27, 8.28 Hz, 1H), 3.82 (s, 2H), 2.74–2.84 (m, 4H), 2.70 (t, <i>J</i> = 5.6 Hz, 2H), 2.62–2.65 (m, 2H), 2.38 (s, 3H), 1.81–1.8 (m, 2H).</div><div class="NLM_p"><b>38</b>: 1-methyl-4-(naphthalen-2-ylmethyl)-1,4-diazepane, C<sub>17</sub>H<sub>22</sub>N<sub>2</sub>, yellow oil, yield 82%. LCMS <i>m</i>/<i>z</i> 255 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.81–7.85 (m, 3H), 7.76 (s, 1H), 7.55 (dd, <i>J</i> = 1.6, 8.2 Hz, 1H), 7.44–7.51 (m, 2H), 3.82 (s, 2H), 2.77–2.82 (m, 4H), 2.73 (t, <i>J</i> = 5.6 Hz, 2H), 2.65–2.68 (m, 2H), 2.41 (s, 1H), 1.83–1.90 (m, 1H).</div><div class="NLM_p"><b>39</b>: 6-((4-methyl-1,4-diazepan-1-yl)methyl)isoquinoline, C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>, yellow oil, yield 49%. LCMS <i>m</i>/<i>z</i> 256 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.24 (s, 1H), 8.52 (d, <i>J</i> = 5.8 Hz, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 7.76 (s, 1H), 7.69 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 7.63 (d, <i>J</i> = 5.7 Hz, 1H), 3.84 (s, 2H), 2.76–2.81 (m, 4H), 2.72 (t, <i>J</i> = 5.6 Hz, 2H), 2.63–2.67 (m, 2H), 2.40 (s, 3H), 1.82–1.90 (m, 2H).</div><div class="NLM_p"><b>40</b>: 7-((4-methyl-1,4-diazepan-1-yl)methyl)isoquinoline, C<sub>16</sub>H<sub>21</sub>N<sub>3</sub>, yellow oil, yield 57%. LCMS <i>m</i>/<i>z</i> 256 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 9.24 (s, 1H), 8.52 (d, <i>J</i> = 5.7 Hz, 1H), 7.89 (s, 1H), 7.76–7.82 (m, 2H), 7.64 (td, <i>J</i> = 0.8, 5.7 Hz, 1H), 3.84 (s, 2H), 2.76–2.81 (m, 4H), 2.73 (t, <i>J</i> = 5.6 Hz, 2H), 2.64–2.68 (m, 2H), 2.40 (s, 3H), 1.83–1.90 (m, 2H).</div><div class="NLM_p"><b>41</b>: 1-methyl-6-((4-methyl-1,4-diazepan-1-yl)methyl)-1H-indazole, C<sub>15</sub>H<sub>22</sub>N<sub>4</sub>, yellow oil, yield 54%. LCMS <i>m</i>/<i>z</i> 259 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.95 (d, <i>J</i> = 0.8 Hz, 1H), 7.66 (dd, <i>J</i> = 0.8, 8.4 Hz, 1H), 7.39 (d, <i>J</i> = 0.8 Hz, 1H), 7.28 (s, 1H), 7.18 (dd, <i>J</i> = 1.2, 8.0 Hz, 1H), 4.09 (s, 3H), 3.80 (s, 2H), 2.75–2.81 (m, 4H), 2.71 (t, <i>J</i> = 5.6 Hz, 2H), 2.63–2.67 (m, 2H), 2.40 (s, 3H), 1.82–1.90 (m, 2H).</div><div class="NLM_p"><b>42</b>: 6-((4-methyl-1,4-diazepan-1-yl)methyl)quinoxaline, C<sub>15</sub>H<sub>20</sub>N<sub>4</sub>, yellow oil, yield 69%. LCMS <i>m</i>/<i>z</i> 257 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.84 (d, <i>J</i> = 6.4 Hz, 1H), 8.82 (d, <i>J</i> = 6.4 Hz, 1H), 8.08 (d, <i>J</i> = 8.8 Hz, 1H), 8.03 (s, 1H), 7.88 (dd, <i>J</i> = 1.6, 8.8 Hz, 1H), 3.90 (s, 2H), 2.77–2.83 (m, 4H), 2.71 (t, <i>J</i> = 5.6 Hz, 2H), 2.64–2.67 (m, 2H), 2.40 (s, 3H), 1.83–1.90 (m, 2H).</div><div class="NLM_p"><b>43</b>: 1-([1,1′-biphenyl]-4-ylmethyl)-4-methyl-1,4-diazepane, C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>, yellow oil, yield 57%. LCMS <i>m</i>/<i>z</i> 281 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.60–7.65 (m, 2H), 7.54–7.59 (m, 2H), 7.42–7.48 (m, 4H), 7.35 (tt, <i>J</i> = 1.6, 7.2 Hz, 1H), 3.71 (s, 2H), 2.75–2.81 (m, 4H), 2.70–2.74 (m, 2H), 2.65–2.69 (m, 2H), 2.41 (s, 3H), 1.83–1.90 (m, 2H).</div><div class="NLM_p"><b>44</b>: 1-methyl-4-((4′-(4-methylpiperazin-1-yl)-[1,1′-biphenyl]-4-yl)methyl)-1,4-diazepane, C<sub>24</sub>H<sub>34</sub>N<sub>4</sub>. Precursor hexahydro-1-methyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-1<i>H</i>-1,4-diazepine, C<sub>19</sub>H<sub>31</sub>BN<sub>2</sub>O<sub>2</sub> (<b>76</b>): To a solution of <b>72a</b> (5.0 g, 43.8 mmol) in DCM (30 mL) <b>75</b> (6.0 g, 20.2 mmol) was added at room temperature. The mixture was stirred for 6 h and purified by chromatography on silica gel (DCM/MeOH = 100:12) to give white solid <b>76</b> (4.5 g, 67%). Compound <b>44</b> was synthesized by utilizing general procedure 2 from <b>76</b> and <b>77</b> as yellow solid (yield 20 mg, 11%). LCMS <i>m</i>/<i>z</i> 379 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.50–7.56 (m, 4H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 6.99–7.04 (m, 2H), 3.68 (s, 2H), 3.27–3.32 (m, 4H), 2.74–2.80 (m, 4H), 2.69–2.73 (m, 2H), 2.65–2.68 (m, 2H), 2.60–2.64 (m, 4H), 2.40 (s, 3H), 2.39 (s, 3H), 1.86 (q, <i>J</i> = 6.0 Hz, 2H).</div><div class="NLM_p"><b>45</b>: methyl 4′-((4-methyl-1,4-diazepan-1-yl)methyl)-[1,1′-biphenyl]-4-carboxylate, C<sub>21</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>. A mixture of <b>72a</b> (2.6 mL, 24.8 mmol) and <b>74</b> (5.0 g, 20.8 mmol) in DCM (150 mL) was added over molecular sieves (4 Å, 10 g). The mixture was stirred at room temperature for 1 h, and NaHB(OAc)<sub>3</sub> (8.5 g, 40.0 mmol) was introduced. The mixture was stirred for an additional 5 h. After aqueous workup, the product was purified by flash column to give a yellow oil (yield 4.5 g, 64%). LCMS <i>m</i>/<i>z</i> 339 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.13 (td, <i>J</i> = 2.0, 12.8 Hz, 2H), 7.69 (td, <i>J</i> = 2.0, 8.4 Hz, 2H), 7.62 (br, s, 1H), 7.53 (td, <i>J</i> = 2.0, 7.6 Hz, 1H), 7.37–7.45 (m, 2H), 3.97 (s, 3H), 3.75 (s, 2H), 2.70–2.91 (m, 8H), 2.48 (s, 3H), 1.90–1.98 (m, 2H).</div><div class="NLM_p"><b>46</b>: 1-((4′-methoxy-[1,1′-biphenyl]-4-yl)methyl)-4-methyl-1,4-diazepane, C<sub>20</sub>H<sub>26</sub>N<sub>2</sub>O, yellow oil, yield 27%. LCMS <i>m</i>/<i>z</i> 311 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.51–7.57 (m, 4H), 7.40 (d, <i>J</i> = 8.28 Hz, 2H), 6.97 (dd, <i>J</i> = 2.0, 8.8 Hz, 2H), 3.87 (s, 3H), 3.69 (s, 2H), 2.67–2.81 (m, 8H), 2.42 (s, 3H), 1.84–1.91 (m, 2H).</div><div class="NLM_p"><b>47</b>: 1-methyl-4-((4′-(trifluoromethyl)-[1,1′-biphenyl]-4-yl)methyl)-1,4-diazepane, C<sub>20</sub>H<sub>23</sub>F<sub>3</sub>N<sub>2</sub>, yellow oil, yield 32%. LCMS <i>m</i>/<i>z</i> 349 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.71 (s, 4H), 7.53–7.60 (m, 2H), 7.47 (d, <i>J</i> = 8.4 Hz, 2H), 3.72 (s, 2H), 2.75--2.80 (m, 4H), 2.73 (t, <i>J</i> = 6.0 Hz, 2H), 2.66–2.69 (m, 2H), 2.42 (s, 3H), 1.88 (quin, <i>J</i> = 6.0 Hz, 2H).</div><div class="NLM_p"><b>48</b>: (4-methyl-1,4-diazepan-1-yl)(4′-((4-methyl-1,4-diazepan-1-yl)methyl)-[1,1′-biphenyl]-4-yl)methanone, C<sub>26</sub>H<sub>36</sub>N<sub>4</sub>O. To a mixture of <b>45</b> (30 mg, 0.086 mmol) and <b>72a</b> (0.016 mL, 0.13 mmol) in 1,2-dichloroethane (1.5 mL) Me<sub>3</sub>Al (0.1 mL, 2.0 M solution in toluene) was slowly added. The mixture was stirred at room temperature for 20 min and then heated to reflux for 5 min. The mixture was poured onto wet NaHCO<sub>3</sub> and extracted with DCM. Solvent was removed and the residue was purified by preparative TLC plate (DCM/MeOH = 100:15) to give yellow oil (22 mg, 61%). LCMS <i>m</i>/<i>z</i> 421 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.61–7.67 (m, 2H), 7.54–7.58 (m, 2H), 7.42–7.50 (m, 4H), 3.80–3.89 (m, 2H), 3.70 (s, 2H), 3.60 (m, 1H), 3.54 (t, <i>J</i> = 6.0 Hz, 1H), 2.57–2.81 (m, 12H), 2.37–2.45 (m, 6H), 2.04 (m, 1H), 1.82–1.92 (m, 3H).</div><div class="NLM_p"><b>49</b>: 4,4′-bis((4-methyl-1,4-diazepan-1-yl)methyl)-1,1′-biphenyl, C<sub>26</sub>H<sub>38</sub>N<sub>4</sub>. To a solution of <b>48</b> (50 mg, 0.12 mmol) in dioxane (3.0 mL) LAH (20 mg, 0.53 mmol) was added at room temperature. The mixture was heated to reflux and then cooled to room temperature. The mixture was poured onto ice and extracted with DCM. Solvent was removed and the residue was purified by preparative TLC plate (DCM/MeOH = 100:15) to give a colorless oil (35 mg, 72%). LCMS <i>m</i>/<i>z</i> 407 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.56 (d, <i>J</i> = 8.2 Hz, 4H), 7.41 (d, <i>J</i> = 8.2 Hz, 4H), 3.65–3.76 (m, 4H), 2.74–2.80 (m, 8H), 2.71 (t, <i>J</i> = 6.0 Hz, 4H), 2.64–2.68 (m, 4H), 2.40 (s, 6H), 1.86 (quin, <i>J</i> = 6.0 Hz, 4H).</div><div class="NLM_p"><b>50</b>: 1-allyl-4-(naphthalen-2-ylmethyl)-1,4-diazepane, C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>, yellow oil, yield 39%. LCMS <i>m</i>/<i>z</i> 281 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.90 (m, 3H), 7.77 (s, 1H), 7.56 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.43–7.52 (m, 2H), 5.92 (tdd, <i>J</i> = 6.4, 10.0, 16.8 Hz, 1H), 5.12–5.23 (m, 2H), 3.83 (s, 2H), 3.17 (td, <i>J</i> = 1.2, 6.4 Hz, 2H), 2.70–2.82 (m, 8H), 1.82–1.89 (m, 2H).</div><div class="NLM_p"><b>51</b>: <i>N</i>,<i>N</i>-dimethyl-2-(4-(naphthalen-2-ylmethyl)-1,4-diazepan-1-yl)ethan-1-amine, C<sub>20</sub>H<sub>29</sub>N<sub>3</sub>, yellow oil, yield 28%. LCMS <i>m</i>/<i>z</i> 312 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.88 (m, 3H), 7.75 (s, 1H), 7.55 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.43–7.49 (m, 2H), 3.81 (s, 2H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.72–2.79 (m, 6H), 2.65–2.70 (m, 2H), 2.43 (dd, <i>J</i> = 6.8, 8.8 Hz, 2H), 2.27 (s, 6H), 1.79–1.83 (m, 2H).</div><div class="NLM_p"><b>52</b>: 1,1-dimethyl-4-(naphthalen-2-ylmethyl)-1,4-diazepan-1-ium iodide, C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>. A mixture of <b>38</b> (255 mg, 1.0 mmol) and iodomethane (1.0 mmol) in DCM (2.0 mL) was stirred at room temperature for 2 h. The product was purified by preparative TLC plate (DCM/MeOH = 100:15) to give a yellow solid (71 mg, yield 18%). LCMS <i>m</i>/<i>z</i> 269 [M<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.87 (m, 3H), 7.73 (s, 1H), 7.45–7.52 (m, 2H), 3.87 (t, <i>J</i> = 5.2 Hz, 2H), 3.85 (s, 2H), 3.77 (t, <i>J</i> = 4.8 Hz, 2H), 3.51 (s, 6H), 3.01 (br, 3H), 2.88 (t, <i>J</i> = 5.6 Hz, 2H), 2.09 (br, 2H).</div><div class="NLM_p"><b>53</b>: 4-(2-(dimethylamino)ethyl)-1-(naphthalen-2-ylmethyl)-1,4-diazepan-5-one, C<sub>20</sub>H<sub>27</sub>N<sub>3</sub>O, yellow oil, yield 31%. LCMS <i>m</i>/<i>z</i> 326 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.88 (m, 3H), 7.74 (s, 1H), 7.45–7.54 (m, 3H), 3.75 (s, 2H), 3.45–3.56 (m, 4H), 2.63–2.75 (m, 6H), 2.45 (t, <i>J</i> = 7.0 Hz, 2H), 2.29 (s, 6H).</div><div class="NLM_p"><b>54</b>: 4-(naphthalen-2-ylmethyl)-1,4-diazepane-1-carboxamide, C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>O, white solid, yield 26%. LCMS <i>m</i>/<i>z</i> 284 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.88 (m, 3H), 7.76 (s, 1H), 7.44–7.56 (m, 3H), 4.41 (s, 2H), 3.83 (s, 2H), 3.43–3.59 (m, 4H), 2.67–2.80 (m, 4H), 1.93 (quin, <i>J</i> = 6.0 Hz, 2H).</div><div class="NLM_p"><b>55</b>: 2-(4-(naphthalen-2-ylmethyl)-1,4-diazepan-1-yl)ethan-1-ol, C<sub>18</sub>H<sub>24</sub>N<sub>2</sub>O, yellow oil, yield 51%. LCMS <i>m</i>/<i>z</i> 285 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.81–7.88 (m, 3H), 7.75 (s, 1H), 7.55 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.44–7.51 (m, 2H), 3.82 (s, 2H), 3.58 (t, <i>J</i> = 5.6 Hz, 2H), 2.84 (t, <i>J</i> = 6.0 Hz, 2H), 2.70–2.80 (m, 9H), 1.81–1.89 (m, 2H).</div><div class="NLM_p"><b>56</b>: 2,4-dimethyl-1-(naphthalen-2-ylmethyl)-1,4-diazepane, C<sub>18</sub>H<sub>24</sub>N<sub>2</sub>, yellow oil, yield 23%. LCMS <i>m</i>/<i>z</i> 269 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79–7.86 (m, 3H), 7.78 (s, 1H), 7.56 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.43–7.50 (m, 2H), 3.96 (d, <i>J</i> = 13.9 Hz, 1H), 3.85 (d, <i>J</i> = 13.9 Hz, 1H), 3.08 (ddd, <i>J</i> = 3.8, 6.5, 7.8 Hz, 1H), 2.88 (ddd, <i>J</i> = 3.2, 8.0, 14.4 Hz, 1H), 2.71–2.78 (m, 2H), 2.68 (dd, <i>J</i> = 3.6, 13.6 Hz, 1H), 2.48–2.60 (m, 2H), 2.45 (s, 3H), 1.79–1.89 (m, 1H), 1.61–1.71 (m, 1H), 1.17 (d, <i>J</i> = 6.53 Hz, 3H)</div><div class="NLM_p"><b>57</b>: (1<i>S</i>,6<i>R</i>)-3-methyl-9-(naphthalen-2-ylmethyl)-3,9-diazabicyclo[4.2.1]nonane, C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>, yellow oil, yield 35%. LCMS <i>m</i>/<i>z</i> 281 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.82–7.87 (m, 3H), 7.81 (s, 1H), 7.64 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 7.43–7.51 (m, 2H), 3.93 (d, <i>J</i> = 14.0 Hz, 1H), 3.91 (d, <i>J</i> = 14.0 Hz, 1H), 3.37 (t, <i>J</i> = 8.0 Hz, 1H), 3.21–3.27 (m, 1H), 2.69 (ddd, <i>J</i> = 6.0, 8.0, 10.4 Hz, 1H), 2.55–2.63 (m, 1H), 2.47 (ddd, <i>J</i> = 1.6, 2.4, 11.6 Hz, 1H), 2.39 (dd, <i>J</i> = 2.4, 11.6 Hz, 1H), 2.36 (s, 3H), 2.20–2.30 (m, 1H), 2.06–2.16 (m, 1H), 1.89–1.97 (m, 1H), 1.67–1.80 (m, 2H), 1.44–1.54 (m, 1H).</div><div class="NLM_p"><b>58</b>: 1-(<i>tert</i>-butyl)-4-(naphthalen-2-ylmethyl)-1,4-diazepane, C<sub>20</sub>H<sub>28</sub>N<sub>2</sub>, yellow oil, yield 45%. LCMS <i>m</i>/<i>z</i> 297 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.88 (m, 3H), 7.77 (s, 1H), 7.55 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.43–7.51 (m, 2H), 3.83 (s, 2H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.74–2.78 (m, 4H), 2.69–2.72 (m, 2H), 1.81 (q, <i>J</i> = 6.0 Hz, 2H), 1.10 (s, 9H).</div><div class="NLM_p"><b>59</b>: (<i>S</i>)-2-(naphthalen-2-ylmethyl)octahydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>][1,4]diazepine, C<sub>19</sub>H<sub>24</sub>N<sub>2</sub>, yellow oil, yield 66%. LCMS <i>m</i>/<i>z</i> 281 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80–7.88 (m, 3H), 7.77 (s, 1H), 7.55 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.43–7.51 (m, 2H), 3.83 (s, 2H), 3.02–3.13 (m, 2H), 2.86–2.96 (m, 2H), 2.77–2.81 (m, 2H), 2.39–2.58 (m, 3H), 1.79–1.95 (m, 4H), 1.69–1.74 (m, 1H), 1.36–1.42 (m, 1H).</div><div class="NLM_p"><b>60</b>: cyclopropyl(4-(naphthalen-2-ylmethyl)-1,4-diazepan-1-yl)methanone, C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O, yellow oil, yield 53%. LCMS <i>m</i>/<i>z</i> 309 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79–7.89 (m, 3H), 7.76 (br s, 1H), 7.55 (ddd, <i>J</i> = 1.2, 4.0, 8.0 Hz), 7.45–7.52 (m, 2H), 3.66–3.84 (m, 6H), 2.82 (t, <i>J</i> = 5.2 Hz, 1H), 2.76 (t, <i>J</i> = 5.2 Hz, 1H), 2.72 (t, <i>J</i> = 5.6 Hz, 2H), 1.86–1.92 (m, 2H), 1.62–1.81 (m, 2H), 1.01–1.06 (m, 2H), 0.74–0.81 (m, 2H).</div><div class="NLM_p"><b>61</b>: (3<i>R</i>,4<i>S</i>)-4-(4-(naphthalen-2-ylmethyl)-1,4-diazepan-1-yl)tetrahydrofuran-3-ol, C<sub>20</sub>H<sub>26</sub>N<sub>2</sub>O<sub>2</sub>, green oil, yield 61%. LCMS <i>m</i>/<i>z</i> 327 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79–7.89 (m, 3H), 7.75 (s, 1H), 7.54 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 7.44–7.52 (m, 2H), 4.36 (td, <i>J</i> = 4.05, 5.83 Hz, 1H), 4.06 (dd, <i>J</i> = 7.2, 9.2 Hz, 1H), 4.01 (dd, <i>J</i> = 6.0, 10.0 Hz, 1H), 3.84 (d, <i>J</i> = 13.2 Hz, 1H), 3.81 (d, <i>J</i> = 13.2 Hz, 1H), 3.71 (dd, <i>J</i> = 4.0, 9.6 Hz, 1H), 3.64 (dd, <i>J</i> = 6.8, 9.2 Hz, 1H), 3.20 (dt, <i>J</i> = 3.89, 7.03 Hz, 1H), 2.73–2.91 (m, 8H), 2.50 (br, 1H), 1.77–1.90 (m, 2H)</div><div class="NLM_p"><b>62</b>: 1-(4-chlorobenzyl)-4-(naphthalen-2-ylmethyl)-1,4-diazepane, C<sub>23</sub>H<sub>25</sub>ClN<sub>2</sub>, yellow oil, yield 74%. LCMS <i>m</i>/<i>z</i> 365 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79–7.88 (m, 3H), 7.76 (s, 1H), 7.56 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 7.41–7.51 (m, 2H), 7.27–7.32 (m, 4H), 3.84 (s, 2H), 3.64 (s, 2H), 2.81 (t, <i>J</i> = 6.0 Hz, 2H), 2.73–2.78 (m, 4H), 2.60–2.71 (m, 2H), 1.84 (quin, <i>J</i> = 5.9 Hz, 2H).</div><div class="NLM_p"><b>63</b>: <i>N</i>-methyl-2-(4-(naphthalen-2-ylmethyl)-1,4-diazepan-1-yl)acetamide, C<sub>19</sub>H<sub>25</sub>N<sub>3</sub>O, green oil, yield 72%. LCMS <i>m</i>/<i>z</i> 312 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.78–7.89 (m, 3H), 7.75 (s, 1H), 7.55 (dd, <i>J</i> = 1.2, 8.4 Hz, 1H), 7.44–7.52 (m, 2H), 7.29 (br, 1H), 3.83 (s, 2H), 3.18 (s, 2H), 2.87 (d, <i>J</i> = 4.8 Hz, 3H), 2.83 (t, <i>J</i> = 6.0 Hz, 2H), 2.71–2.80 (m, 6H), 1.83 (quin, <i>J</i> = 5.9 Hz, 2H).</div><div class="NLM_p"><b>64</b>: 4-(naphthalen-2-ylmethyl)-1,4-diazepane-1-carbaldehyde, C<sub>17</sub>H<sub>20</sub>N<sub>2</sub>O, yellow oil, yield 41%. LCMS <i>m</i>/<i>z</i> 269 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.13 (d, <i>J</i> = 10.9 Hz, 1H), 7.80–7.87 (m, 3H), 7.74 (br s, 1H), 7.53 (td, <i>J</i> = 2.0, 8.4 Hz, 1H), 7.45–7.51 (m, 2H), 3.82 (d, <i>J</i> = 8.4 Hz, 2H), 3.57–3.62 (m, 2H), 3.46–3.53 (m, 2H), 2.78–2.82 (m, 1H), 2.67–2.76 (m, 3H), 1.87–1.98 (m, 2H).</div><div class="NLM_p"><b>65</b>: 4,4′-bis((4-methyl-1,4-diazepan-1-yl)methyl)-[1,1′-biphenyl]-2-carbonitrile, C<sub>27</sub>H<sub>37</sub>N<sub>5</sub>. To a solution of <b>72a</b> (5.5 mL, 44.2 mmol) in DCM (50 mL) <b>81</b> (5.5 g, 20.0 mmol) was added portionwise. The mixture was stirred at room temperature for 15 min and then treated with K<sub>2</sub>CO<sub>3</sub> (15 g) and water (10 mL). The organic phase was evaporated and the residue was purified on a column (DCM/MeOH = 100:20) to give <b>82</b> (C<sub>14</sub>H<sub>18</sub>BrN<sub>3</sub>) as yellow oil (4.3 g, 70%). Suzuki coupling of <b>82</b> with <b>79</b> by utilizing general procedure 2 gave <b>65</b> as yellow oil, yield 59%. LCMS <i>m</i>/<i>z</i> 432 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.77 (d, <i>J</i> = 1.6 Hz, 1H), 7.63 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.40–7.58 (m, 5H), 3.69–3.77 (m, 4H), 2.65–2.81 (m, 16H), 2.42 (s, 3H), 2.41 (s, 3H), 1.83–1.92 (m, 4H).</div><div class="NLM_p"><b>66</b>, <b>68</b>–<b>70</b> were synthesized in a parallel fashion. Suzuki coupling of <b>79</b> with boronic acids <b>78a</b>–<b>d</b> by utilizing general procedure 2 gave the corresponding intermediates <b>80a</b>–<b>d</b> followed by reductive amination with <b>72a</b> by utilizing general procedure 1.</div><div class="NLM_p"><b>66</b>: 4,4′-((2,3-difluoro-[1,1′-biphenyl]-4,4′-diyl)bis(methylene))bis(1-methyl-1,4-diazepane), C<sub>26</sub>H<sub>36</sub>F<sub>2</sub>N<sub>4</sub>, yellow oil, yield 12% for two steps. LCMS <i>m</i>/<i>z</i> 443 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.49–7.57 (m, 2H), 7.43–7.46 (m, 2H), 7.23–7.27 (m, 1H), 7.15–7.20 (m, 1H), 3.78 (s, 2H), 3.71 (s, 2H), 2.65–2.84 (m, 16H), 2.41 (s, 3H), 2.40 (s, 3H), 1.87(quin, <i>J</i> = 6.0 Hz, 4H).</div><div class="NLM_p"><b>67</b>: 2′-fluoro-4,4′-bis((4-methyl-1,4-diazepan-1-yl)methyl)-[1,1′-biphenyl]-2-carbonitrile, C<sub>27</sub>H<sub>36</sub>FN<sub>5</sub>. Suzuki coupling of <b>82</b> with <b>83</b> utilizing general procedure 2 gave 2′-fluoro-4′-formyl-4-((4-methyl-1,4-diazepan-1-yl)methyl)-[1,1′-biphenyl]-2-carbonitrile, C<sub>21</sub>H<sub>22</sub>FN<sub>3</sub>O (<b>84</b>) which was used in next step without fully characterization. Reductive amination of <b>84</b> with <b>72a</b> (general procedure 1) gave <b>67</b> as brown oil. Yield 25 mg, 34% for two steps. LCMS <i>m</i>/<i>z</i> 450 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79 (d, <i>J</i> = 1.2 Hz, 1H), 7.64 (dd, <i>J</i> = 1.6, 8.0 Hz, 1H), 7.46 (dd, <i>J</i> = 0.8, 8.0 Hz, 1H), 7.37 (t, <i>J</i> = 7.6 Hz, 1H), 7.22–7.28 (m, 2H), 3.72 (s, 2H), 3.71 (s, 2H), 3.54 (s, 1H), 2.65–2.81 (m, 16H), 2.42 (s, 3H), 2.41 (s, 3H), 2.37–2.45 (m, 6H), 1.83–1.92 (m, 4H).</div><div class="NLM_p"><b>68</b>: 4,4′-((3-chloro-[1,1′-biphenyl]-4,4′-diyl)bis(methylene))bis(1-methyl-1,4-diazepane), C<sub>26</sub>H<sub>37</sub>ClN<sub>4</sub>, yellow oil, yield 12% for two steps. LCMS <i>m</i>/<i>z</i> 441 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.57–7.61 (m, 2H), 7.51–7.55 (m, 2H), 7.48 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.41–7.45 (m, 2H), 3.80 (s, 2H), 3.70 (s, 2H), 2.63–2.86 (m, 16H), 2.42 (s, 3H), 2.40 (s, 3H), 1.82–1.94 (m, 4H).</div><div class="NLM_p"><b>69:</b> 4,4′-((2-fluoro-[1,1′-biphenyl]-4,4′-diyl)bis(methylene))bis(1-methyl-1,4-diazepane), C<sub>26</sub>H<sub>37</sub>FN<sub>4</sub>, yellow oil, yield 14% for two steps. LCMS <i>m</i>/<i>z</i> 425 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.50–7.54 (m, 2H), 7.36–7.45 (m, 3H), 7.16–7.22 (m, 2H), 3.70 (s, 2H), 3.68 (s, 2H), 2.64–2.80 (m, 16H), 2.41 (s, 3H), 2.40 (s, 3H), 1.86 (quin, <i>J</i> = 6.0 Hz, 4H).</div><div class="NLM_p last"><b>70</b>: 4,4′-((3,5-difluoro-[1,1′-biphenyl]-4,4′-diyl)bis(methylene))bis(1-methyl-1,4-diazepane), C<sub>26</sub>H<sub>36</sub>F<sub>2</sub>N<sub>4</sub>, yellow oil, yield 15% for two steps. LCMS <i>m</i>/<i>z</i> 443 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.49–7.53 (m, 2H), 7.44 (d, <i>J</i> = 8.4 Hz, 2H), 7.10–7.16 (m, 2H), 3.85 (s, 2H), 3.70 (s, 2H), 2.83–2.89 (m, 4H), 2.64–2.79 (m, 12H), 2.40 (s, 3H), 2.38 (s, 3H), 2.01 (s, 1H), 1.80–1.89 (m, 2H).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01552">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01552" class="ext-link">10.1021/acs.jmedchem.5b01552</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional SAR tables, X-ray crystallography refinement data, structures of reference compounds, NMR spectra, and X-ray structures (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf">jm5b01552_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_002.csv">jm5b01552_si_002.csv (3.46 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The following X-ray crystal structures have been deposited in the RCSB Protein Data Bank: codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQE">5EQE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQP">5EQP</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQY">5EQY</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b01552" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephan G. Zech</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#792a0d1c0911181757231c1a1139180b10181d571a1614"><span class="__cf_email__" data-cfemail="df8cabbaafb7beb1f185babcb79fbeadb6bebbf1bcb0b2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Kohlmann</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tianjun Zhou</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Li</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel M. Squillace</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lois E. Parillon</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew T. Greenfield</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David P. Miller</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiwei Qi</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Mathew Thomas</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihan Wang</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongjin Xu</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan J. Miret</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William C. Shakespeare</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaotian Zhu</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Dalgarno</span> - <span class="hlFld-Affiliation affiliation">ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.G.Z., A.K., T.Z., and F.L. contributed equally to the work and manuscript preparation</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): This work was funded by ARIAD Pharmaceuticals, Inc. All authors are employees and equity holders of ARIAD or were at the time that this study was conducted.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2047e3373-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank D. Myszka (Biosensor Tools, LLC) and A. Vinitzky (Affinia Biotechnologies, Inc.) for SPR measurements, and S. Zhang and T. Padukkavidana for critical reading of the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> Abbreviations Used</h2><tr><td class="NLM_term">ChoK</td><td class="NLM_def"><p class="first last">choline kinase</p></td></tr><tr><td class="NLM_term">STD NMR</td><td class="NLM_def"><p class="first last">saturation transfer difference nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">FAXS</td><td class="NLM_def"><p class="first last">fluorine chemical shift anisotropy and exchange for screening</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">CA-II</td><td class="NLM_def"><p class="first last">carbonic anhydrase II</p></td></tr><tr><td class="NLM_term">pCho</td><td class="NLM_def"><p class="first last">phosphocholine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolfi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2959</span><span class="NLM_x">–</span> <span class="NLM_lpage">2968</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=8414498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK2cXmslGg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=2959-2968&author=A.+Cuadradoauthor=A.+Carneroauthor=F.+Dolfiauthor=B.+Jim%C3%A9nezauthor=J.+C.+Lacal&title=Phosphorylcholine%3A+a+novel+second+messenger+essential+for+mitogenic+activity+of+growth+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors</span></div><div class="casAuthors">Cuadrado, Antonio; Carnero, Amancio; Dolfi, Fabrizio; Jimenez, Benilde; Lacal, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2959-68</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">Growth factor stimulation of quiescent cells induces a series of intracellular early and late events that ultimately lead to DNA synthesis and cell division.  The authors describe here that prodn. of phosphorylcholine is an essential component of the late events involved in the induction of DNA synthesis by platelet-derived growth factor (PDGF-BB), a prototype mitogen for fibroblasts.  Moreover, phosphorylcholine itself is mitogenic when added exogenously to NIH3T3 cells, further indicating its role as a crucial intracellular messenger for DNA synthesis.  Choline kinase, the first step in the route of phosphatidylcholine synthesis appears to be the crit. regulatory enzyme in phosphorylcholine prodn., indicating that regulation of choline kinase represents a key step during mitogenic stimulation.  Several growth factors (PDGF-AA, basic FGF, EGF and phorbol esters) rely on their ability to generate phosphorylcholine for their proliferating activity.  In contrast, DNA synthesis induced by serum did not require phosphorylcholine.  Moreover, the requirement for phosphorylcholine prodn. in PDGF-stimulated cells can be over-ruled by addn. of insulin.  Thus, cell proliferation in NIH3T3 cells can be triggered by alternative pathways and one of them involves generation of phosphorylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraL2acf3VUTrVg90H21EOLACvtfcHk0lglczwDAI5tVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslGg&md5=110e358e64bcfaa1370e467daf4d6f3e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DDolfi%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DB.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DPhosphorylcholine%253A%2520a%2520novel%2520second%2520messenger%2520essential%2520for%2520mitogenic%2520activity%2520of%2520growth%2520factors%26jtitle%3DOncogene%26date%3D1993%26volume%3D8%26spage%3D2959%26epage%3D2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Nishizuka, Y.</span><span> </span><span class="NLM_article-title">Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1126/science.1411571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1126%2Fscience.1411571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1411571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK38XmsVyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=607-614&author=Y.+Nishizuka&title=Intracellular+signaling+by+hydrolysis+of+phospholipids+and+activation+of+protein+kinase+C&doi=10.1126%2Fscience.1411571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C</span></div><div class="casAuthors">Nishizuka, Yasutomi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5082</span>),
    <span class="NLM_cas:pages">607-14</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review, with 107 refs., on protein kinase C (PKC) activation by diacylglycerols and phospholipases D and A2, Ca2+ signals and phospholipid degrdn., and Ca2+ and lipid requirements of PKC isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogM810LsZLaLVg90H21EOLACvtfcHk0lglczwDAI5tVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVyqsbo%253D&md5=4e0b994bb9e03c778000a4b74a691fde</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1411571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1411571%26sid%3Dliteratum%253Aachs%26aulast%3DNishizuka%26aufirst%3DY.%26atitle%3DIntracellular%2520signaling%2520by%2520hydrolysis%2520of%2520phospholipids%2520and%2520activation%2520of%2520protein%2520kinase%2520C%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D607%26epage%3D614%26doi%3D10.1126%2Fscience.1411571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gallego-Ortega, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdes-Mora, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barderas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarmentero-Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7819</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1371%2Fjournal.pone.0007819" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7819&author=D.+Gallego-Ortegaauthor=A.+Ramirez+de+Molinaauthor=M.+A.+Ramosauthor=F.+Valdes-Moraauthor=M.+G.+Barderasauthor=J.+Sarmentero-Estradaauthor=J.+C.+Lacal&title=Differential+role+of+human+choline+kinase+alpha+and+beta+enzymes+in+lipid+metabolism%3A+implications+in+cancer+onset+and+treatment&doi=10.1371%2Fjournal.pone.0007819"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007819%26sid%3Dliteratum%253Aachs%26aulast%3DGallego-Ortega%26aufirst%3DD.%26aulast%3DRamirez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DM.%2BA.%26aulast%3DValdes-Mora%26aufirst%3DF.%26aulast%3DBarderas%26aufirst%3DM.%2BG.%26aulast%3DSarmentero-Estrada%26aufirst%3DJ.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DDifferential%2520role%2520of%2520human%2520choline%2520kinase%2520alpha%2520and%2520beta%2520enzymes%2520in%2520lipid%2520metabolism%253A%2520implications%2520in%2520cancer%2520onset%2520and%2520treatment%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7819%26doi%3D10.1371%2Fjournal.pone.0007819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Glunde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhujwalla, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronen, S. M.</span><span> </span><span class="NLM_article-title">Choline metabolism in malignant transformation</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/nrc3162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fnrc3162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=22089420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOisb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=835-848&author=K.+Glundeauthor=Z.+M.+Bhujwallaauthor=S.+M.+Ronen&title=Choline+metabolism+in+malignant+transformation&doi=10.1038%2Fnrc3162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Choline metabolism in malignant transformation</span></div><div class="casAuthors">Glunde, Kristine; Bhujwalla, Zaver M.; Ronen, Sabrina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">835-848</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Abnormal choline metab. is emerging as a metabolic hallmark that is assocd. with oncogenesis and tumor progression.  Following transformation, the modulation of enzymes that control anabolic and catabolic pathways causes increased levels of choline-contg. precursors and breakdown products of membrane phospholipids.  These increased levels are assocd. with proliferation, and recent studies emphasize the complex reciprocal interactions between oncogenic signalling and choline metab.  Because choline-contg. compds. are detected by non-invasive magnetic resonance spectroscopy (MRS), increased levels of these compds. provide a non-invasive biomarker of transformation, staging and response to therapy.  Furthermore, enzymes of choline metab., such as choline kinase, present novel targets for image-guided cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTIzH3dwf9JbVg90H21EOLACvtfcHk0lgN-6jRDsIvxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOisb7P&md5=507254b352e1c68fdca10194449216eb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc3162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3162%26sid%3Dliteratum%253Aachs%26aulast%3DGlunde%26aufirst%3DK.%26aulast%3DBhujwalla%26aufirst%3DZ.%2BM.%26aulast%3DRonen%26aufirst%3DS.%2BM.%26atitle%3DCholine%2520metabolism%2520in%2520malignant%2520transformation%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D835%26epage%3D848%26doi%3D10.1038%2Fnrc3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Granata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perego, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iorio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamachary, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benigni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhujwalla, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span> </span><span class="NLM_article-title">Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">11216</span><span class="NLM_x">–</span> <span class="NLM_lpage">11230</span><span class="refDoi"> DOI: 10.18632/oncotarget.3589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.18632%2Foncotarget.3589" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=11216-11230&author=A.+Granataauthor=R.+Nicolettiauthor=P.+Peregoauthor=E.+Iorioauthor=B.+Krishnamacharyauthor=F.+Benigniauthor=A.+Ricciauthor=F.+Podoauthor=Z.+M.+Bhujwallaauthor=S.+Canevariauthor=M.+Bagnoliauthor=D.+Mezzanzanica&title=Global+metabolic+profile+identifies+choline+kinase+alpha+as+a+key+regulator+of+glutathione-dependent+antioxidant+cell+defense+in+ovarian+carcinoma&doi=10.18632%2Foncotarget.3589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3589%26sid%3Dliteratum%253Aachs%26aulast%3DGranata%26aufirst%3DA.%26aulast%3DNicoletti%26aufirst%3DR.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DIorio%26aufirst%3DE.%26aulast%3DKrishnamachary%26aufirst%3DB.%26aulast%3DBenigni%26aufirst%3DF.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DPodo%26aufirst%3DF.%26aulast%3DBhujwalla%26aufirst%3DZ.%2BM.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DBagnoli%26aufirst%3DM.%26aulast%3DMezzanzanica%26aufirst%3DD.%26atitle%3DGlobal%2520metabolic%2520profile%2520identifies%2520choline%2520kinase%2520alpha%2520as%2520a%2520key%2520regulator%2520of%2520glutathione-dependent%2520antioxidant%2520cell%2520defense%2520in%2520ovarian%2520carcinoma%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D11216%26epage%3D11230%26doi%3D10.18632%2Foncotarget.3589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ramírez De Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4317</span><span class="NLM_x">–</span> <span class="NLM_lpage">4322</span><span class="refDoi"> DOI: 10.1038/sj.onc.1205556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fsj.onc.1205556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=4317-4322&author=A.+Ram%C3%ADrez+De+Molinaauthor=R.+Guti%C3%A9rrezauthor=M.+A.+Ramosauthor=J.+Silvaauthor=J.+M.+Silvaauthor=F.+Bonillaauthor=J.+Sanchezauthor=J.+C.+Lacal&title=Increased+choline+kinase+activity+in+human+breast+carcinomas%3A+clinical+evidence+for+a+potential+novel+antitumor+strategy&doi=10.1038%2Fsj.onc.1205556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205556%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez%2BDe%2BMolina%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DR.%26aulast%3DRamos%26aufirst%3DM.%2BA.%26aulast%3DSilva%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DJ.%2BM.%26aulast%3DBonilla%26aufirst%3DF.%26aulast%3DSanchez%26aufirst%3DJ.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DIncreased%2520choline%2520kinase%2520activity%2520in%2520human%2520breast%2520carcinomas%253A%2520clinical%2520evidence%2520for%2520a%2520potential%2520novel%2520antitumor%2520strategy%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D4317%26epage%3D4322%26doi%3D10.1038%2Fsj.onc.1205556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gribbestad, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelson, D.</span><span> </span><span class="NLM_article-title">Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1737</span><span class="NLM_x">–</span> <span class="NLM_lpage">1746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10470108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFClt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=1737-1746&author=I.+S.+Gribbestadauthor=B.+Sitterauthor=S.+Lundgrenauthor=J.+Kraneauthor=D.+Axelson&title=Metabolite+composition+in+breast+tumors+examined+by+proton+nuclear+magnetic+resonance+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy</span></div><div class="casAuthors">Gribbestad, I. S.; Sitter, B.; Lundgren, S.; Krane, J.; Axelson, D.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3A</span>),
    <span class="NLM_cas:pages">1737-1746</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">In vivo characterization of breast tumors using proton (1H) MR spectroscopy relies upon in vitro interpretation of tissue samples.  The present study has investigated metabolite compn. in exts. from breast tumors and non-involved breast tissue.  Multivariate data anal. was used to determinate combinations of metabolites important for differentiation.  Tumor and non-involved breast tissue were obtained from 16 patients undergoing surgical treatment.  1H NMR spectra of perchloric acid tissue exts. were obtained at a BRUKER Avance DRX600 spectrometer.  The data was analyzed using principal component anal. and probabilistic neural networks.  Low levels of glucose and high content of choline compds. were dominant findings in the tumor spectra.  Principal component loadings demonstrated this strong assocn.  The spectra were correctly classified using neural network anal.  Large differences in the metabolite compn. of breast tumors and surrounding breast tissues have been documented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFOdqpnemnA7Vg90H21EOLACvtfcHk0lj6ySpelqtdnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFClt7s%253D&md5=23eef885847029a2d6c6d6768c655181</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGribbestad%26aufirst%3DI.%2BS.%26aulast%3DSitter%26aufirst%3DB.%26aulast%3DLundgren%26aufirst%3DS.%26aulast%3DKrane%26aufirst%3DJ.%26aulast%3DAxelson%26aufirst%3DD.%26atitle%3DMetabolite%2520composition%2520in%2520breast%2520tumors%2520examined%2520by%2520proton%2520nuclear%2520magnetic%2520resonance%2520spectroscopy%26jtitle%3DAnticancer%2520Res.%26date%3D1999%26volume%3D19%26spage%3D1737%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yalcin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brock, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, J.</span><span> </span><span class="NLM_article-title">Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.1038/onc.2009.317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fonc.2009.317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=139-149&author=A.+Yalcinauthor=B.+Clemauthor=S.+Makoniauthor=A.+Clemauthor=K.+Nelsonauthor=J.+Thornburgauthor=D.+Siowauthor=A.+N.+Laneauthor=S.+E.+Brockauthor=U.+Goswamiauthor=J.+W.+Eatonauthor=S.+Telangauthor=J.+Chesney&title=Selective+inhibition+of+choline+kinase+simultaneously+attenuates+MAPK+and+PI3K%2FAKT+signaling&doi=10.1038%2Fonc.2009.317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.317%26sid%3Dliteratum%253Aachs%26aulast%3DYalcin%26aufirst%3DA.%26aulast%3DClem%26aufirst%3DB.%26aulast%3DMakoni%26aufirst%3DS.%26aulast%3DClem%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DK.%26aulast%3DThornburg%26aufirst%3DJ.%26aulast%3DSiow%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DBrock%26aufirst%3DS.%2BE.%26aulast%3DGoswami%26aufirst%3DU.%26aulast%3DEaton%26aufirst%3DJ.%2BW.%26aulast%3DTelang%26aufirst%3DS.%26aulast%3DChesney%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520choline%2520kinase%2520simultaneously%2520attenuates%2520MAPK%2520and%2520PI3K%252FAKT%2520signaling%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D139%26epage%3D149%26doi%3D10.1038%2Fonc.2009.317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Clem, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalcin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, J.</span><span> </span><span class="NLM_article-title">A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3370</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span><span class="refDoi"> DOI: 10.1038/onc.2011.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fonc.2011.51" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3370-3380&author=B.+F.+Clemauthor=A.+L.+Clemauthor=A.+Yalcinauthor=U.+Goswamiauthor=S.+Arumugamauthor=S.+Telangauthor=J.+O.+Trentauthor=J.+Chesney&title=A+novel+small+molecule+antagonist+of+choline+kinase-%CE%B1+that+simultaneously+suppresses+MAPK+and+PI3K%2FAKT+signaling&doi=10.1038%2Fonc.2011.51"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.51%26sid%3Dliteratum%253Aachs%26aulast%3DClem%26aufirst%3DB.%2BF.%26aulast%3DClem%26aufirst%3DA.%2BL.%26aulast%3DYalcin%26aufirst%3DA.%26aulast%3DGoswami%26aufirst%3DU.%26aulast%3DArumugam%26aufirst%3DS.%26aulast%3DTelang%26aufirst%3DS.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DChesney%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small%2520molecule%2520antagonist%2520of%2520choline%2520kinase-%25CE%25B1%2520that%2520simultaneously%2520suppresses%2520MAPK%2520and%2520PI3K%252FAKT%2520signaling%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D3370%26epage%3D3380%26doi%3D10.1038%2Fonc.2011.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-González, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penalva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Inhibition of ChoK Is an Efficient Antitumor Strategy for Harvey-, Kirsten-, and N-ras-Transformed Cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1006/bbrc.2001.5250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1006%2Fbbrc.2001.5250" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2001&pages=873-879&author=A.+Ram%C3%ADrez+de+Molinaauthor=A.+Rodr%C3%ADguez-Gonz%C3%A1lezauthor=V.+Penalvaauthor=L.+Lucasauthor=J.+C.+Lacal&title=Inhibition+of+ChoK+Is+an+Efficient+Antitumor+Strategy+for+Harvey-%2C+Kirsten-%2C+and+N-ras-Transformed+Cells&doi=10.1006%2Fbbrc.2001.5250"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.5250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.5250%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Gonz%25C3%25A1lez%26aufirst%3DA.%26aulast%3DPenalva%26aufirst%3DV.%26aulast%3DLucas%26aufirst%3DL.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520ChoK%2520Is%2520an%2520Efficient%2520Antitumor%2520Strategy%2520for%2520Harvey-%252C%2520Kirsten-%252C%2520and%2520N-ras-Transformed%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D285%26spage%3D873%26epage%3D879%26doi%3D10.1006%2Fbbrc.2001.5250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, S. J.</span><span> </span><span class="NLM_article-title">Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span><span class="refDoi"> DOI: 10.1038/onc.2011.332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fonc.2011.332" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1431-1441&author=T.+Miyakeauthor=S.+J.+Parsons&title=Functional+interactions+between+Choline+kinase+%CE%B1%2C+epidermal+growth+factor+receptor+and+c-Src+in+breast+cancer+cell+proliferation&doi=10.1038%2Fonc.2011.332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.332%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DParsons%26aufirst%3DS.%2BJ.%26atitle%3DFunctional%2520interactions%2520between%2520Choline%2520kinase%2520%25CE%25B1%252C%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520c-Src%2520in%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D1431%26epage%3D1441%26doi%3D10.1038%2Fonc.2011.332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sanchez-Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez del Pulgar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal Sanjuan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebrian, A.</span><span> </span><span class="NLM_article-title">Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e933</span><span class="refDoi"> DOI: 10.1038/cddis.2013.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fcddis.2013.453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e933&author=E.+Sanchez-Lopezauthor=T.+Zimmermanauthor=T.+Gomez+del+Pulgarauthor=M.+P.+Moyerauthor=J.+C.+Lacal+Sanjuanauthor=A.+Cebrian&title=Choline+kinase+inhibition+induces+exacerbated+endoplasmic+reticulum+stress+and+triggers+apoptosis+via+CHOP+in+cancer+cells&doi=10.1038%2Fcddis.2013.453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.453%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Lopez%26aufirst%3DE.%26aulast%3DZimmerman%26aufirst%3DT.%26aulast%3DGomez%2Bdel%2BPulgar%26aufirst%3DT.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DLacal%2BSanjuan%26aufirst%3DJ.%2BC.%26aulast%3DCebrian%26aufirst%3DA.%26atitle%3DCholine%2520kinase%2520inhibition%2520induces%2520exacerbated%2520endoplasmic%2520reticulum%2520stress%2520and%2520triggers%2520apoptosis%2520via%2520CHOP%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De933%26doi%3D10.1038%2Fcddis.2013.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Janardhan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastry, G. N.</span><span> </span><span class="NLM_article-title">Choline kinase: an important target for cancer</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.2174/092986706776360923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.2174%2F092986706776360923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=16719778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Krur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1169-1186&author=S.+Janardhanauthor=P.+Srivaniauthor=G.+N.+Sastry&title=Choline+kinase%3A+an+important+target+for+cancer&doi=10.2174%2F092986706776360923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Choline kinase: an important target for cancer</span></div><div class="casAuthors">Janardhan, S.; Srivani, P.; Sastry, G. Narahari</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1169-1186</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Choline kinase (ChoK) is a cytosolic enzyme present in various tissues, which catalyzes the phosphorylation of choline to form phosphorylcholine (PCho) in the presence of ATP and magnesium.  ChoK is important for the generation of 2 major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM), and subsequently for the cell division.  ChoK plays a vital role in cell signaling pathways and regulation of cell growth along with PCho involved in malignant transformation through ras oncogenes in different cancers such as breast, lung, colon, prostate, neuroblastoma, hepatic lymphomas, meningiomas, and diverse murine tumors.  The Ras effectors serine/threonine kinase (Raf-1), the Ral-GDP dissocn. stimulator (Ral-GDS), and the phosphatidylinositol 3-kinase (PI3K) are involved in the activation of ChoK during tumorigenesis.  ChoK gene induction seems to be assocd. with certain cell stress or cell defense.  Nowadays, RNAi appear to be one of the most promising routes in the cancer therapy.  The anticancer potential of both stable expression of siRNAs and their high sequence specificity by RNAi-mediated suppression of oncogenic ras in human pancreatic carcinoma, human melanomas, and ovarian cancer has been obsd.  It has an important role in sequence specific post-transcriptional gene silencing mechanism.  Presently, the crystal structure of Caenorhabditis elegans choline kinase A-2 (ChoKA-2) is available, which may be useful for comparative modeling of human ChoK and further modeling studies.  The present review aims at the general overview of importance, expression, structure, progress in mol. modeling, active site anal., and inhibitors of ChoK.  It also highlights the recent role of ChoK in various types of Ras-dependent and Ras-independent carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbwuclS8KSYrVg90H21EOLACvtfcHk0lhPZ0WMYdKK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Krur4%253D&md5=dd49f50cfd576a230f93f581427c8529</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F092986706776360923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776360923%26sid%3Dliteratum%253Aachs%26aulast%3DJanardhan%26aufirst%3DS.%26aulast%3DSrivani%26aufirst%3DP.%26aulast%3DSastry%26aufirst%3DG.%2BN.%26atitle%3DCholine%2520kinase%253A%2520an%2520important%2520target%2520for%2520cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1169%26epage%3D1186%26doi%3D10.2174%2F092986706776360923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, D. E.</span><span> </span><span class="NLM_article-title">Choline kinase and its function</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1139/O09-160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1139%2FO09-160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=20651826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=559-564&author=G.+Wuauthor=D.+E.+Vance&title=Choline+kinase+and+its+function&doi=10.1139%2FO09-160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Choline kinase and its function</span></div><div class="casAuthors">Wu, Gengshu; Vance, Dennis E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-564</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Choline kinase (CK) was discovered in 1953.  Progress in understanding the function of CK was slow until its purifn. in 1984.  The subsequent cloning and expression of the cDNA led to the description of the gene structures.  Two genes (Chka and Chkb) encode CK, and 3 isoforms of the enzyme have been identified (CKα-1, CKα-2, and CKβ) and the active form of CK is a hetero- or homo-dimer.  More recently, gene-disrupted mice have been described.  Mice that lack CKα die early in embryogenesis.  In contrast, mice that lack CKβ survive to adulthood, but develop hindlimb muscular dystrophy and forelimb bone deformity.  It has been shown that this hindlimb muscular dystrophy is due to decreased biosynthesis of phosphatidylcholine (PC) and increased catabolism of PC in the hindlimbs, but not the forelimbs, of mice.  CK and its product, phosphocholine, have also been implicated in the development of numerous cancers.  Thus, a possible treatment for some kinds of cancer may involve drug inhibition of CK or targeting the expression of CK with RNA interference.  In the mid 1950s, it was clear that CK was important for the biosynthesis of phosphatidylcholine, but no one predicted a role for CK in muscular dystrophy, bone deformities, or cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9AzJyYM7Pb7Vg90H21EOLACvtfcHk0lhPZ0WMYdKK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKjt74%253D&md5=f1fa2ff83579f267697a276d27d2428c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1139%2FO09-160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252FO09-160%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DVance%26aufirst%3DD.%2BE.%26atitle%3DCholine%2520kinase%2520and%2520its%2520function%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D88%26spage%3D559%26epage%3D564%26doi%3D10.1139%2FO09-160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hamza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloveras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribbes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douste-Blazy, L.</span><span> </span><span class="NLM_article-title">An in vitro study of hemicholinium-3 on phospholipid metabolism of Krebs II ascites cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1897</span><span class="refDoi"> DOI: 10.1016/0006-2952(83)90055-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2F0006-2952%2883%2990055-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1983&pages=1893-1897&author=M.+Hamzaauthor=J.+Lloverasauthor=G.+Ribbesauthor=G.+Soulaauthor=L.+Douste-Blazy&title=An+in+vitro+study+of+hemicholinium-3+on+phospholipid+metabolism+of+Krebs+II+ascites+cells&doi=10.1016%2F0006-2952%2883%2990055-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2883%2990055-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252883%252990055-2%26sid%3Dliteratum%253Aachs%26aulast%3DHamza%26aufirst%3DM.%26aulast%3DLloveras%26aufirst%3DJ.%26aulast%3DRibbes%26aufirst%3DG.%26aulast%3DSoula%26aufirst%3DG.%26aulast%3DDouste-Blazy%26aufirst%3DL.%26atitle%3DAn%2520in%2520vitro%2520study%2520of%2520hemicholinium-3%2520on%2520phospholipid%2520metabolism%2520of%2520Krebs%2520II%2520ascites%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1983%26volume%3D32%26spage%3D1893%26epage%3D1897%26doi%3D10.1016%2F0006-2952%2883%2990055-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hernández-Alcoceba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">In vivo antitumor activity of choline kinase inhibitors a novel target for anticancer drug discovery</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3112</span><span class="NLM_x">–</span> <span class="NLM_lpage">3118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=3112-3118&author=R.+Hern%C3%A1ndez-Alcocebaauthor=F.+Fern%C3%A1ndezauthor=J.+C.+Lacal&title=In+vivo+antitumor+activity+of+choline+kinase+inhibitors+a+novel+target+for+anticancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-Alcoceba%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520choline%2520kinase%2520inhibitors%2520a%2520novel%2520target%2520for%2520anticancer%2520drug%2520discovery%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D3112%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hernández-Alcoceba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saniger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaless, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Choline kinase inhibitors as a novel approach for antiproliferative drug design</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2301</span><span class="refDoi"> DOI: 10.1038/sj.onc.1201414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fsj.onc.1201414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=2289-2301&author=R.+Hern%C3%A1ndez-Alcocebaauthor=L.+Sanigerauthor=J.+Camposauthor=M.+C.+N%C3%BA%C3%B1ezauthor=F.+Khalessauthor=M.+A.+Galloauthor=A.+Espinosaauthor=J.+C.+Lacal&title=Choline+kinase+inhibitors+as+a+novel+approach+for+antiproliferative+drug+design&doi=10.1038%2Fsj.onc.1201414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1201414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1201414%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-Alcoceba%26aufirst%3DR.%26aulast%3DSaniger%26aufirst%3DL.%26aulast%3DCampos%26aufirst%3DJ.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DM.%2BC.%26aulast%3DKhaless%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DCholine%2520kinase%2520inhibitors%2520as%2520a%2520novel%2520approach%2520for%2520antiproliferative%2520drug%2520design%26jtitle%3DOncogene%26date%3D1997%26volume%3D15%26spage%3D2289%26epage%3D2301%26doi%3D10.1038%2Fsj.onc.1201414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rodríguez-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, M. d. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8803</span><span class="NLM_x">–</span> <span class="NLM_lpage">8812</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fsj.onc.1207062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=8803-8812&author=A.+Rodr%C3%ADguez-Gonzalezauthor=A.+Ram%C3%ADrez+de+Molinaauthor=F.+Fern%C3%A1ndezauthor=M.+A.+Ramosauthor=M.+d.+C.+Nunezauthor=J.+Camposauthor=J.+C.+Lacal&title=Inhibition+of+choline+kinase+as+a+specific+cytotoxic+strategy+in+oncogene-transformed+cells&doi=10.1038%2Fsj.onc.1207062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207062%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Gonzalez%26aufirst%3DA.%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DRamos%26aufirst%3DM.%2BA.%26aulast%3DNunez%26aufirst%3DM.%2Bd.%2BC.%26aulast%3DCampos%26aufirst%3DJ.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520choline%2520kinase%2520as%2520a%2520specific%2520cytotoxic%2520strategy%2520in%2520oncogene-transformed%2520cells%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D8803%26epage%3D8812%26doi%3D10.1038%2Fsj.onc.1207062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ramirez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-González, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.canlet.2003.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.canlet.2003.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=15013519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2004&pages=137-148&author=A.+Ramirez+de+Molinaauthor=A.+Rodriguez-Gonz%C3%A1lezauthor=J.+C.+Lacal&title=From+Ras+signalling+to+ChoK+inhibitors%3A+a+further+advance+in+anticancer+drug+design&doi=10.1016%2Fj.canlet.2003.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">From Ras signaling to ChoK inhibitors: a further advance in anticancer drug design</span></div><div class="casAuthors">Ramirez de Molina, Ana; Rodriguez-Gonzalez, Agustin; Lacal, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-148</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer is a genetic disease, most prominent in developed countries, with still a high mortality rate .  Cancer cells are continuously proliferating, and this uncontrolled growth is mediated by the activation of different signal transduction pathways that ultimately lead to the carcinogenic process.  Consequently, a large effort was devoted to design specific mols. that interfere with these signaling cascades involved in tumorigenesis.  In the last decades, research has resulted in improvements in both detection and treatment of cancer.  However, it is still necessary to develop novel antitumoral therapies that would allow an appropriate treatment for each cancer patient.  These novel, tumor- and patient-specific therapies will have a dramatic impact in improving the overall survival rates.  Ras is one of the most important oncogenes so far identified in human carcinogenesis.  Understanding the regulation of Ras-dependent signalling under normal and oncogenic environments may provide clues for the design of efficient specific antitumor strategies.  In this review the authors will illustrate how the family of Ras GTPases may be a valid model for the development of new cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpgb9CvDDFJLVg90H21EOLACvtfcHk0lhLHx3laMxnMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu70%253D&md5=9da88d585738ccd84c15210ba899ca24</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2003.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2003.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DRodriguez-Gonz%25C3%25A1lez%26aufirst%3DA.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DFrom%2520Ras%2520signalling%2520to%2520ChoK%2520inhibitors%253A%2520a%2520further%2520advance%2520in%2520anticancer%2520drug%2520design%26jtitle%3DCancer%2520Lett.%26date%3D2004%26volume%3D206%26spage%3D137%26epage%3D148%26doi%3D10.1016%2Fj.canlet.2003.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Falcon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaram, H.</span><span> </span><span class="NLM_article-title">A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival</span> <span class="citation_source-journal">Oncogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e38</span><span class="refDoi"> DOI: 10.1038/oncsis.2013.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Foncsis.2013.2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e38&author=S.+C.+Falconauthor=C.+S.+Hudsonauthor=Y.+Huangauthor=M.+Mortimoreauthor=J.+M.+Golecauthor=P.+A.+Charltonauthor=P.+Weberauthor=H.+Sundaram&title=A+non-catalytic+role+of+choline+kinase+alpha+is+important+in+promoting+cancer+cell+survival&doi=10.1038%2Foncsis.2013.2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2013.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2013.2%26sid%3Dliteratum%253Aachs%26aulast%3DFalcon%26aufirst%3DS.%2BC.%26aulast%3DHudson%26aufirst%3DC.%2BS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMortimore%26aufirst%3DM.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DSundaram%26aufirst%3DH.%26atitle%3DA%2520non-catalytic%2520role%2520of%2520choline%2520kinase%2520alpha%2520is%2520important%2520in%2520promoting%2520cancer%2520cell%2520survival%26jtitle%3DOncogenesis%26date%3D2013%26volume%3D2%26spage%3De38%26doi%3D10.1038%2Foncsis.2013.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hudson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knegtel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span> </span><span class="NLM_article-title">Kinetic and mechanistic characterisation of Choline Kinase-α</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1834</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.bbapap.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=23416529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslCht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1834&publication_year=2013&pages=1107-1116&author=C.+S.+Hudsonauthor=R.+M.+Knegtelauthor=K.+Brownauthor=P.+A.+Charltonauthor=J.+R.+Pollard&title=Kinetic+and+mechanistic+characterisation+of+Choline+Kinase-%CE%B1&doi=10.1016%2Fj.bbapap.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and mechanistic characterisation of Choline Kinase-α</span></div><div class="casAuthors">Hudson, Catherine S.; Knegtel, Ronald M.; Brown, Kieron; Charlton, Peter A.; Pollard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1834</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1107-1116</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Choline Kinase is a key component of the Kennedy pathway that converts choline into a no. of structural and signalling lipids that are essential for cell growth and survival.  One member of the family, Choline Kinase-α (ChoKα) is frequently up-regulated in human cancers, and expression of ChoKα is sufficient to transform cells.  Consequently ChoKα has been studied as a potential target for therapeutic agents in cancer research.  Despite great interest in the enzyme, mechanistic studies have not been reported.  In this study, a combination of initial velocity and product inhibition studies, together with the kinetic and structural characterization of a novel ChoKα inhibitor is used to support a mechanism of action for human ChoKα.  Substrate and inhibition kinetics are consistent with an iso double displacement mechanism, in which the γ-phosphate from ATP is transferred to choline in two distinct steps via a phospho-enzyme intermediate.  Co-crystal structures, and existing site-specific mutation studies, support an important role for Asp306, in stabilizing the phospho-enzyme intermediate.  The kinetics also indicate a distinct kinetic (isomerisation) step assocd. with product release, which may be attributed to a conformational change in the protein to disrupt an interaction between Asp306 and the phosphocholine product, facilitating product release.  This study describes a mechanism for ChoKα that is unusual amongst kinases, and highlights the availability of different enzyme states that can be exploited for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzeRhSDMs697Vg90H21EOLACvtfcHk0lgCsD6hhKs9ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslCht70%253D&md5=07c07850f67b6cb481510a928f31b22e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DC.%2BS.%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26atitle%3DKinetic%2520and%2520mechanistic%2520characterisation%2520of%2520Choline%2520Kinase-%25CE%25B1%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2013%26volume%3D1834%26spage%3D1107%26epage%3D1116%26doi%3D10.1016%2Fj.bbapap.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J. M.</span><span> </span><span class="NLM_article-title">Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1158%2F1535-7163.MCT-14-0531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25487918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=31-39&author=J.+C.+Lacalauthor=J.+M.+Campos&title=Preclinical+characterization+of+RSM-932A%2C+a+novel+anticancer+drug+targeting+the+human+choline+kinase+alpha%2C+an+enzyme+involved+in+increased+lipid+metabolism+of+cancer+cells&doi=10.1158%2F1535-7163.MCT-14-0531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells</span></div><div class="casAuthors">Lacal, Juan Carlos; Campos, Joaquin M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-39</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Choline kinase α (CHKA; here designated as ChoKα) is the first enzyme in the CDP-choline pathway, implicated in phospholipids metab.  It is overexpressed in several human tumors such as breast, lung, bladder, colorectal, prostate, ovary, and liver.  The overexpression of ChoKα has oncogenic potential and synergizes with other known oncogenes.  It has been proposed as a novel cancer drug target with a distinct mechanism of action.  We have generated a set of ChoKα inhibitors with potent in vitro antiproliferative and in vivo antitumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles.  Among these inhibitors, RSM-932A has been chosen for further clin. development due to its potent antiproliferative activity in vitro against a large variety of tumor-derived cell lines, a potent in vivo anticancer activity, and lack of toxicity at the EDs.  Here, we provide the preclin. evidence to support the use of RSM-932A as a good candidate to be tested in clin. trials as the "first in humans" drug targeting ChoKα.  Mol Cancer Ther; 14(1); 31-39. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGE3uBNGhPhLVg90H21EOLACvtfcHk0lgCsD6hhKs9ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWluw%253D%253D&md5=11fa90eab6eb5cf83c64a9cd9dbb7588</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0531%26sid%3Dliteratum%253Aachs%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DCampos%26aufirst%3DJ.%2BM.%26atitle%3DPreclinical%2520characterization%2520of%2520RSM-932A%252C%2520a%2520novel%2520anticancer%2520drug%2520targeting%2520the%2520human%2520choline%2520kinase%2520alpha%252C%2520an%2520enzyme%2520involved%2520in%2520increased%2520lipid%2520metabolism%2520of%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D31%26epage%3D39%26doi%3D10.1158%2F1535-7163.MCT-14-0531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Castro-Navas, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiaffino-Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco-Jimenez, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ríos-Marco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariotto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena-Guadix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Cara, L. C.</span><span> </span><span class="NLM_article-title">New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.4155/fmc.15.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.4155%2Ffmc.15.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25875870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=417-436&author=F.+F.+Castro-Navasauthor=S.+Schiaffino-Ortegaauthor=M.+P.+Carrasco-Jimenezauthor=P.+R%C3%ADos-Marcoauthor=C.+Marcoauthor=A.+Espinosaauthor=M.+A.+Galloauthor=E.+Mariottoauthor=G.+Bassoauthor=G.+Violaauthor=A.+Entrena-Guadixauthor=L.+C.+L%C3%B3pez-Cara&title=New+more+polar+symmetrical+bipyridinic+compounds%3A+new+strategy+for+the+inhibition+of+choline+kinase+%CE%B11&doi=10.4155%2Ffmc.15.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1</span></div><div class="casAuthors">Castro-Navas, Francisco Fermin; Schiaffino-Ortega, Santiago; Carrasco-Jimenez, Maria Paz; Rios-Marco, Pablo; Marco, Carmen; Espinosa, Antonio; Gallo, Miguel Angel; Mariotto, Elena; Basso, Giuseppe; Viola, Giampietro; Entrena-Guadix, Antonio; Lopez-Cara, Luisa Carlota</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">417-436</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: Research of the antitumor properties of biscationic compds. has received significant attention over the last few years.  Results: A novel family of 1,1'-([2,2'-bipyridine]-5,5'-diylbis(methylene))bis-substituted bromide (9a-k), contg. two nitrogen atoms in the linker, considered as hypothetical hydrogen bond acceptors, were synthesized and evaluated as ChoK inhibitors and their antiproliferative activity against six cancer cell lines.  Conclusion: The most promising compds. in this series are 1,1'-([2,2'-bipyridine]-5,5'-diylbis(methylene))bis(4-(methyl(phenyl)amino)-quinolinium bromide derivs. 9g-i (analogs to RSM932A), that significantly inhibit cancer cell growth at even submicromolar concns., esp. against leukemia cells. Compds. 9g-i also inhibit the ChoKα1 with good or moderate values, as predicted by initial docking studies.  In addn., the most active compd. 9h remarkably induces apoptosis in two cell lines following the mitochondrial pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7kW4QSpq277Vg90H21EOLACvtfcHk0lgCsD6hhKs9ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lt7g%253D&md5=6cb3e2a44c4c5cff5019886d6defb220</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.1%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Navas%26aufirst%3DF.%2BF.%26aulast%3DSchiaffino-Ortega%26aufirst%3DS.%26aulast%3DCarrasco-Jimenez%26aufirst%3DM.%2BP.%26aulast%3DR%25C3%25ADos-Marco%26aufirst%3DP.%26aulast%3DMarco%26aufirst%3DC.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DMariotto%26aufirst%3DE.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26aulast%3DEntrena-Guadix%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Cara%26aufirst%3DL.%2BC.%26atitle%3DNew%2520more%2520polar%2520symmetrical%2520bipyridinic%2520compounds%253A%2520new%2520strategy%2520for%2520the%2520inhibition%2520of%2520choline%2520kinase%2520%25CE%25B11%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D417%26epage%3D436%26doi%3D10.4155%2Ffmc.15.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Serrán-Aguilera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Cara, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo Mezo, M. Á.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Guerrero, R.</span><span> </span><span class="NLM_article-title">Pharmacophore-based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1002/minf.201400140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1002%2Fminf.201400140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=458-466&author=L.+Serr%C3%A1n-Aguileraauthor=R.+Nutiauthor=L.+C.+L%C3%B3pez-Caraauthor=M.+%C3%81.+Gallo+Mezoauthor=A.+Macchiaruloauthor=A.+Entrenaauthor=R.+Hurtado-Guerrero&title=Pharmacophore-based+Virtual+Screening+to+Discover+New+Active+Compounds+for+Human+Choline+Kinase+%CE%B11&doi=10.1002%2Fminf.201400140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1</span></div><div class="casAuthors">Serran-Aguilera, Lucia; Nuti, Roberto; Lopez-Cara, Luisa C.; Mezo, Miguel A. Gallo; Macchiarulo, Antonio; Entrena, Antonio; Hurtado-Guerrero, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">458-466</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Choline kinase (CK) catalyzes the transfer of the ATP γ-phosphate to choline to generate phosphocholine and ADP in the presence of magnesium leading to the synthesis of phosphatidylcholine.  Of the three isoforms of CK described in humans, only the α isoforms (HsCKα) are strongly assocd. with cancer and have been validated as drug targets to treat this disease.  Over the years, a large no. of Hemicholinium-3 (HC-3)-based HsCKα biscationic inhibitors have been developed though the relevant common features important for the biol. function have not been defined.  Here, selecting a large no. of previous HC-3-based inhibitors, we discover through computational studies a pharmacophore model formed by five moieties that are included in the 1-benzyl-4-(N-methylaniline)pyridinium fragment.  Using a pharmacophore-guided virtual screening, we then identified 6 mols. that showed binding affinities in the low μM range to HsCKα1.  Finally, protein crystn. studies suggested that one of these mols. is bound to the choline and ATP-binding sites.  In conclusion, we have developed a pharmacophore model that not only allowed us to dissect the structural important features of the previous HC-3 derivs., but also enabled the identification of novel chem. tools with good ligand efficiencies to investigate the biol. functions of HsCKα1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf2JAwlyu3WrVg90H21EOLACvtfcHk0ljLwFuaFjMfeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7rN&md5=71a03f22eb62776360e0b29cc605f8f1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fminf.201400140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201400140%26sid%3Dliteratum%253Aachs%26aulast%3DSerr%25C3%25A1n-Aguilera%26aufirst%3DL.%26aulast%3DNuti%26aufirst%3DR.%26aulast%3DL%25C3%25B3pez-Cara%26aufirst%3DL.%2BC.%26aulast%3DGallo%2BMezo%26aufirst%3DM.%2B%25C3%2581.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DEntrena%26aufirst%3DA.%26aulast%3DHurtado-Guerrero%26aufirst%3DR.%26atitle%3DPharmacophore-based%2520Virtual%2520Screening%2520to%2520Discover%2520New%2520Active%2520Compounds%2520for%2520Human%2520Choline%2520Kinase%2520%25CE%25B11%26jtitle%3DMol.%2520Inf.%26date%3D2015%26volume%3D34%26spage%3D458%26epage%3D466%26doi%3D10.1002%2Fminf.201400140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rubio-Ruiz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figuerola-Conchas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos-Torrecillas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capitán-Cañadas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ríos-Marco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. Á.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Guerrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conejo-García, A.</span><span> </span><span class="NLM_article-title">Discovery of a New Binding Site on Human Choline Kinase α1: Design, Synthesis, Crystallographic Studies, and Biological Evaluation of Asymmetrical Bispyridinium Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1021/jm401665x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401665x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=507-515&author=B.+Rubio-Ruizauthor=A.+Figuerola-Conchasauthor=J.+Ramos-Torrecillasauthor=F.+Capit%C3%A1n-Ca%C3%B1adasauthor=P.+R%C3%ADos-Marcoauthor=M.+P.+Carrascoauthor=M.+%C3%81.+Galloauthor=A.+Espinosaauthor=C.+Marcoauthor=C.+Ruizauthor=A.+Entrenaauthor=R.+Hurtado-Guerreroauthor=A.+Conejo-Garc%C3%ADa&title=Discovery+of+a+New+Binding+Site+on+Human+Choline+Kinase+%CE%B11%3A+Design%2C+Synthesis%2C+Crystallographic+Studies%2C+and+Biological+Evaluation+of+Asymmetrical+Bispyridinium+Derivatives&doi=10.1021%2Fjm401665x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm401665x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401665x%26sid%3Dliteratum%253Aachs%26aulast%3DRubio-Ruiz%26aufirst%3DB.%26aulast%3DFiguerola-Conchas%26aufirst%3DA.%26aulast%3DRamos-Torrecillas%26aufirst%3DJ.%26aulast%3DCapit%25C3%25A1n-Ca%25C3%25B1adas%26aufirst%3DF.%26aulast%3DR%25C3%25ADos-Marco%26aufirst%3DP.%26aulast%3DCarrasco%26aufirst%3DM.%2BP.%26aulast%3DGallo%26aufirst%3DM.%2B%25C3%2581.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DMarco%26aufirst%3DC.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DEntrena%26aufirst%3DA.%26aulast%3DHurtado-Guerrero%26aufirst%3DR.%26aulast%3DConejo-Garc%25C3%25ADa%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520New%2520Binding%2520Site%2520on%2520Human%2520Choline%2520Kinase%2520%25CE%25B11%253A%2520Design%252C%2520Synthesis%252C%2520Crystallographic%2520Studies%252C%2520and%2520Biological%2520Evaluation%2520of%2520Asymmetrical%2520Bispyridinium%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D507%26epage%3D515%26doi%3D10.1021%2Fjm401665x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wittenberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornberg, A.</span><span> </span><span class="NLM_article-title">Choline Phosphokinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1953&pages=431-444&author=J.+Wittenbergauthor=A.+Kornberg&title=Choline+Phosphokinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittenberg%26aufirst%3DJ.%26aulast%3DKornberg%26aufirst%3DA.%26atitle%3DCholine%2520Phosphokinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1953%26volume%3D202%26spage%3D431%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterization+of+Ligand+Binding+by+Saturation+Transfer+Difference+NMR+Spectroscopy&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1784-1788</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The difference between a satn. transfer spectrum and a normal NMR spectrum provides a new and fast method (satn. transfer difference (STD) NMR spectroscopy) to screen compd. libraries for binding activity to proteins.  STD NMR spectroscopy of mixts. of potential ligands with as little as 1 nmol of protein yields 1D and 2D NMR spectra that exclusively show signals from mols. with binding affinity.  In addn., the ligand's binding epitope is easily identified because ligand residues in direct contact to the protein show much stronger STD signals.  For example, the binding specificity of Lewisb-hexasaccharide to Aleulria aurantia agglutinin (AAA) can be mapped to the two fucosyl residues.  The efficiency of the STD NMR technique is shown by the binding of N-acetylglucosamine (GlcNAc) to wheat germ agglutinin (WGA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8j8HiAqDArVg90H21EOLACvtfcHk0lhogMQfaSZhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D&md5=03f825af40d22911062112dc6074cf46</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1784%253A%253AAID-ANIE1784%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520Ligand%2520Binding%2520by%2520Saturation%2520Transfer%2520Difference%2520NMR%2520Spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">6108</span><span class="NLM_x">–</span> <span class="NLM_lpage">6117</span><span class="refDoi"> DOI: 10.1021/ja0100120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0100120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=6108-6117&author=M.+Mayerauthor=B.+Meyer&title=Group+epitope+mapping+by+saturation+transfer+difference+NMR+to+identify+segments+of+a+ligand+in+direct+contact+with+a+protein+receptor&doi=10.1021%2Fja0100120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Group Epitope Mapping by Saturation Transfer Difference NMR To Identify Segments of a Ligand in Direct Contact with a Protein Receptor</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6108-6117</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A protocol based on satn. transfer difference (STD) NMR spectra was developed to characterize the binding interactions at an atom level, termed group epitope mapping (GEM).  As an example we chose the well-studied system of galactose binding to the 120-kDa lectin Ricinus communis agglutinin I (RCA120).  As ligands we used Me β-D-galactoside and a biantennary decasaccharide.  Anal. of the satn. transfer effects of Me β-D-galactoside showed that the H2, H3, and H4 protons are satd. to the highest degree, giving evidence of their close proximity to protons of the RCA120 lectin.  The direct interaction of the lectin with this region of the galactose is in excellent agreement with results obtained from the anal. of the binding specificities of many chem. modified galactose derivs. (Bhattacharyya, L.; Brewer, C. F., 1988).  This new NMR technique can identify the binding epitope of even complex ligands very quickly, which is a great improvement over time-consuming chem. modifications.  Efficient GEM benefits from a relatively high off rate of the ligand and a large excess of the ligand over the receptor.  Even for a ligand like the biantennary decasaccharide with micromolar binding affinity, the binding epitopes could easily be mapped to the terminal β-D-Gal-(1-4)-β-D-GlcNAc (β-D-GlcNAc = N-acetyl-D-glucosamine) residues located at the nonreducing end of the two carbohydrate chains.  The binding contribution of the terminal galactose residue is stronger than those of the penultimate GlcNAc residues.  We could show that the GlcNAc residues bind "edge-on" with the region from H2 to H4, making contact with the protein.  Anal. of STD NMR expts. performed under competitive conditions proved that the two saccharides studied bind at the same receptor site, thereby ruling out unspecific binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9BVgPNWHCsLVg90H21EOLACvtfcHk0lhogMQfaSZhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFamsbg%253D&md5=5fe9d7d46114ee1cc96a8a50f8da972c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja0100120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0100120%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DGroup%2520epitope%2520mapping%2520by%2520saturation%2520transfer%2520difference%2520NMR%2520to%2520identify%2520segments%2520of%2520a%2520ligand%2520in%2520direct%2520contact%2520with%2520a%2520protein%2520receptor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D6108%26epage%3D6117%26doi%3D10.1021%2Fja0100120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagerness, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadden, D. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockman, B. J.</span><span> </span><span class="NLM_article-title">Fluorine-NMR Experiments for High-Throughput Screening: Theoretical Aspects, Practical Considerations, and Range of Applicability</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">7696</span><span class="NLM_x">–</span> <span class="NLM_lpage">7703</span><span class="refDoi"> DOI: 10.1021/ja034646d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja034646d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvFOitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=7696-7703&author=C.+Dalvitauthor=P.+E.+Fagernessauthor=D.+T.+A.+Haddenauthor=R.+W.+Sarverauthor=B.+J.+Stockman&title=Fluorine-NMR+Experiments+for+High-Throughput+Screening%3A+Theoretical+Aspects%2C+Practical+Considerations%2C+and+Range+of+Applicability&doi=10.1021%2Fja034646d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-NMR experiments for high-throughput screening: Theoretical aspects, practical considerations, and range of applicability</span></div><div class="casAuthors">Dalvit, Claudio; Fagerness, Paul E.; Hadden, Daneen T. A.; Sarver, Ronald W.; Stockman, Brian J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7696-7703</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Competition ligand-based NMR screening expts. have recently been introduced to overcome most of the problems assocd. with traditional ligand-based NMR screening.  Mols. with marginal soly. and high affinity for a given target can be easily identified in a high-throughput manner by screening chem. mixts. against the target in the presence of a weak- to medium-affinity ligand of known binding const.  While the original competition-based approaches utilized 1H detection, significant advantages are obtained using 19F detection.  The absence of spectral overlap permits the screening of large chem. mixts. and allows for automated anal. of the spectra, even in the presence of protonated buffers, solvents, and detergents.  The large chem. shift anisotropy of fluorine and the significant exchange contribution allow for the selection of a weak-affinity spy mol., thus resulting in a lower binding affinity threshold for the identified NMR hits.  The method, labeled FAXS (fluorine chem. shift anisotropy and exchange for screening) is rapid and requires only a limited amt. of protein and, therefore, compares favorably with the other established non-NMR techniques used in high-throughput screening.  Herein the theor. aspects of this powerful 19F-based approach are presented and discussed in detail.  The exptl. conditions together with the detection limits and binding const. measurements are investigated using human serum albumin as the target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrluTqHSItDBLVg90H21EOLACvtfcHk0lhogMQfaSZhcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvFOitbs%253D&md5=58b7a2db41871c28e06873302d4a1ecb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja034646d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034646d%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DFagerness%26aufirst%3DP.%2BE.%26aulast%3DHadden%26aufirst%3DD.%2BT.%2BA.%26aulast%3DSarver%26aufirst%3DR.%2BW.%26aulast%3DStockman%26aufirst%3DB.%2BJ.%26atitle%3DFluorine-NMR%2520Experiments%2520for%2520High-Throughput%2520Screening%253A%2520Theoretical%2520Aspects%252C%2520Practical%2520Considerations%252C%2520and%2520Range%2520of%2520Applicability%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D7696%26epage%3D7703%26doi%3D10.1021%2Fja034646d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Shuker, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovering high-affinity ligands for proteins: SAR by NMR</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1531</span><span class="NLM_x">–</span> <span class="NLM_lpage">1534</span><span class="refDoi"> DOI: 10.1126/science.274.5292.1531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1126%2Fscience.274.5292.1531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=8929414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1531-1534&author=S.+B.+Shukerauthor=P.+J.+Hajdukauthor=R.+P.+Meadowsauthor=S.+W.+Fesik&title=Discovering+high-affinity+ligands+for+proteins%3A+SAR+by+NMR&doi=10.1126%2Fscience.274.5292.1531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands for proteins: SAR by NMR</span></div><div class="casAuthors">Shuker, Suzanne B.; Hajduk, Philip J.; Meadows, Robert P.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5292</span>),
    <span class="NLM_cas:pages">1531-1534</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A NMR-based method is described in which small org. mols. that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands.  The approach is called "SAR by NMR" because structure-activity relationships (SAR) are obtained from NMR.  With this technique, compds. with nanomolar affinities for the FK506 binding protein were rapidly discovered by tethering two ligands with micromolar affinities.  The method reduces the amt. of chem. synthesis and time required for the discovery of high-affinity ligands and appears particularly useful in target-directed drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwkuE4EVU_yrVg90H21EOLACvtfcHk0lg9GTTydS-KUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D&md5=1b9a5a5e4f2d6ee4b1c249e3e1faf2ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5292.1531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5292.1531%26sid%3Dliteratum%253Aachs%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520for%2520proteins%253A%2520SAR%2520by%2520NMR%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1531%26epage%3D1534%26doi%3D10.1126%2Fscience.274.5292.1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M. F.</span><span> </span><span class="NLM_article-title">Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">574</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1021/jm700952v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700952v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1entg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=574-580&author=A.+M.+Giannettiauthor=B.+D.+Kochauthor=M.+F.+Browner&title=Surface+plasmon+resonance+based+assay+for+the+detection+and+characterization+of+promiscuous+inhibitors&doi=10.1021%2Fjm700952v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Surface Plasmon Resonance Based Assay for the Detection and Characterization of Promiscuous Inhibitors</span></div><div class="casAuthors">Giannetti, Anthony M.; Koch, Bruce D.; Browner, Michelle F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">574-580</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Promiscuous binders achieve enzyme inhibition using a nonspecific aggregation-type binding mechanism to proteins.  These compds. are a source of false-pos. hits in biochem. inhibition assays and should be removed from screening hit lists because they are not good candidates to initiate medicinal chem. programs.  The authors introduce a robust approach to identify these mols. early in the lead generation process using real time surface plasmon resonance based biosensors to observe the behavior of the binding interactions between promiscuous compds. and proteins.  Furthermore, the time resoln. of the assay reveals a no. of distinct mechanisms that promiscuous compds. employ to inhibit enzyme function and indicate that the type of mechanism can vary depending on the protein target.  A classification scheme for these compds. is presented that can be used to rapidly characterize the hits from high-throughput screens and eliminate compds. with a nonspecific mechanism of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTh2kYyROf7Vg90H21EOLACvtfcHk0lg9GTTydS-KUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1entg%253D%253D&md5=b2869c5be1cd6f455503f8e812ed6f23</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm700952v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700952v%26sid%3Dliteratum%253Aachs%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DKoch%26aufirst%3DB.%2BD.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26atitle%3DSurface%2520plasmon%2520resonance%2520based%2520assay%2520for%2520the%2520detection%2520and%2520characterization%2520of%2520promiscuous%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D574%26epage%3D580%26doi%3D10.1021%2Fjm700952v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Malito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekulic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Too, W. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavie, A.</span><span> </span><span class="NLM_article-title">Elucidation of Human Choline Kinase Crystal Structures in Complex with the Products ADP or Phosphocholine</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1016/j.jmb.2006.08.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.jmb.2006.08.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2006&pages=136-151&author=E.+Malitoauthor=N.+Sekulicauthor=W.+C.+S.+Tooauthor=M.+Konradauthor=A.+Lavie&title=Elucidation+of+Human+Choline+Kinase+Crystal+Structures+in+Complex+with+the+Products+ADP+or+Phosphocholine&doi=10.1016%2Fj.jmb.2006.08.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2006.08.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2006.08.084%26sid%3Dliteratum%253Aachs%26aulast%3DMalito%26aufirst%3DE.%26aulast%3DSekulic%26aufirst%3DN.%26aulast%3DToo%26aufirst%3DW.%2BC.%2BS.%26aulast%3DKonrad%26aufirst%3DM.%26aulast%3DLavie%26aufirst%3DA.%26atitle%3DElucidation%2520of%2520Human%2520Choline%2520Kinase%2520Crystal%2520Structures%2520in%2520Complex%2520with%2520the%2520Products%2520ADP%2520or%2520Phosphocholine%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D364%26spage%3D136%26epage%3D151%26doi%3D10.1016%2Fj.jmb.2006.08.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Aoyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishidate, K.</span><span> </span><span class="NLM_article-title">Structure and function of choline kinase isoforms in mammalian cells</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/j.plipres.2003.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.plipres.2003.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=15003397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs12js7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=266-281&author=C.+Aoyamaauthor=H.+Liaoauthor=K.+Ishidate&title=Structure+and+function+of+choline+kinase+isoforms+in+mammalian+cells&doi=10.1016%2Fj.plipres.2003.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of choline kinase isoforms in mammalian cells</span></div><div class="casAuthors">Aoyama, Chieko; Liao, Huanan; Ishidate, Kozo</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">266-281</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Choline kinase (CK) catalyzes the 1st phosphorylation reaction in the CDP-choline pathway for the biosynthesis of phosphatidylcholine (PC), yielding phosphocholine (P-Cho) from choline and ATP in the presence of Mg2+.  CK exists in mammalian cells as at least 3 isoforms that are encoded by 2 sep. genes termed ck-α and ck-β.  Each isoform is inactive in its monomeric form.  The active enzyme consists of either homo- or hetero-dimeric (or oligomeric) forms.  In recent years, the roles of CK in cell growth and cell stress/defense mechanisms have been intensely investigated.  These functions of CK do not seem to be directly related to net PC biosynthesis, but predict another important role of this enzyme in certain cell physiol.  This review summarizes briefly the recent progress of mammalian CK study which includes the gene structure of each isoform and its possible transcriptional regulation, the active configuration of the enzyme, induction of the particular isoform in chem. induced cell stress, and the possible role of this enzyme as well as of its reaction product, P-Cho, in cell growth and other cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLHF2RgVFzrVg90H21EOLACvtfcHk0lg3ts94JinMHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs12js7g%253D&md5=d20280a9cb9d4b987f10035ffd5b61bd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2003.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2003.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DAoyama%26aufirst%3DC.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DIshidate%26aufirst%3DK.%26atitle%3DStructure%2520and%2520function%2520of%2520choline%2520kinase%2520isoforms%2520in%2520mammalian%2520cells%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2004%26volume%3D43%26spage%3D266%26epage%3D281%26doi%3D10.1016%2Fj.plipres.2003.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishidate, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teraoka, H.</span><span> </span><span class="NLM_article-title">Deletion and alanine mutation analyses for the formation of active homo-or hetero-dimer complexes of mouse choline kinase-α and-β</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1761</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2006.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.bbalip.2006.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=16490392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Ogsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1761&publication_year=2006&pages=111-120&author=H.+Liaoauthor=C.+Aoyamaauthor=K.+Ishidateauthor=H.+Teraoka&title=Deletion+and+alanine+mutation+analyses+for+the+formation+of+active+homo-or+hetero-dimer+complexes+of+mouse+choline+kinase-%CE%B1+and-%CE%B2&doi=10.1016%2Fj.bbalip.2006.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion and alanine mutation analyses for the formation of active homo- or hetero-dimer complexes of mouse choline kinase-α and -β</span></div><div class="casAuthors">Liao, Huanan; Aoyama, Chieko; Ishidate, Kozo; Teraoka, Hirobumi</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1761</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-120</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Choline kinase (CK) is the first-step regulatory enzyme for the biosynthesis of phosphatidylcholine in all mammalian cells.  It exists as at least three isoforms (α1, α2 and β) that are encoded by two sep. genes termed ck-α and ck-β.  The active enzyme has been proposed to consist of either their homo- or hetero-dimeric forms.  Here, we report on the identification of several essential domains and amino acid residues involved in their active dimer formation.  Full-length cDNAs or their truncated or alanine-mutated versions for mouse CK-α1 and CK-β tagged with either HA or Myc at their N-termini were expressed in COS-7 cells.  Each dimer formation was analyzed by immuno-pptn. followed by Western blotting.  Kinetic anal. for CK reaction was performed with different expression products.  Both the N-terminal domain-1 and C-terminal portions (E424-K430 for CK-α1 and Q379-K385 for CK-β) were shown to be crit. for the formation of active homo- or hetero-dimer complex.  Interestingly, D320 in the CK-motif of CK-α1 was found to be essential for α1/α1 homo-dimerization but not for α1/β hetero-dimerization.  A mutation of the corresponding D276 of CK-β to A276 did not show any effect on either its homo- or hetero-dimerization but it caused a strong inhibition of CK activity in either case.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NivcFHFUPLVg90H21EOLACvtfcHk0lg3ts94JinMHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Ogsr8%253D&md5=bc0b79fa5c2c62519df774ccade8bcc8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2006.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2006.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DAoyama%26aufirst%3DC.%26aulast%3DIshidate%26aufirst%3DK.%26aulast%3DTeraoka%26aufirst%3DH.%26atitle%3DDeletion%2520and%2520alanine%2520mutation%2520analyses%2520for%2520the%2520formation%2520of%2520active%2520homo-or%2520hetero-dimer%2520complexes%2520of%2520mouse%2520choline%2520kinase-%25CE%25B1%2520and-%25CE%25B2%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2006%26volume%3D1761%26spage%3D111%26epage%3D120%26doi%3D10.1016%2Fj.bbalip.2006.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hong, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allali-Hassani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finerty, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-W.</span><span> </span><span class="NLM_article-title">Crystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3 Single Amino Acid near the Active Site Influences Inhibitor Sensitivity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">16330</span><span class="NLM_x">–</span> <span class="NLM_lpage">16340</span><span class="refDoi"> DOI: 10.1074/jbc.M109.039024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1074%2Fjbc.M109.039024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=16330-16340&author=B.+S.+Hongauthor=A.+Allali-Hassaniauthor=W.+Tempelauthor=P.+J.+Finertyauthor=F.+MacKenzieauthor=S.+Dimovauthor=M.+Vedadiauthor=H.-W.+Park&title=Crystal+Structures+of+Human+Choline+Kinase+Isoforms+in+Complex+with+Hemicholinium-3+Single+Amino+Acid+near+the+Active+Site+Influences+Inhibitor+Sensitivity&doi=10.1074%2Fjbc.M109.039024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.039024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.039024%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DB.%2BS.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DFinerty%26aufirst%3DP.%2BJ.%26aulast%3DMacKenzie%26aufirst%3DF.%26aulast%3DDimov%26aufirst%3DS.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DH.-W.%26atitle%3DCrystal%2520Structures%2520of%2520Human%2520Choline%2520Kinase%2520Isoforms%2520in%2520Complex%2520with%2520Hemicholinium-3%2520Single%2520Amino%2520Acid%2520near%2520the%2520Active%2520Site%2520Influences%2520Inhibitor%2520Sensitivity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D16330%26epage%3D16340%26doi%3D10.1074%2Fjbc.M109.039024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug–target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span><span class="refDoi"> DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug%E2%80%93target+residence+time+and+its+implications+for+lead+optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lg3ts94JinMHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug%25E2%2580%2593target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">The role of binding kinetics in therapeutically useful drug action</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=19152211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt12ltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=31-39&author=D.+C.+Swinney&title=The+role+of+binding+kinetics+in+therapeutically+useful+drug+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The role of binding kinetics in therapeutically useful drug action</span></div><div class="casAuthors">Swinney, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-39</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Binding kinetics help define how a medicine will communicate with physiol. to produce a desired therapeutic response.  Clin. efficacy, duration of action, clin. differentiation and safety may all be influenced by binding kinetics.  The optimization of binding kinetics can be used to maximize a drug's therapeutic index and thereby decrease drug attrition.  The gap between basic scientific principles and the potential medical value of a drug is currently bridged by the use of empirical assays.  The value of binding kinetics to drug discovery will be increased through an improved ability to identify optimal kinetic mechanisms and define kinetic structure activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8IoReBfGAabVg90H21EOLACvtfcHk0ljdfyTa63NwXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt12ltrk%253D&md5=129948a7fb0a60f3b9995e5aedb700a4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DThe%2520role%2520of%2520binding%2520kinetics%2520in%2520therapeutically%2520useful%2520drug%2520action%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D31%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F.</span><span> </span><span class="NLM_article-title">The importance of drug-target residence time</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=19562645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=488-496&author=R.+Zhangauthor=F.+Monsma&title=The+importance+of+drug-target+residence+time"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of drug-target residence time</span></div><div class="casAuthors">Zhang, Rumin; Monsma, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of kinetics in drug-target interactions, and particularly the residence time of a drug with its target, is increasingly recognized to play a pivotal role in detg. both the efficacy and toxicity of a drug.  Drug residence time can often be demonstrated to be a key differentiating factor between drugs that act upon a common target.  Drug-target residence time can result in either favorable or unfavorable outcomes, and the use of such information could lead to the more efficient design of best-in-class drugs.  This review highlights several key concepts and observations related to drug-target residence time, and suggests the use of a kinetics-perceptive and energetics-informed approach to address the challenges facing current drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMGAUQvzpC3LVg90H21EOLACvtfcHk0ljdfyTa63NwXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClsbvF&md5=cf0982ae64a3b5e5294e033ffbd99ca0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DMonsma%26aufirst%3DF.%26atitle%3DThe%2520importance%2520of%2520drug-target%2520residence%2520time%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">Survey of the 2009 commercial optical biosensor literature</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span><span class="refDoi"> DOI: 10.1002/jmr.1138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1002%2Fjmr.1138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=22038797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=892-914&author=R.+L.+Richauthor=D.+G.+Myszka&title=Survey+of+the+2009+commercial+optical+biosensor+literature&doi=10.1002%2Fjmr.1138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Survey of the 2009 commercial optical biosensor literature</span></div><div class="casAuthors">Rich, Rebecca L.; Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-914</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  We took a different approach to reviewing the com. biosensor literature this year by inviting 22 biosensor users to serve as a review committee.  They set the criteria for what to expect in a publication and ultimately decided to use a pass/fail system for selecting which papers to include in this year's ref. list.  Of the 1514 publications in 2009 that reported using com. available optical biosensor technol., only 20% passed their cutoff.  The most common criticism the reviewers had with the literature was that "the biosensor expts. could have been done better.".  They selected 10 papers to highlight good exptl. technique, data presentation, and unique applications of the technol.  This communal review process was educational for everyone involved and one we will not soon forget.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVUTUDTLIbLbVg90H21EOLACvtfcHk0lgJXB9bpwY7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsL%252FI&md5=4a316816101a79565ddc287567eb2829</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjmr.1138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.1138%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DSurvey%2520of%2520the%25202009%2520commercial%2520optical%2520biosensor%2520literature%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2011%26volume%3D24%26spage%3D892%26epage%3D914%26doi%3D10.1002%2Fjmr.1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wilson, W. D.</span><span> </span><span class="NLM_article-title">Analyzing biomolecular interactions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="refDoi"> DOI: 10.1126/science.295.5562.2103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1126%2Fscience.295.5562.2103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=11896282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1Ohurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=2103&author=W.+D.+Wilson&title=Analyzing+biomolecular+interactions&doi=10.1126%2Fscience.295.5562.2103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Tech sight: Analyzing biomolecular interactions</span></div><div class="casAuthors">Wilson, W. David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5562</span>),
    <span class="NLM_cas:pages">2103, 2105</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_MPii95I1LVg90H21EOLACvtfcHk0lgJXB9bpwY7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1Ohurg%253D&md5=1178b2938fde58488f9b4874cda13b06</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscience.295.5562.2103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.295.5562.2103%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DW.%2BD.%26atitle%3DAnalyzing%2520biomolecular%2520interactions%26jtitle%3DScience%26date%3D2002%26volume%3D295%26spage%3D2103%26doi%3D10.1126%2Fscience.295.5562.2103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonge, P. J.</span><span> </span><span class="NLM_article-title">Drug–target residence time: critical information for lead optimization</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2010.06.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.cbpa.2010.06.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=20663707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=467-474&author=H.+Luauthor=P.+J.+Tonge&title=Drug%E2%80%93target+residence+time%3A+critical+information+for+lead+optimization&doi=10.1016%2Fj.cbpa.2010.06.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time: Critical information for lead optimization</span></div><div class="casAuthors">Lu, Hao; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Failure due to poor in vivo efficacy is a primary contributor to attrition during the development of new chemotherapeutics.  Lead optimization programs that in their quest for efficacy focus solely on improving the affinity of drug-target binding are flawed, since this approach ignores the fluctuations in drug concn. that occur in vivo.  Instead the lifetime of the drug-target complex must also be considered, since drugs only act when they are bound to their targets.  Consequently, to improve the correlation between the in vitro and in vivo activity of drugs, measurements of drug-target residence time must be incorporated into the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodk2kN_txuMLVg90H21EOLACvtfcHk0lgJXB9bpwY7ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D&md5=3189f56032106db858cfb4269d3fc11f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.06.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.06.176%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DDrug%25E2%2580%2593target%2520residence%2520time%253A%2520critical%2520information%2520for%2520lead%2520optimization%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D467%26epage%3D474%26doi%3D10.1016%2Fj.cbpa.2010.06.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Dahl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerud, T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and the drug–target residence time concept</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span><span class="refDoi"> DOI: 10.1016/j.drudis.2013.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.drudis.2013.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=23500610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVyqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=697-707&author=G.+Dahlauthor=T.+Akerud&title=Pharmacokinetics+and+the+drug%E2%80%93target+residence+time+concept&doi=10.1016%2Fj.drudis.2013.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and the drug-target residence time concept</span></div><div class="casAuthors">Dahl, Goeran; Akerud, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The concept of drug-target residence time has been in focus in recent drug discovery literature.  However, few studies consider the combined effect of pharmacokinetics (PK) and binding kinetics (BK) on the duration of effect of a drug.  Using a simple model that takes both PK and BK into account, we found that prolongation of binding owing to a long drug-target residence time can only occur when the binding dissocn. is slower than the PK elimination.  Data for several drugs and/or drug candidates in the literature indicate that the opposite is obsd., i.e., they have a slower elimination compared with dissocn.  These observations greatly reduce the usability of drug-target residence times for estg. the duration of effect of a drug in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon2xZ9fJkTybVg90H21EOLACvtfcHk0lg5d_q3u6dgqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVyqtL0%253D&md5=73b190a44d359f55ee19af9099846505</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DAkerud%26aufirst%3DT.%26atitle%3DPharmacokinetics%2520and%2520the%2520drug%25E2%2580%2593target%2520residence%2520time%2520concept%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D697%26epage%3D707%26doi%3D10.1016%2Fj.drudis.2013.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Vilums, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wapenaar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmare, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, J.</span><span> </span><span class="NLM_article-title">Structure–Kinetic Relationships: An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7706</span><span class="NLM_x">–</span> <span class="NLM_lpage">7714</span><span class="refDoi"> DOI: 10.1021/jm4011737</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011737" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7706-7714&author=M.+Vilumsauthor=A.+J.+Zweemerauthor=Z.+Yuauthor=H.+de+Vriesauthor=J.+M.+Hillgerauthor=H.+Wapenaarauthor=I.+A.+Bollenauthor=F.+Barmareauthor=R.+Grossauthor=J.+Clemens&title=Structure%E2%80%93Kinetic+Relationships%3A+An+Overlooked+Parameter+in+Hit-to-Lead+Optimization%3A+A+Case+of+Cyclopentylamines+as+Chemokine+Receptor+2+Antagonists&doi=10.1021%2Fjm4011737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm4011737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011737%26sid%3Dliteratum%253Aachs%26aulast%3DVilums%26aufirst%3DM.%26aulast%3DZweemer%26aufirst%3DA.%2BJ.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DHillger%26aufirst%3DJ.%2BM.%26aulast%3DWapenaar%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DI.%2BA.%26aulast%3DBarmare%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DR.%26aulast%3DClemens%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593Kinetic%2520Relationships%253A%2520An%2520Overlooked%2520Parameter%2520in%2520Hit-to-Lead%2520Optimization%253A%2520A%2520Case%2520of%2520Cyclopentylamines%2520as%2520Chemokine%2520Receptor%25202%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7706%26epage%3D7714%26doi%3D10.1021%2Fjm4011737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Al-Saffar, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I. R.</span><span> </span><span class="NLM_article-title">Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-1338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1158%2F0008-5472.CAN-05-1338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=427-434&author=N.+M.+Al-Saffarauthor=H.+Troyauthor=A.+Ram%C3%ADrez+de+Molinaauthor=L.+E.+Jacksonauthor=B.+Madhuauthor=J.+R.+Griffithsauthor=M.+O.+Leachauthor=P.+Workmanauthor=J.+C.+Lacalauthor=I.+R.+Judson&title=Noninvasive+magnetic+resonance+spectroscopic+pharmacodynamic+markers+of+the+choline+kinase+inhibitor+MN58b+in+human+carcinoma+models&doi=10.1158%2F0008-5472.CAN-05-1338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-1338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-1338%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Saffar%26aufirst%3DN.%2BM.%26aulast%3DTroy%26aufirst%3DH.%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DL.%2BE.%26aulast%3DMadhu%26aufirst%3DB.%26aulast%3DGriffiths%26aufirst%3DJ.%2BR.%26aulast%3DLeach%26aufirst%3DM.%2BO.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DJudson%26aufirst%3DI.%2BR.%26atitle%3DNoninvasive%2520magnetic%2520resonance%2520spectroscopic%2520pharmacodynamic%2520markers%2520of%2520the%2520choline%2520kinase%2520inhibitor%2520MN58b%2520in%2520human%2520carcinoma%2520models%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D427%26epage%3D434%26doi%3D10.1158%2F0008-5472.CAN-05-1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Al-Saffar, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. O.</span><span> </span><span class="NLM_article-title">The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase α leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5507</span><span class="NLM_x">–</span> <span class="NLM_lpage">5517</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-4476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1158%2F0008-5472.CAN-09-4476" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=5507-5517&author=N.+M.+Al-Saffarauthor=L.+E.+Jacksonauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=A.+Ram%C3%ADrez+de+Molinaauthor=J.+C.+Lacalauthor=P.+Workmanauthor=M.+O.+Leach&title=The+phosphoinositide+3-kinase+inhibitor+PI-103+downregulates+choline+kinase+%CE%B1+leading+to+phosphocholine+and+total+choline+decrease+detected+by+magnetic+resonance+spectroscopy&doi=10.1158%2F0008-5472.CAN-09-4476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-4476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-4476%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Saffar%26aufirst%3DN.%2BM.%26aulast%3DJackson%26aufirst%3DL.%2BE.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DLeach%26aufirst%3DM.%2BO.%26atitle%3DThe%2520phosphoinositide%25203-kinase%2520inhibitor%2520PI-103%2520downregulates%2520choline%2520kinase%2520%25CE%25B1%2520leading%2520to%2520phosphocholine%2520and%2520total%2520choline%2520decrease%2520detected%2520by%2520magnetic%2520resonance%2520spectroscopy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D5507%26epage%3D5517%26doi%3D10.1158%2F0008-5472.CAN-09-4476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Guma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Carbonell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiziani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">Choline kinase inhibition in rheumatoid arthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2014-205696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1136%2Fannrheumdis-2014-205696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25274633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A280%3ADC%252BC2M7msVWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2015&pages=1399-1407&author=M.+Gumaauthor=E.+Sanchez-Lopezauthor=A.+Lodiauthor=R.+Garcia-Carbonellauthor=S.+Tizianiauthor=M.+Karinauthor=J.+C.+Lacalauthor=G.+S.+Firestein&title=Choline+kinase+inhibition+in+rheumatoid+arthritis&doi=10.1136%2Fannrheumdis-2014-205696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Choline kinase inhibition in rheumatoid arthritis</span></div><div class="casAuthors">Guma M; Firestein G S; Sanchez-Lopez E; Garcia-Carbonell R; Karin M; Lodi A; Tiziani S; Lacal J C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-407</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Little is known about targeting the metabolome in non-cancer conditions.  Choline kinase (ChoKα), an essential enzyme for phosphatidylcholine biosynthesis, is required for cell proliferation and has been implicated in cancer invasiveness.  Aggressive behaviour of fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) led us to evaluate whether this metabolic pathway could play a role in RA FLS function and joint damage.  METHODS:  Choline metabolic profile of FLS cells was determined by (1)H magnetic resonance spectroscopy ((1)HMRS) under conditions of ChoKα inhibition.  FLS function was evaluated using the ChoKα inhibitor MN58b (IC50=4.2 μM).  For arthritis experiments, mice were injected with K/BxN sera.  MN58b (3 mg/kg) was injected daily intraperitoneal beginning on day 0 or day 4 after serum administration.  RESULTS:  The enzyme is expressed in synovial tissue and in cultured RA FLS.  Tumour necrosis factor (TNF) and platelet-derived growth factor (PDGF) stimulation increased ChoKα expression and levels of phosphocholine in FLS measured by Western Blot (WB) and metabolomic studies of choline-containing compounds in cultured RA FLS extracts respectively, suggesting activation of this pathway in RA synovial environment.  A ChoKα inhibitor also suppressed the behaviour of cultured FLS, including cell migration and resistance to apoptosis, which might contribute to cartilage destruction in RA.  In a passive K/BxN arthritis model, pharmacologic ChoKα inhibition significantly decreased arthritis in pretreatment protocols as well as in established disease.  CONCLUSIONS:  These data suggest that ChoKα inhibition could be an effective strategy in inflammatory arthritis.  It also suggests that targeting the metabolome can be a new treatment strategy in non-cancer conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs3K3z7lK6Ol1C8OJBvdfbfW6udTcc2ebDRT-IPqgqOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7msVWrtA%253D%253D&md5=7fde813ebbc0f5642ed3843417416182</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2014-205696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2014-205696%26sid%3Dliteratum%253Aachs%26aulast%3DGuma%26aufirst%3DM.%26aulast%3DSanchez-Lopez%26aufirst%3DE.%26aulast%3DLodi%26aufirst%3DA.%26aulast%3DGarcia-Carbonell%26aufirst%3DR.%26aulast%3DTiziani%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DCholine%2520kinase%2520inhibition%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2015%26volume%3D74%26spage%3D1399%26epage%3D1407%26doi%3D10.1136%2Fannrheumdis-2014-205696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Bernard, N. J.</span><span> </span><span class="NLM_article-title">Rheumatoid arthritis: Choline kinase: more than a cancer therapy target?</span> <span class="citation_source-journal">Nat. Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1038/nrrheum.2014.180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fnrrheum.2014.180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25330780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A280%3ADC%252BC2M3hvFeqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=699-699&author=N.+J.+Bernard&title=Rheumatoid+arthritis%3A+Choline+kinase%3A+more+than+a+cancer+therapy+target%3F&doi=10.1038%2Fnrrheum.2014.180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Rheumatoid arthritis: Choline kinase--more than a cancer therapy target?</span></div><div class="casAuthors">Bernard Nicholas J</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">699</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgc4UZLZDFNgvupmecNw_lfW6udTcc2eZz8HBqKjW8Abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3hvFeqsg%253D%253D&md5=9804194be86e51e666018dd415f46169</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2014.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2014.180%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DN.%2BJ.%26atitle%3DRheumatoid%2520arthritis%253A%2520Choline%2520kinase%253A%2520more%2520than%2520a%2520cancer%2520therapy%2520target%253F%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2014%26volume%3D10%26spage%3D699%26epage%3D699%26doi%3D10.1038%2Fnrrheum.2014.180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Identifying and characterizing binding sites and assessing druggability</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1021/ci800324m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800324m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=377-389&author=T.+A.+Halgren&title=Identifying+and+characterizing+binding+sites+and+assessing+druggability&doi=10.1021%2Fci800324m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying and Characterizing Binding Sites and Assessing Druggability</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-389</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Identification and characterization of binding sites is key in the process of structure-based drug design.  In some cases there may not be any information about the binding site for a target of interest.  In other cases, a putative binding site has been identified by computational or exptl. means, but the druggability of the target is not known.  Even when a site for a given target is known, it may be desirable to find addnl. sites whose targeting could produce a desired biol. response.  A new program, called SiteMap, is presented for identifying and analyzing binding sites and for predicting target druggability.  In a large-scale validation, SiteMap correctly identifies the known binding site as the top-ranked site in 86% of the cases, with best results (>98%) coming for sites that bind ligands with subnanomolar affinity.  In addn., a modified version of the score employed for binding-site identification allows SiteMap to accurately classify the druggability of proteins as measured by their ability to bind passively absorbed small mols. tightly.  In characterizing binding sites, SiteMap provides quant. and graphical information that can help guide efforts to critically assess virtual hits in a lead-discovery application or to modify ligand structure to enhance potency or improve phys. properties in a lead-optimization context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfAt0-gvcXDLVg90H21EOLACvtfcHk0lisgdMOih5Iiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D&md5=f03c7b27e30ae03d10e4127ed1f1ed3c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fci800324m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800324m%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DIdentifying%2520and%2520characterizing%2520binding%2520sites%2520and%2520assessing%2520druggability%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D377%26epage%3D389%26doi%3D10.1021%2Fci800324m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span>SiteMap, version <span class="NLM_edition">2.4</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SiteMap%2C+version+2.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSiteMap%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>Glide, version <span class="NLM_edition">5.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>LigPrep, version <span class="NLM_edition">2.3</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>Prime, version <span class="NLM_edition">2.1</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+2.1%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Claudio Dalvit, <span class="NLM_string-name hlFld-ContribAuthor">Anna Vulpetti</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2218-2244. <a href="https://doi.org/10.1021/acs.jmedchem.8b01210" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01210%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand-Based%252BFluorine%252BNMR%252BScreening%25253A%252BPrinciples%252Band%252BApplications%252Bin%252BDrug%252BDiscovery%252BProjects%26aulast%3DDalvit%26aufirst%3DClaudio%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01082018%26date%3D29102018%26date%3D08102018%26volume%3D62%26issue%3D5%26spage%3D2218%26epage%3D2244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher N. Johnson, Daniel A. Erlanson, Wolfgang Jahnke, Paul N. Mortenson, <span class="NLM_string-name hlFld-ContribAuthor">David C. Rees</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2016. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1774-1784. <a href="https://doi.org/10.1021/acs.jmedchem.7b01298" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2016%26aulast%3DJohnson%26aufirst%3DChristopher%2BN.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D31082017%26date%3D31102017%26volume%3D61%26issue%3D5%26spage%3D1774%26epage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie L.  Kall</span>, <span class="hlFld-ContribAuthor ">Edward J.  Delikatny</span>, and <span class="hlFld-ContribAuthor ">Arnon  Lavie</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Unique Inhibitor-Binding Site on Choline Kinase α. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (8)
                                     , 1316-1325. <a href="https://doi.org/10.1021/acs.biochem.7b01257" title="DOI URL">https://doi.org/10.1021/acs.biochem.7b01257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.7b01257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.7b01257%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DIdentification%252Bof%252Ba%252BUnique%252BInhibitor-Binding%252BSite%252Bon%252BCholine%252BKinase%252B%2525CE%2525B1%26aulast%3DKall%26aufirst%3DStefanie%2BL.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D2018%26date%3D15122017%26date%3D19012018%26date%3D08022018%26date%3D27022018%26date%3D01022018%26volume%3D57%26issue%3D8%26spage%3D1316%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesus  Pacheco-Torres</span>, <span class="hlFld-ContribAuthor ">Marie-France  Penet</span>, <span class="hlFld-ContribAuthor ">Yelena  Mironchik</span>, <span class="hlFld-ContribAuthor ">Balaji  Krishnamachary</span>, <span class="hlFld-ContribAuthor ">Zaver M.  Bhujwalla</span>. </span><span class="cited-content_cbyCitation_article-title">The PD-L1 metabolic interactome intersects with choline metabolism and inflammation. </span><span class="cited-content_cbyCitation_journal-name">Cancer & Metabolism</span><span> <strong>2021,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40170-021-00245-w" title="DOI URL">https://doi.org/10.1186/s40170-021-00245-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40170-021-00245-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40170-021-00245-w%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520%2526%2520Metabolism%26atitle%3DThe%252BPD-L1%252Bmetabolic%252Binteractome%252Bintersects%252Bwith%252Bcholine%252Bmetabolism%252Band%252Binflammation%26aulast%3DPacheco-Torres%26aufirst%3DJesus%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Diana  Brickute</span>, <span class="hlFld-ContribAuthor ">Marta  Braga</span>, <span class="hlFld-ContribAuthor ">Chris  Barnes</span>, <span class="hlFld-ContribAuthor ">Haonan  Lu</span>, <span class="hlFld-ContribAuthor ">Louis  Allott</span>, <span class="hlFld-ContribAuthor ">Eric O.  Aboagye</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 1078. <a href="https://doi.org/10.3390/pharmaceutics13071078" title="DOI URL">https://doi.org/10.3390/pharmaceutics13071078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13071078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13071078%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DNovel%252BNon-Congeneric%252BDerivatives%252Bof%252Bthe%252BCholine%252BKinase%252BAlpha%252BInhibitor%252BICL-CCIC-0019%26aulast%3DWang%26aufirst%3DNing%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D1078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan Carlos  Lacal</span>, <span class="hlFld-ContribAuthor ">Tahl  Zimmerman</span>, <span class="hlFld-ContribAuthor ">Joaquín M.  Campos</span>. </span><span class="cited-content_cbyCitation_article-title">Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 788. <a href="https://doi.org/10.3390/pharmaceutics13060788" title="DOI URL">https://doi.org/10.3390/pharmaceutics13060788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13060788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13060788%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DCholine%252BKinase%25253A%252BAn%252BUnexpected%252BJourney%252Bfor%252Ba%252BPrecision%252BMedicine%252BStrategy%252Bin%252BHuman%252BDiseases%26aulast%3DLacal%26aufirst%3DJuan%2BCarlos%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belén  Rubio‐Ruiz</span>, <span class="hlFld-ContribAuthor ">Lucía  Serrán‐Aguilera</span>, <span class="hlFld-ContribAuthor ">Ramón  Hurtado‐Guerrero</span>, <span class="hlFld-ContribAuthor ">Ana  Conejo‐García</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (2)
                                     , 902-927. <a href="https://doi.org/10.1002/med.21746" title="DOI URL">https://doi.org/10.1002/med.21746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21746%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdesign%252Bof%252Bcholine%252Bkinase%252B%2525CE%2525B1%252Binhibitors%252Band%252Bthe%252Bmolecular%252Bbasis%252Bof%252Btheir%252Binhibition%26aulast%3DRubio%25E2%2580%2590Ruiz%26aufirst%3DBel%25C3%25A9n%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D2%26spage%3D902%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucía  Serrán- Aguilera</span>, <span class="hlFld-ContribAuthor ">Elena  Mariotto</span>, <span class="hlFld-ContribAuthor ">Gianluca  Rubbini</span>, <span class="hlFld-ContribAuthor ">Francisco Fermín  Castro Navas</span>, <span class="hlFld-ContribAuthor ">Carmen  Marco</span>, <span class="hlFld-ContribAuthor ">María Paz  Carrasco-Jiménez</span>, <span class="hlFld-ContribAuthor ">Marco  Ballarotto</span>, <span class="hlFld-ContribAuthor ">Antonio  Macchiarulo</span>, <span class="hlFld-ContribAuthor ">Ramón  Hurtado-Guerrero</span>, <span class="hlFld-ContribAuthor ">Giampietro  Viola</span>, <span class="hlFld-ContribAuthor ">Luisa Carlota  Lopez-Cara</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>207 </em>, 112797. <a href="https://doi.org/10.1016/j.ejmech.2020.112797" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112797%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Bin%252Bsilico%252Bmodeling%252Band%252Bcrystallization%252Bof%252Bnovel%252Bsmall%252Bmonocationic%252Bmolecules%252Bwith%252Bpotent%252Bantiproliferative%252Bactivity%252Bby%252Bdual%252Bmechanism%26aulast%3DSerr%25C3%25A1n-%2BAguilera%26aufirst%3DLuc%25C3%25ADa%26date%3D2020%26volume%3D207%26spage%3D112797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaj S.  Troelsen</span>, <span class="hlFld-ContribAuthor ">Mads H.  Clausen</span>. </span><span class="cited-content_cbyCitation_article-title">Library Design Strategies To Accelerate Fragment‐Based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (50)
                                     , 11391-11403. <a href="https://doi.org/10.1002/chem.202000584" title="DOI URL">https://doi.org/10.1002/chem.202000584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202000584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202000584%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DLibrary%252BDesign%252BStrategies%252BTo%252BAccelerate%252BFragment%2525E2%252580%252590Based%252BDrug%252BDiscovery%26aulast%3DTroelsen%26aufirst%3DNikolaj%2BS.%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D50%26spage%3D11391%26epage%3D11403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael A.  Zoeller</span>, <span class="hlFld-ContribAuthor ">Kathleen  Geoghegan-Barek</span>. </span><span class="cited-content_cbyCitation_article-title">A cell-based high-throughput screen identifies tyrphostin AG 879 as an inhibitor of animal cell phospholipid and fatty acid biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry and Biophysics Reports</span><span> <strong>2019,</strong> <em>18 </em>, 100621. <a href="https://doi.org/10.1016/j.bbrep.2019.100621" title="DOI URL">https://doi.org/10.1016/j.bbrep.2019.100621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrep.2019.100621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrep.2019.100621%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520and%2520Biophysics%2520Reports%26atitle%3DA%252Bcell-based%252Bhigh-throughput%252Bscreen%252Bidentifies%252Btyrphostin%252BAG%252B879%252Bas%252Ban%252Binhibitor%252Bof%252Banimal%252Bcell%252Bphospholipid%252Band%252Bfatty%252Bacid%252Bbiosynthesis%26aulast%3DZoeller%26aufirst%3DRaphael%2BA.%26date%3D2019%26volume%3D18%26spage%3D100621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dylan T.  Jones</span>, <span class="hlFld-ContribAuthor ">Alessandro  Valli</span>, <span class="hlFld-ContribAuthor ">Syed  Haider</span>, <span class="hlFld-ContribAuthor ">Qifeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Smethurst</span>, <span class="hlFld-ContribAuthor ">Zachary T.  Schug</span>, <span class="hlFld-ContribAuthor ">Barrie  Peck</span>, <span class="hlFld-ContribAuthor ">Eric O.  Aboagye</span>, <span class="hlFld-ContribAuthor ">Susan E.  Critchlow</span>, <span class="hlFld-ContribAuthor ">Almut  Schulze</span>, <span class="hlFld-ContribAuthor ">Eyal  Gottlieb</span>, <span class="hlFld-ContribAuthor ">Michael J.O.  Wakelam</span>, <span class="hlFld-ContribAuthor ">Adrian L.  Harris</span>. </span><span class="cited-content_cbyCitation_article-title">3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (2)
                                     , 376-388. <a href="https://doi.org/10.1158/1535-7163.MCT-17-0857" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-0857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-0857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-0857%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3D3D%252BGrowth%252Bof%252BCancer%252BCells%252BElicits%252BSensitivity%252Bto%252BKinase%252BInhibitors%252Bbut%252BNot%252BLipid%252BMetabolism%252BModifiers%26aulast%3DJones%26aufirst%3DDylan%2BT.%26date%3D2019%26date%3D2018%26volume%3D18%26issue%3D2%26spage%3D376%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Mariotto</span>, <span class="hlFld-ContribAuthor ">Roberta  Bortolozzi</span>, <span class="hlFld-ContribAuthor ">Ilaria  Volpin</span>, <span class="hlFld-ContribAuthor ">Davide  Carta</span>, <span class="hlFld-ContribAuthor ">Valentina  Serafin</span>, <span class="hlFld-ContribAuthor ">Benedetta  Accordi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Basso</span>, <span class="hlFld-ContribAuthor ">Pilar Luque  Navarro</span>, <span class="hlFld-ContribAuthor ">Luisa Carlota  López-Cara</span>, <span class="hlFld-ContribAuthor ">Giampietro  Viola</span>. </span><span class="cited-content_cbyCitation_article-title">EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>155 </em>, 213-223. <a href="https://doi.org/10.1016/j.bcp.2018.07.004" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DEB-3D%252Ba%252Bnovel%252Bcholine%252Bkinase%252Binhibitor%252Binduces%252Bderegulation%252Bof%252Bthe%252BAMPK-mTOR%252Bpathway%252Band%252Bapoptosis%252Bin%252Bleukemia%252BT-cells%26aulast%3DMariotto%26aufirst%3DElena%26date%3D2018%26volume%3D155%26spage%3D213%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluca  Rubbini</span>, <span class="hlFld-ContribAuthor ">Ana Begoña  Buades-Martín</span>, <span class="hlFld-ContribAuthor ">María  Kimatrai-Salvador</span>, <span class="hlFld-ContribAuthor ">Antonio  Entrena</span>, <span class="hlFld-ContribAuthor ">Miguel Ángel  Gallo-Mezo</span>, <span class="hlFld-ContribAuthor ">Pablo  Ríos-Marco</span>, <span class="hlFld-ContribAuthor ">Carmen  Marco</span>, <span class="hlFld-ContribAuthor ">Elena  Mattiuzzo</span>, <span class="hlFld-ContribAuthor ">Roberta  Bortolozzi</span>, <span class="hlFld-ContribAuthor ">Elena  Mariotto</span>, <span class="hlFld-ContribAuthor ">Francesco Antonio  Greco</span>, <span class="hlFld-ContribAuthor ">Antonio  Macchiarulo</span>, <span class="hlFld-ContribAuthor ">María Paz  Carrasco-Jiménez</span>, <span class="hlFld-ContribAuthor ">Giampietro  Viola</span>, <span class="hlFld-ContribAuthor ">Luisa Carlota  López-Cara</span>. </span><span class="cited-content_cbyCitation_article-title">Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (15)
                                     , 1769-1786. <a href="https://doi.org/10.4155/fmc-2018-0059" title="DOI URL">https://doi.org/10.4155/fmc-2018-0059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0059%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DLead%252Boptimization-hit%252Bexpansion%252Bof%252Bnew%252Basymmetrical%252Bpyridinium%25252Fquinolinium%252Bcompounds%252Bas%252Bcholine%252Bkinase%252B%2525CE%2525B11%252Binhibitors%26aulast%3DRubbini%26aufirst%3DGianluca%26date%3D2018%26volume%3D10%26issue%3D15%26spage%3D1769%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Dalvit</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">19
              F NMR isotropic chemical shift for efficient screening of fluorinated fragments which are racemates and/or display multiple conformers. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2017,</strong> <em>55 </em>
                                    (12)
                                     , 1091-1095. <a href="https://doi.org/10.1002/mrc.4640" title="DOI URL">https://doi.org/10.1002/mrc.4640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.4640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.4640%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3D19%252BF%252BNMR%252Bisotropic%252Bchemical%252Bshift%252Bfor%252Befficient%252Bscreening%252Bof%252Bfluorinated%252Bfragments%252Bwhich%252Bare%252Bracemates%252Band%25252For%252Bdisplay%252Bmultiple%252Bconformers%26aulast%3DDalvit%26aufirst%3DClaudio%26date%3D2017%26date%3D2017%26volume%3D55%26issue%3D12%26spage%3D1091%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belén  Rubio-Ruiz</span>, <span class="hlFld-ContribAuthor ">Pablo  Ríos-Marco</span>, <span class="hlFld-ContribAuthor ">María Paz  Carrasco-Jiménez</span>, <span class="hlFld-ContribAuthor ">Antonio  Espinosa</span>, <span class="hlFld-ContribAuthor ">Ramon  Hurtado-Guerrero</span>, <span class="hlFld-ContribAuthor ">Carmen  Marco</span>, <span class="hlFld-ContribAuthor ">Ana  Conejo-García</span>, <span class="hlFld-ContribAuthor ">Antonio  Entrena</span>. </span><span class="cited-content_cbyCitation_article-title">Choline kinase inhibition and docking studies of a series of 6-(benzylthio)-9H-purin-9-yl-pyridinium derivatives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2017,</strong> <em>26 </em>
                                    (11)
                                     , 2809-2815. <a href="https://doi.org/10.1007/s00044-017-1979-6" title="DOI URL">https://doi.org/10.1007/s00044-017-1979-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-017-1979-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-017-1979-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DCholine%252Bkinase%252Binhibition%252Band%252Bdocking%252Bstudies%252Bof%252Ba%252Bseries%252Bof%252B6-%252528benzylthio%252529-9H-purin-9-yl-pyridinium%252Bderivatives%26aulast%3DRubio-Ruiz%26aufirst%3DBel%25C3%25A9n%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D11%26spage%3D2809%26epage%3D2815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Dalvit</span>, <span class="hlFld-ContribAuthor ">Martial  Piotto</span>. </span><span class="cited-content_cbyCitation_article-title">19
              F NMR transverse and longitudinal relaxation filter experiments for screening: a theoretical and experimental analysis. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2017,</strong> <em>55 </em>
                                    (2)
                                     , 106-114. <a href="https://doi.org/10.1002/mrc.4500" title="DOI URL">https://doi.org/10.1002/mrc.4500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.4500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.4500%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3D19%252BF%252BNMR%252Btransverse%252Band%252Blongitudinal%252Brelaxation%252Bfilter%252Bexperiments%252Bfor%252Bscreening%25253A%252Ba%252Btheoretical%252Band%252Bexperimental%252Banalysis%26aulast%3DDalvit%26aufirst%3DClaudio%26date%3D2017%26date%3D2016%26volume%3D55%26issue%3D2%26spage%3D106%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Heng  Qiu</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Yuan</span>, <span class="hlFld-ContribAuthor ">Jennifer  Tickner</span>, <span class="hlFld-ContribAuthor ">Jiake  Xu</span>, <span class="hlFld-ContribAuthor ">Jun  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular structure and differential function of choline kinases CHKα and CHKβ in musculoskeletal system and cancer. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2017,</strong> <em>33 </em>, 65-72. <a href="https://doi.org/10.1016/j.cytogfr.2016.10.002" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2016.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2016.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2016.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DMolecular%252Bstructure%252Band%252Bdifferential%252Bfunction%252Bof%252Bcholine%252Bkinases%252BCHK%2525CE%2525B1%252Band%252BCHK%2525CE%2525B2%252Bin%252Bmusculoskeletal%252Bsystem%252Band%252Bcancer%26aulast%3DChen%26aufirst%3DXi%26date%3D2017%26volume%3D33%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Hu</span>, <span class="hlFld-ContribAuthor ">Ruo-Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Cai</span>, <span class="hlFld-ContribAuthor ">Dan  Feng</span>, <span class="hlFld-ContribAuthor ">Guang-Zhen  Yang</span>, <span class="hlFld-ContribAuthor ">Qing-Guo  Xu</span>, <span class="hlFld-ContribAuthor ">Yan-Xia  Zhai</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei-Ping  Zhou</span>, <span class="hlFld-ContribAuthor ">Qing-Ping  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (41)
                                     , 66660-66678. <a href="https://doi.org/10.18632/oncotarget.11433" title="DOI URL">https://doi.org/10.18632/oncotarget.11433</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.11433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.11433%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DOverexpression%252Bof%252BCHKA%252Bcontributes%252Bto%252Btumor%252Bprogression%252Band%252Bmetastasis%252Band%252Bpredicts%252Bpoor%252Bprognosis%252Bin%252Bcolorectal%252Bcarcinoma%26aulast%3DHu%26aufirst%3DLiang%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D41%26spage%3D66660%26epage%3D66678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Bagnoli</span>, <span class="hlFld-ContribAuthor ">Anna  Granata</span>, <span class="hlFld-ContribAuthor ">Roberta  Nicoletti</span>, <span class="hlFld-ContribAuthor ">Balaji  Krishnamachary</span>, <span class="hlFld-ContribAuthor ">Zaver M.  Bhujwalla</span>, <span class="hlFld-ContribAuthor ">Rossella  Canese</span>, <span class="hlFld-ContribAuthor ">Franca  Podo</span>, <span class="hlFld-ContribAuthor ">Silvana  Canevari</span>, <span class="hlFld-ContribAuthor ">Egidio  Iorio</span>, <span class="hlFld-ContribAuthor ">Delia  Mezzanzanica</span>. </span><span class="cited-content_cbyCitation_article-title">Choline Metabolism Alteration: A Focus on Ovarian Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2016,</strong> <em>6 </em><a href="https://doi.org/10.3389/fonc.2016.00153" title="DOI URL">https://doi.org/10.3389/fonc.2016.00153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2016.00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2016.00153%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DCholine%252BMetabolism%252BAlteration%25253A%252BA%252BFocus%252Bon%252BOvarian%252BCancer%26aulast%3DBagnoli%26aufirst%3DMarina%26date%3D2016%26date%3D2016%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian  Trousil</span>, <span class="hlFld-ContribAuthor ">Maciej  Kaliszczak</span>, <span class="hlFld-ContribAuthor ">Zachary  Schug</span>, <span class="hlFld-ContribAuthor ">Quang-De  Nguyen</span>, <span class="hlFld-ContribAuthor ">Giampaolo  Tomasi</span>, <span class="hlFld-ContribAuthor ">Rosy  Favicchio</span>, <span class="hlFld-ContribAuthor ">Diana  Brickute</span>, <span class="hlFld-ContribAuthor ">Robin  Fortt</span>, <span class="hlFld-ContribAuthor ">Frazer J.  Twyman</span>, <span class="hlFld-ContribAuthor ">Laurence  Carroll</span>, <span class="hlFld-ContribAuthor ">Andrew  Kalusa</span>, <span class="hlFld-ContribAuthor ">Naveenan  Navaratnam</span>, <span class="hlFld-ContribAuthor ">Thomas  Adejumo</span>, <span class="hlFld-ContribAuthor ">David  Carling</span>, <span class="hlFld-ContribAuthor ">Eyal  Gottlieb</span>, <span class="hlFld-ContribAuthor ">Eric O.  Aboagye</span>. </span><span class="cited-content_cbyCitation_article-title">The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (24)
                                     , 37103-37120. <a href="https://doi.org/10.18632/oncotarget.9466" title="DOI URL">https://doi.org/10.18632/oncotarget.9466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.9466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.9466%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Bnovel%252Bcholine%252Bkinase%252Binhibitor%252BICL-CCIC-0019%252Breprograms%252Bcellular%252Bmetabolism%252Band%252Binhibits%252Bcancer%252Bcell%252Bgrowth%26aulast%3DTrousil%26aufirst%3DSebastian%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D24%26spage%3D37103%26epage%3D37120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. STD NMR fragment screening. (A) Reference NMR spectrum of <b>7</b> and STD NMR spectrum (red) in the presence of 30 μM ChoK indicating reversible binding of <b>7</b>. (B) Reference spectrum and STD NMR spectrum of <b>8</b>. The stronger STD signals observed for the diazepane moiety compared to the aromatic signals imply a close contact of the diazepane with the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR validation of fragment hits. Sensograms for compounds <b>12</b>, <b>11</b>, and <b>13</b> binding to a surface with immobilized ChoKα (left) or the reference protein CA-II (right). The sensograms were obtained at 25 °C using a 2-fold dilution series with an upper concentration of 300 μM. <i>K</i><sub>d</sub> values were obtained by fitting the data to a 1:1 binding model (error margin of ∼2-fold, ∗ = injection artifact).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of ChoKα bound by compound <b>11</b> at 2.4 Å (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQE">5EQE</a>). (A) Overview of the ChoKα complex structure. Compound <b>11</b>, binding in the choline site is shown as sticks and colored in green. The superimposed phosphochloline (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKQ">2CKQ</a>) in cyan is included for comparison. The ATP site of the enzyme is also indicated. Structural figures were prepared using PyMol unless noted otherwise. (B) Binding mode of compound <b>11</b> in the substrate site of ChoKα. The protein is shown as cartoon with amino acid side chains as sticks. The hydrophobic residues lining the “hydrophobic groove” are labeled. The purple dashed line denotes hydrogen bonding interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Key SAR elements of the fragment hit-to-lead progression. Ligand efficiency was calculated as LE = −1.4 log(<i>K</i><sub>d</sub>)/(no. of heavy atoms).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of ChoKα bound by a lead compound <b>65</b> (2.5 Å, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQY">5EQY</a>). ChoKα is colored in green, and compound <b>65</b> is in orange. Red spheres are water molecules that bridge the interactions between the protein and inhibitor molecules. The purple dashed line denotes hydrogen bonding interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular activity of elaborated ChoK inhibitors. Growth inhibition of breast cancer cell lines by ChoK inhibitors <b>67</b> (A) and <b>49</b> (B). Both compounds selectively induced cell death of breast cancer but not breast epithelial lines. (C) Summary of GI<sub>50</sub> values and maximum growth inhibition. The markers identify the respective inhibition curves shown above. Numbers in red indicate cell death (>100% growth inhibition). Apoptosis signals measured for ChoK lead compounds <b>67</b> (D) and <b>49</b> (E) for cell lines MDA-MB-415 (top, solid red curves) and MCF-12A (bottom, solid blue curves).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/medium/jm-2015-015524_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. NMR detected reduction of cellular pCho levels as a function of compound treatment. (A) Overlay of NMR spectra of cell extracts from cell line MDA-MB-468 treated with increasing amounts of <b>49</b>. The level of pCho at ∼3.24 ppm shows a dose dependent inhibition. To account for slight variations in cell count and extraction efficiency, the spectral intensities have been calibrated to match the signals of lactate at ∼1.34 ppm. (B) NMR spectra of metabolites extracted from cell line MDA-MB-415 treated with <b>67</b>. Metabolites at 3.26–3.29 ppm have been used as internal reference. The pCho levels show a dose dependent decrease. Spectral positions for glycerolphosphocholine (GPC) and choline (Ch) are indicated. Table: Approximate cellular IC<sub>50</sub> of pCho inhibition evaluated from panels A and B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-2/acs.jmedchem.5b01552/20160122/images/large/jm-2015-015524_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01552&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cuadrado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolfi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2959</span><span class="NLM_x">–</span> <span class="NLM_lpage">2968</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=8414498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK2cXmslGg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1993&pages=2959-2968&author=A.+Cuadradoauthor=A.+Carneroauthor=F.+Dolfiauthor=B.+Jim%C3%A9nezauthor=J.+C.+Lacal&title=Phosphorylcholine%3A+a+novel+second+messenger+essential+for+mitogenic+activity+of+growth+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors</span></div><div class="casAuthors">Cuadrado, Antonio; Carnero, Amancio; Dolfi, Fabrizio; Jimenez, Benilde; Lacal, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2959-68</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    </div><div class="casAbstract">Growth factor stimulation of quiescent cells induces a series of intracellular early and late events that ultimately lead to DNA synthesis and cell division.  The authors describe here that prodn. of phosphorylcholine is an essential component of the late events involved in the induction of DNA synthesis by platelet-derived growth factor (PDGF-BB), a prototype mitogen for fibroblasts.  Moreover, phosphorylcholine itself is mitogenic when added exogenously to NIH3T3 cells, further indicating its role as a crucial intracellular messenger for DNA synthesis.  Choline kinase, the first step in the route of phosphatidylcholine synthesis appears to be the crit. regulatory enzyme in phosphorylcholine prodn., indicating that regulation of choline kinase represents a key step during mitogenic stimulation.  Several growth factors (PDGF-AA, basic FGF, EGF and phorbol esters) rely on their ability to generate phosphorylcholine for their proliferating activity.  In contrast, DNA synthesis induced by serum did not require phosphorylcholine.  Moreover, the requirement for phosphorylcholine prodn. in PDGF-stimulated cells can be over-ruled by addn. of insulin.  Thus, cell proliferation in NIH3T3 cells can be triggered by alternative pathways and one of them involves generation of phosphorylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraL2acf3VUTrVg90H21EOLACvtfcHk0liY5weW7LJP_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslGg&md5=110e358e64bcfaa1370e467daf4d6f3e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DCarnero%26aufirst%3DA.%26aulast%3DDolfi%26aufirst%3DF.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DB.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DPhosphorylcholine%253A%2520a%2520novel%2520second%2520messenger%2520essential%2520for%2520mitogenic%2520activity%2520of%2520growth%2520factors%26jtitle%3DOncogene%26date%3D1993%26volume%3D8%26spage%3D2959%26epage%3D2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Nishizuka, Y.</span><span> </span><span class="NLM_article-title">Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">614</span><span class="refDoi"> DOI: 10.1126/science.1411571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1126%2Fscience.1411571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1411571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK38XmsVyqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=607-614&author=Y.+Nishizuka&title=Intracellular+signaling+by+hydrolysis+of+phospholipids+and+activation+of+protein+kinase+C&doi=10.1126%2Fscience.1411571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C</span></div><div class="casAuthors">Nishizuka, Yasutomi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5082</span>),
    <span class="NLM_cas:pages">607-14</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review, with 107 refs., on protein kinase C (PKC) activation by diacylglycerols and phospholipases D and A2, Ca2+ signals and phospholipid degrdn., and Ca2+ and lipid requirements of PKC isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogM810LsZLaLVg90H21EOLACvtfcHk0liY5weW7LJP_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVyqsbo%253D&md5=4e0b994bb9e03c778000a4b74a691fde</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1411571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1411571%26sid%3Dliteratum%253Aachs%26aulast%3DNishizuka%26aufirst%3DY.%26atitle%3DIntracellular%2520signaling%2520by%2520hydrolysis%2520of%2520phospholipids%2520and%2520activation%2520of%2520protein%2520kinase%2520C%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D607%26epage%3D614%26doi%3D10.1126%2Fscience.1411571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gallego-Ortega, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdes-Mora, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barderas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarmentero-Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e7819</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1371%2Fjournal.pone.0007819" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7819&author=D.+Gallego-Ortegaauthor=A.+Ramirez+de+Molinaauthor=M.+A.+Ramosauthor=F.+Valdes-Moraauthor=M.+G.+Barderasauthor=J.+Sarmentero-Estradaauthor=J.+C.+Lacal&title=Differential+role+of+human+choline+kinase+alpha+and+beta+enzymes+in+lipid+metabolism%3A+implications+in+cancer+onset+and+treatment&doi=10.1371%2Fjournal.pone.0007819"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007819%26sid%3Dliteratum%253Aachs%26aulast%3DGallego-Ortega%26aufirst%3DD.%26aulast%3DRamirez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DM.%2BA.%26aulast%3DValdes-Mora%26aufirst%3DF.%26aulast%3DBarderas%26aufirst%3DM.%2BG.%26aulast%3DSarmentero-Estrada%26aufirst%3DJ.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DDifferential%2520role%2520of%2520human%2520choline%2520kinase%2520alpha%2520and%2520beta%2520enzymes%2520in%2520lipid%2520metabolism%253A%2520implications%2520in%2520cancer%2520onset%2520and%2520treatment%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De7819%26doi%3D10.1371%2Fjournal.pone.0007819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Glunde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhujwalla, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronen, S. M.</span><span> </span><span class="NLM_article-title">Choline metabolism in malignant transformation</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/nrc3162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fnrc3162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=22089420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOisb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=835-848&author=K.+Glundeauthor=Z.+M.+Bhujwallaauthor=S.+M.+Ronen&title=Choline+metabolism+in+malignant+transformation&doi=10.1038%2Fnrc3162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Choline metabolism in malignant transformation</span></div><div class="casAuthors">Glunde, Kristine; Bhujwalla, Zaver M.; Ronen, Sabrina M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">835-848</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Abnormal choline metab. is emerging as a metabolic hallmark that is assocd. with oncogenesis and tumor progression.  Following transformation, the modulation of enzymes that control anabolic and catabolic pathways causes increased levels of choline-contg. precursors and breakdown products of membrane phospholipids.  These increased levels are assocd. with proliferation, and recent studies emphasize the complex reciprocal interactions between oncogenic signalling and choline metab.  Because choline-contg. compds. are detected by non-invasive magnetic resonance spectroscopy (MRS), increased levels of these compds. provide a non-invasive biomarker of transformation, staging and response to therapy.  Furthermore, enzymes of choline metab., such as choline kinase, present novel targets for image-guided cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTIzH3dwf9JbVg90H21EOLACvtfcHk0lgcEviRWiGVKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOisb7P&md5=507254b352e1c68fdca10194449216eb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc3162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3162%26sid%3Dliteratum%253Aachs%26aulast%3DGlunde%26aufirst%3DK.%26aulast%3DBhujwalla%26aufirst%3DZ.%2BM.%26aulast%3DRonen%26aufirst%3DS.%2BM.%26atitle%3DCholine%2520metabolism%2520in%2520malignant%2520transformation%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D835%26epage%3D848%26doi%3D10.1038%2Fnrc3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Granata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perego, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iorio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamachary, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benigni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhujwalla, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mezzanzanica, D.</span><span> </span><span class="NLM_article-title">Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">11216</span><span class="NLM_x">–</span> <span class="NLM_lpage">11230</span><span class="refDoi"> DOI: 10.18632/oncotarget.3589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.18632%2Foncotarget.3589" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=11216-11230&author=A.+Granataauthor=R.+Nicolettiauthor=P.+Peregoauthor=E.+Iorioauthor=B.+Krishnamacharyauthor=F.+Benigniauthor=A.+Ricciauthor=F.+Podoauthor=Z.+M.+Bhujwallaauthor=S.+Canevariauthor=M.+Bagnoliauthor=D.+Mezzanzanica&title=Global+metabolic+profile+identifies+choline+kinase+alpha+as+a+key+regulator+of+glutathione-dependent+antioxidant+cell+defense+in+ovarian+carcinoma&doi=10.18632%2Foncotarget.3589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3589%26sid%3Dliteratum%253Aachs%26aulast%3DGranata%26aufirst%3DA.%26aulast%3DNicoletti%26aufirst%3DR.%26aulast%3DPerego%26aufirst%3DP.%26aulast%3DIorio%26aufirst%3DE.%26aulast%3DKrishnamachary%26aufirst%3DB.%26aulast%3DBenigni%26aufirst%3DF.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DPodo%26aufirst%3DF.%26aulast%3DBhujwalla%26aufirst%3DZ.%2BM.%26aulast%3DCanevari%26aufirst%3DS.%26aulast%3DBagnoli%26aufirst%3DM.%26aulast%3DMezzanzanica%26aufirst%3DD.%26atitle%3DGlobal%2520metabolic%2520profile%2520identifies%2520choline%2520kinase%2520alpha%2520as%2520a%2520key%2520regulator%2520of%2520glutathione-dependent%2520antioxidant%2520cell%2520defense%2520in%2520ovarian%2520carcinoma%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D11216%26epage%3D11230%26doi%3D10.18632%2Foncotarget.3589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ramírez De Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4317</span><span class="NLM_x">–</span> <span class="NLM_lpage">4322</span><span class="refDoi"> DOI: 10.1038/sj.onc.1205556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fsj.onc.1205556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=4317-4322&author=A.+Ram%C3%ADrez+De+Molinaauthor=R.+Guti%C3%A9rrezauthor=M.+A.+Ramosauthor=J.+Silvaauthor=J.+M.+Silvaauthor=F.+Bonillaauthor=J.+Sanchezauthor=J.+C.+Lacal&title=Increased+choline+kinase+activity+in+human+breast+carcinomas%3A+clinical+evidence+for+a+potential+novel+antitumor+strategy&doi=10.1038%2Fsj.onc.1205556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205556%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez%2BDe%2BMolina%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DR.%26aulast%3DRamos%26aufirst%3DM.%2BA.%26aulast%3DSilva%26aufirst%3DJ.%26aulast%3DSilva%26aufirst%3DJ.%2BM.%26aulast%3DBonilla%26aufirst%3DF.%26aulast%3DSanchez%26aufirst%3DJ.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DIncreased%2520choline%2520kinase%2520activity%2520in%2520human%2520breast%2520carcinomas%253A%2520clinical%2520evidence%2520for%2520a%2520potential%2520novel%2520antitumor%2520strategy%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D4317%26epage%3D4322%26doi%3D10.1038%2Fsj.onc.1205556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gribbestad, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitter, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelson, D.</span><span> </span><span class="NLM_article-title">Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1737</span><span class="NLM_x">–</span> <span class="NLM_lpage">1746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10470108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFClt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=1737-1746&author=I.+S.+Gribbestadauthor=B.+Sitterauthor=S.+Lundgrenauthor=J.+Kraneauthor=D.+Axelson&title=Metabolite+composition+in+breast+tumors+examined+by+proton+nuclear+magnetic+resonance+spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy</span></div><div class="casAuthors">Gribbestad, I. S.; Sitter, B.; Lundgren, S.; Krane, J.; Axelson, D.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3A</span>),
    <span class="NLM_cas:pages">1737-1746</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">In vivo characterization of breast tumors using proton (1H) MR spectroscopy relies upon in vitro interpretation of tissue samples.  The present study has investigated metabolite compn. in exts. from breast tumors and non-involved breast tissue.  Multivariate data anal. was used to determinate combinations of metabolites important for differentiation.  Tumor and non-involved breast tissue were obtained from 16 patients undergoing surgical treatment.  1H NMR spectra of perchloric acid tissue exts. were obtained at a BRUKER Avance DRX600 spectrometer.  The data was analyzed using principal component anal. and probabilistic neural networks.  Low levels of glucose and high content of choline compds. were dominant findings in the tumor spectra.  Principal component loadings demonstrated this strong assocn.  The spectra were correctly classified using neural network anal.  Large differences in the metabolite compn. of breast tumors and surrounding breast tissues have been documented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFOdqpnemnA7Vg90H21EOLACvtfcHk0lgcEviRWiGVKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFClt7s%253D&md5=23eef885847029a2d6c6d6768c655181</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGribbestad%26aufirst%3DI.%2BS.%26aulast%3DSitter%26aufirst%3DB.%26aulast%3DLundgren%26aufirst%3DS.%26aulast%3DKrane%26aufirst%3DJ.%26aulast%3DAxelson%26aufirst%3DD.%26atitle%3DMetabolite%2520composition%2520in%2520breast%2520tumors%2520examined%2520by%2520proton%2520nuclear%2520magnetic%2520resonance%2520spectroscopy%26jtitle%3DAnticancer%2520Res.%26date%3D1999%26volume%3D19%26spage%3D1737%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yalcin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brock, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaton, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, J.</span><span> </span><span class="NLM_article-title">Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span><span class="refDoi"> DOI: 10.1038/onc.2009.317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fonc.2009.317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=139-149&author=A.+Yalcinauthor=B.+Clemauthor=S.+Makoniauthor=A.+Clemauthor=K.+Nelsonauthor=J.+Thornburgauthor=D.+Siowauthor=A.+N.+Laneauthor=S.+E.+Brockauthor=U.+Goswamiauthor=J.+W.+Eatonauthor=S.+Telangauthor=J.+Chesney&title=Selective+inhibition+of+choline+kinase+simultaneously+attenuates+MAPK+and+PI3K%2FAKT+signaling&doi=10.1038%2Fonc.2009.317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.317%26sid%3Dliteratum%253Aachs%26aulast%3DYalcin%26aufirst%3DA.%26aulast%3DClem%26aufirst%3DB.%26aulast%3DMakoni%26aufirst%3DS.%26aulast%3DClem%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DK.%26aulast%3DThornburg%26aufirst%3DJ.%26aulast%3DSiow%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DA.%2BN.%26aulast%3DBrock%26aufirst%3DS.%2BE.%26aulast%3DGoswami%26aufirst%3DU.%26aulast%3DEaton%26aufirst%3DJ.%2BW.%26aulast%3DTelang%26aufirst%3DS.%26aulast%3DChesney%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520choline%2520kinase%2520simultaneously%2520attenuates%2520MAPK%2520and%2520PI3K%252FAKT%2520signaling%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D139%26epage%3D149%26doi%3D10.1038%2Fonc.2009.317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Clem, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clem, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalcin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goswami, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arumugam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesney, J.</span><span> </span><span class="NLM_article-title">A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3370</span><span class="NLM_x">–</span> <span class="NLM_lpage">3380</span><span class="refDoi"> DOI: 10.1038/onc.2011.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fonc.2011.51" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3370-3380&author=B.+F.+Clemauthor=A.+L.+Clemauthor=A.+Yalcinauthor=U.+Goswamiauthor=S.+Arumugamauthor=S.+Telangauthor=J.+O.+Trentauthor=J.+Chesney&title=A+novel+small+molecule+antagonist+of+choline+kinase-%CE%B1+that+simultaneously+suppresses+MAPK+and+PI3K%2FAKT+signaling&doi=10.1038%2Fonc.2011.51"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.51%26sid%3Dliteratum%253Aachs%26aulast%3DClem%26aufirst%3DB.%2BF.%26aulast%3DClem%26aufirst%3DA.%2BL.%26aulast%3DYalcin%26aufirst%3DA.%26aulast%3DGoswami%26aufirst%3DU.%26aulast%3DArumugam%26aufirst%3DS.%26aulast%3DTelang%26aufirst%3DS.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DChesney%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small%2520molecule%2520antagonist%2520of%2520choline%2520kinase-%25CE%25B1%2520that%2520simultaneously%2520suppresses%2520MAPK%2520and%2520PI3K%252FAKT%2520signaling%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D3370%26epage%3D3380%26doi%3D10.1038%2Fonc.2011.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-González, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penalva, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Inhibition of ChoK Is an Efficient Antitumor Strategy for Harvey-, Kirsten-, and N-ras-Transformed Cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span><span class="refDoi"> DOI: 10.1006/bbrc.2001.5250</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1006%2Fbbrc.2001.5250" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2001&pages=873-879&author=A.+Ram%C3%ADrez+de+Molinaauthor=A.+Rodr%C3%ADguez-Gonz%C3%A1lezauthor=V.+Penalvaauthor=L.+Lucasauthor=J.+C.+Lacal&title=Inhibition+of+ChoK+Is+an+Efficient+Antitumor+Strategy+for+Harvey-%2C+Kirsten-%2C+and+N-ras-Transformed+Cells&doi=10.1006%2Fbbrc.2001.5250"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.5250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.5250%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Gonz%25C3%25A1lez%26aufirst%3DA.%26aulast%3DPenalva%26aufirst%3DV.%26aulast%3DLucas%26aufirst%3DL.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520ChoK%2520Is%2520an%2520Efficient%2520Antitumor%2520Strategy%2520for%2520Harvey-%252C%2520Kirsten-%252C%2520and%2520N-ras-Transformed%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D285%26spage%3D873%26epage%3D879%26doi%3D10.1006%2Fbbrc.2001.5250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, S. J.</span><span> </span><span class="NLM_article-title">Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span><span class="refDoi"> DOI: 10.1038/onc.2011.332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fonc.2011.332" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=1431-1441&author=T.+Miyakeauthor=S.+J.+Parsons&title=Functional+interactions+between+Choline+kinase+%CE%B1%2C+epidermal+growth+factor+receptor+and+c-Src+in+breast+cancer+cell+proliferation&doi=10.1038%2Fonc.2011.332"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.332%26sid%3Dliteratum%253Aachs%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DParsons%26aufirst%3DS.%2BJ.%26atitle%3DFunctional%2520interactions%2520between%2520Choline%2520kinase%2520%25CE%25B1%252C%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520c-Src%2520in%2520breast%2520cancer%2520cell%2520proliferation%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D1431%26epage%3D1441%26doi%3D10.1038%2Fonc.2011.332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sanchez-Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez del Pulgar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal Sanjuan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebrian, A.</span><span> </span><span class="NLM_article-title">Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via CHOP in cancer cells</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e933</span><span class="refDoi"> DOI: 10.1038/cddis.2013.453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fcddis.2013.453" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=e933&author=E.+Sanchez-Lopezauthor=T.+Zimmermanauthor=T.+Gomez+del+Pulgarauthor=M.+P.+Moyerauthor=J.+C.+Lacal+Sanjuanauthor=A.+Cebrian&title=Choline+kinase+inhibition+induces+exacerbated+endoplasmic+reticulum+stress+and+triggers+apoptosis+via+CHOP+in+cancer+cells&doi=10.1038%2Fcddis.2013.453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2013.453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2013.453%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Lopez%26aufirst%3DE.%26aulast%3DZimmerman%26aufirst%3DT.%26aulast%3DGomez%2Bdel%2BPulgar%26aufirst%3DT.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DLacal%2BSanjuan%26aufirst%3DJ.%2BC.%26aulast%3DCebrian%26aufirst%3DA.%26atitle%3DCholine%2520kinase%2520inhibition%2520induces%2520exacerbated%2520endoplasmic%2520reticulum%2520stress%2520and%2520triggers%2520apoptosis%2520via%2520CHOP%2520in%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2013%26volume%3D4%26spage%3De933%26doi%3D10.1038%2Fcddis.2013.453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Janardhan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sastry, G. N.</span><span> </span><span class="NLM_article-title">Choline kinase: an important target for cancer</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span><span class="refDoi"> DOI: 10.2174/092986706776360923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.2174%2F092986706776360923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=16719778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Krur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1169-1186&author=S.+Janardhanauthor=P.+Srivaniauthor=G.+N.+Sastry&title=Choline+kinase%3A+an+important+target+for+cancer&doi=10.2174%2F092986706776360923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Choline kinase: an important target for cancer</span></div><div class="casAuthors">Janardhan, S.; Srivani, P.; Sastry, G. Narahari</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1169-1186</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Choline kinase (ChoK) is a cytosolic enzyme present in various tissues, which catalyzes the phosphorylation of choline to form phosphorylcholine (PCho) in the presence of ATP and magnesium.  ChoK is important for the generation of 2 major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM), and subsequently for the cell division.  ChoK plays a vital role in cell signaling pathways and regulation of cell growth along with PCho involved in malignant transformation through ras oncogenes in different cancers such as breast, lung, colon, prostate, neuroblastoma, hepatic lymphomas, meningiomas, and diverse murine tumors.  The Ras effectors serine/threonine kinase (Raf-1), the Ral-GDP dissocn. stimulator (Ral-GDS), and the phosphatidylinositol 3-kinase (PI3K) are involved in the activation of ChoK during tumorigenesis.  ChoK gene induction seems to be assocd. with certain cell stress or cell defense.  Nowadays, RNAi appear to be one of the most promising routes in the cancer therapy.  The anticancer potential of both stable expression of siRNAs and their high sequence specificity by RNAi-mediated suppression of oncogenic ras in human pancreatic carcinoma, human melanomas, and ovarian cancer has been obsd.  It has an important role in sequence specific post-transcriptional gene silencing mechanism.  Presently, the crystal structure of Caenorhabditis elegans choline kinase A-2 (ChoKA-2) is available, which may be useful for comparative modeling of human ChoK and further modeling studies.  The present review aims at the general overview of importance, expression, structure, progress in mol. modeling, active site anal., and inhibitors of ChoK.  It also highlights the recent role of ChoK in various types of Ras-dependent and Ras-independent carcinogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbwuclS8KSYrVg90H21EOLACvtfcHk0lhYuFvG8eRdlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Krur4%253D&md5=dd49f50cfd576a230f93f581427c8529</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F092986706776360923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776360923%26sid%3Dliteratum%253Aachs%26aulast%3DJanardhan%26aufirst%3DS.%26aulast%3DSrivani%26aufirst%3DP.%26aulast%3DSastry%26aufirst%3DG.%2BN.%26atitle%3DCholine%2520kinase%253A%2520an%2520important%2520target%2520for%2520cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D1169%26epage%3D1186%26doi%3D10.2174%2F092986706776360923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, D. E.</span><span> </span><span class="NLM_article-title">Choline kinase and its function</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span><span class="refDoi"> DOI: 10.1139/O09-160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1139%2FO09-160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=20651826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2010&pages=559-564&author=G.+Wuauthor=D.+E.+Vance&title=Choline+kinase+and+its+function&doi=10.1139%2FO09-160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Choline kinase and its function</span></div><div class="casAuthors">Wu, Gengshu; Vance, Dennis E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-564</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Choline kinase (CK) was discovered in 1953.  Progress in understanding the function of CK was slow until its purifn. in 1984.  The subsequent cloning and expression of the cDNA led to the description of the gene structures.  Two genes (Chka and Chkb) encode CK, and 3 isoforms of the enzyme have been identified (CKα-1, CKα-2, and CKβ) and the active form of CK is a hetero- or homo-dimer.  More recently, gene-disrupted mice have been described.  Mice that lack CKα die early in embryogenesis.  In contrast, mice that lack CKβ survive to adulthood, but develop hindlimb muscular dystrophy and forelimb bone deformity.  It has been shown that this hindlimb muscular dystrophy is due to decreased biosynthesis of phosphatidylcholine (PC) and increased catabolism of PC in the hindlimbs, but not the forelimbs, of mice.  CK and its product, phosphocholine, have also been implicated in the development of numerous cancers.  Thus, a possible treatment for some kinds of cancer may involve drug inhibition of CK or targeting the expression of CK with RNA interference.  In the mid 1950s, it was clear that CK was important for the biosynthesis of phosphatidylcholine, but no one predicted a role for CK in muscular dystrophy, bone deformities, or cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9AzJyYM7Pb7Vg90H21EOLACvtfcHk0liwDpFpwOVqJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKjt74%253D&md5=f1fa2ff83579f267697a276d27d2428c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1139%2FO09-160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252FO09-160%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DVance%26aufirst%3DD.%2BE.%26atitle%3DCholine%2520kinase%2520and%2520its%2520function%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D88%26spage%3D559%26epage%3D564%26doi%3D10.1139%2FO09-160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hamza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloveras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribbes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douste-Blazy, L.</span><span> </span><span class="NLM_article-title">An in vitro study of hemicholinium-3 on phospholipid metabolism of Krebs II ascites cells</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1897</span><span class="refDoi"> DOI: 10.1016/0006-2952(83)90055-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2F0006-2952%2883%2990055-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1983&pages=1893-1897&author=M.+Hamzaauthor=J.+Lloverasauthor=G.+Ribbesauthor=G.+Soulaauthor=L.+Douste-Blazy&title=An+in+vitro+study+of+hemicholinium-3+on+phospholipid+metabolism+of+Krebs+II+ascites+cells&doi=10.1016%2F0006-2952%2883%2990055-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2883%2990055-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252883%252990055-2%26sid%3Dliteratum%253Aachs%26aulast%3DHamza%26aufirst%3DM.%26aulast%3DLloveras%26aufirst%3DJ.%26aulast%3DRibbes%26aufirst%3DG.%26aulast%3DSoula%26aufirst%3DG.%26aulast%3DDouste-Blazy%26aufirst%3DL.%26atitle%3DAn%2520in%2520vitro%2520study%2520of%2520hemicholinium-3%2520on%2520phospholipid%2520metabolism%2520of%2520Krebs%2520II%2520ascites%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1983%26volume%3D32%26spage%3D1893%26epage%3D1897%26doi%3D10.1016%2F0006-2952%2883%2990055-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hernández-Alcoceba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">In vivo antitumor activity of choline kinase inhibitors a novel target for anticancer drug discovery</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3112</span><span class="NLM_x">–</span> <span class="NLM_lpage">3118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=3112-3118&author=R.+Hern%C3%A1ndez-Alcocebaauthor=F.+Fern%C3%A1ndezauthor=J.+C.+Lacal&title=In+vivo+antitumor+activity+of+choline+kinase+inhibitors+a+novel+target+for+anticancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-Alcoceba%26aufirst%3DR.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520vivo%2520antitumor%2520activity%2520of%2520choline%2520kinase%2520inhibitors%2520a%2520novel%2520target%2520for%2520anticancer%2520drug%2520discovery%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D3112%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hernández-Alcoceba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saniger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Núñez, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaless, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Choline kinase inhibitors as a novel approach for antiproliferative drug design</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2289</span><span class="NLM_x">–</span> <span class="NLM_lpage">2301</span><span class="refDoi"> DOI: 10.1038/sj.onc.1201414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fsj.onc.1201414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=2289-2301&author=R.+Hern%C3%A1ndez-Alcocebaauthor=L.+Sanigerauthor=J.+Camposauthor=M.+C.+N%C3%BA%C3%B1ezauthor=F.+Khalessauthor=M.+A.+Galloauthor=A.+Espinosaauthor=J.+C.+Lacal&title=Choline+kinase+inhibitors+as+a+novel+approach+for+antiproliferative+drug+design&doi=10.1038%2Fsj.onc.1201414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1201414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1201414%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez-Alcoceba%26aufirst%3DR.%26aulast%3DSaniger%26aufirst%3DL.%26aulast%3DCampos%26aufirst%3DJ.%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DM.%2BC.%26aulast%3DKhaless%26aufirst%3DF.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DCholine%2520kinase%2520inhibitors%2520as%2520a%2520novel%2520approach%2520for%2520antiproliferative%2520drug%2520design%26jtitle%3DOncogene%26date%3D1997%26volume%3D15%26spage%3D2289%26epage%3D2301%26doi%3D10.1038%2Fsj.onc.1201414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rodríguez-Gonzalez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, M. d. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8803</span><span class="NLM_x">–</span> <span class="NLM_lpage">8812</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fsj.onc.1207062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=8803-8812&author=A.+Rodr%C3%ADguez-Gonzalezauthor=A.+Ram%C3%ADrez+de+Molinaauthor=F.+Fern%C3%A1ndezauthor=M.+A.+Ramosauthor=M.+d.+C.+Nunezauthor=J.+Camposauthor=J.+C.+Lacal&title=Inhibition+of+choline+kinase+as+a+specific+cytotoxic+strategy+in+oncogene-transformed+cells&doi=10.1038%2Fsj.onc.1207062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207062%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Gonzalez%26aufirst%3DA.%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DRamos%26aufirst%3DM.%2BA.%26aulast%3DNunez%26aufirst%3DM.%2Bd.%2BC.%26aulast%3DCampos%26aufirst%3DJ.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520choline%2520kinase%2520as%2520a%2520specific%2520cytotoxic%2520strategy%2520in%2520oncogene-transformed%2520cells%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D8803%26epage%3D8812%26doi%3D10.1038%2Fsj.onc.1207062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ramirez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-González, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span> </span><span class="NLM_article-title">From Ras signalling to ChoK inhibitors: a further advance in anticancer drug design</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.canlet.2003.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.canlet.2003.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=15013519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2004&pages=137-148&author=A.+Ramirez+de+Molinaauthor=A.+Rodriguez-Gonz%C3%A1lezauthor=J.+C.+Lacal&title=From+Ras+signalling+to+ChoK+inhibitors%3A+a+further+advance+in+anticancer+drug+design&doi=10.1016%2Fj.canlet.2003.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">From Ras signaling to ChoK inhibitors: a further advance in anticancer drug design</span></div><div class="casAuthors">Ramirez de Molina, Ana; Rodriguez-Gonzalez, Agustin; Lacal, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">206</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-148</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer is a genetic disease, most prominent in developed countries, with still a high mortality rate .  Cancer cells are continuously proliferating, and this uncontrolled growth is mediated by the activation of different signal transduction pathways that ultimately lead to the carcinogenic process.  Consequently, a large effort was devoted to design specific mols. that interfere with these signaling cascades involved in tumorigenesis.  In the last decades, research has resulted in improvements in both detection and treatment of cancer.  However, it is still necessary to develop novel antitumoral therapies that would allow an appropriate treatment for each cancer patient.  These novel, tumor- and patient-specific therapies will have a dramatic impact in improving the overall survival rates.  Ras is one of the most important oncogenes so far identified in human carcinogenesis.  Understanding the regulation of Ras-dependent signalling under normal and oncogenic environments may provide clues for the design of efficient specific antitumor strategies.  In this review the authors will illustrate how the family of Ras GTPases may be a valid model for the development of new cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpgb9CvDDFJLVg90H21EOLACvtfcHk0liwDpFpwOVqJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaiu70%253D&md5=9da88d585738ccd84c15210ba899ca24</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2003.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2003.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DRodriguez-Gonz%25C3%25A1lez%26aufirst%3DA.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26atitle%3DFrom%2520Ras%2520signalling%2520to%2520ChoK%2520inhibitors%253A%2520a%2520further%2520advance%2520in%2520anticancer%2520drug%2520design%26jtitle%3DCancer%2520Lett.%26date%3D2004%26volume%3D206%26spage%3D137%26epage%3D148%26doi%3D10.1016%2Fj.canlet.2003.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Falcon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golec, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaram, H.</span><span> </span><span class="NLM_article-title">A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival</span> <span class="citation_source-journal">Oncogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e38</span><span class="refDoi"> DOI: 10.1038/oncsis.2013.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Foncsis.2013.2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=e38&author=S.+C.+Falconauthor=C.+S.+Hudsonauthor=Y.+Huangauthor=M.+Mortimoreauthor=J.+M.+Golecauthor=P.+A.+Charltonauthor=P.+Weberauthor=H.+Sundaram&title=A+non-catalytic+role+of+choline+kinase+alpha+is+important+in+promoting+cancer+cell+survival&doi=10.1038%2Foncsis.2013.2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Foncsis.2013.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foncsis.2013.2%26sid%3Dliteratum%253Aachs%26aulast%3DFalcon%26aufirst%3DS.%2BC.%26aulast%3DHudson%26aufirst%3DC.%2BS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMortimore%26aufirst%3DM.%26aulast%3DGolec%26aufirst%3DJ.%2BM.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DSundaram%26aufirst%3DH.%26atitle%3DA%2520non-catalytic%2520role%2520of%2520choline%2520kinase%2520alpha%2520is%2520important%2520in%2520promoting%2520cancer%2520cell%2520survival%26jtitle%3DOncogenesis%26date%3D2013%26volume%3D2%26spage%3De38%26doi%3D10.1038%2Foncsis.2013.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hudson, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knegtel, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, J. R.</span><span> </span><span class="NLM_article-title">Kinetic and mechanistic characterisation of Choline Kinase-α</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1834</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span><span class="refDoi"> DOI: 10.1016/j.bbapap.2013.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.bbapap.2013.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=23416529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslCht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1834&publication_year=2013&pages=1107-1116&author=C.+S.+Hudsonauthor=R.+M.+Knegtelauthor=K.+Brownauthor=P.+A.+Charltonauthor=J.+R.+Pollard&title=Kinetic+and+mechanistic+characterisation+of+Choline+Kinase-%CE%B1&doi=10.1016%2Fj.bbapap.2013.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic and mechanistic characterisation of Choline Kinase-α</span></div><div class="casAuthors">Hudson, Catherine S.; Knegtel, Ronald M.; Brown, Kieron; Charlton, Peter A.; Pollard, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1834</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1107-1116</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Choline Kinase is a key component of the Kennedy pathway that converts choline into a no. of structural and signalling lipids that are essential for cell growth and survival.  One member of the family, Choline Kinase-α (ChoKα) is frequently up-regulated in human cancers, and expression of ChoKα is sufficient to transform cells.  Consequently ChoKα has been studied as a potential target for therapeutic agents in cancer research.  Despite great interest in the enzyme, mechanistic studies have not been reported.  In this study, a combination of initial velocity and product inhibition studies, together with the kinetic and structural characterization of a novel ChoKα inhibitor is used to support a mechanism of action for human ChoKα.  Substrate and inhibition kinetics are consistent with an iso double displacement mechanism, in which the γ-phosphate from ATP is transferred to choline in two distinct steps via a phospho-enzyme intermediate.  Co-crystal structures, and existing site-specific mutation studies, support an important role for Asp306, in stabilizing the phospho-enzyme intermediate.  The kinetics also indicate a distinct kinetic (isomerisation) step assocd. with product release, which may be attributed to a conformational change in the protein to disrupt an interaction between Asp306 and the phosphocholine product, facilitating product release.  This study describes a mechanism for ChoKα that is unusual amongst kinases, and highlights the availability of different enzyme states that can be exploited for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzeRhSDMs697Vg90H21EOLACvtfcHk0lhx44O9x0T3TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslCht70%253D&md5=07c07850f67b6cb481510a928f31b22e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2013.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2013.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DC.%2BS.%26aulast%3DKnegtel%26aufirst%3DR.%2BM.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DCharlton%26aufirst%3DP.%2BA.%26aulast%3DPollard%26aufirst%3DJ.%2BR.%26atitle%3DKinetic%2520and%2520mechanistic%2520characterisation%2520of%2520Choline%2520Kinase-%25CE%25B1%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2013%26volume%3D1834%26spage%3D1107%26epage%3D1116%26doi%3D10.1016%2Fj.bbapap.2013.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J. M.</span><span> </span><span class="NLM_article-title">Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1158%2F1535-7163.MCT-14-0531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25487918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=31-39&author=J.+C.+Lacalauthor=J.+M.+Campos&title=Preclinical+characterization+of+RSM-932A%2C+a+novel+anticancer+drug+targeting+the+human+choline+kinase+alpha%2C+an+enzyme+involved+in+increased+lipid+metabolism+of+cancer+cells&doi=10.1158%2F1535-7163.MCT-14-0531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells</span></div><div class="casAuthors">Lacal, Juan Carlos; Campos, Joaquin M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-39</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Choline kinase α (CHKA; here designated as ChoKα) is the first enzyme in the CDP-choline pathway, implicated in phospholipids metab.  It is overexpressed in several human tumors such as breast, lung, bladder, colorectal, prostate, ovary, and liver.  The overexpression of ChoKα has oncogenic potential and synergizes with other known oncogenes.  It has been proposed as a novel cancer drug target with a distinct mechanism of action.  We have generated a set of ChoKα inhibitors with potent in vitro antiproliferative and in vivo antitumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles.  Among these inhibitors, RSM-932A has been chosen for further clin. development due to its potent antiproliferative activity in vitro against a large variety of tumor-derived cell lines, a potent in vivo anticancer activity, and lack of toxicity at the EDs.  Here, we provide the preclin. evidence to support the use of RSM-932A as a good candidate to be tested in clin. trials as the "first in humans" drug targeting ChoKα.  Mol Cancer Ther; 14(1); 31-39. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGE3uBNGhPhLVg90H21EOLACvtfcHk0lhx44O9x0T3TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWluw%253D%253D&md5=11fa90eab6eb5cf83c64a9cd9dbb7588</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0531%26sid%3Dliteratum%253Aachs%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DCampos%26aufirst%3DJ.%2BM.%26atitle%3DPreclinical%2520characterization%2520of%2520RSM-932A%252C%2520a%2520novel%2520anticancer%2520drug%2520targeting%2520the%2520human%2520choline%2520kinase%2520alpha%252C%2520an%2520enzyme%2520involved%2520in%2520increased%2520lipid%2520metabolism%2520of%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D31%26epage%3D39%26doi%3D10.1158%2F1535-7163.MCT-14-0531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Castro-Navas, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiaffino-Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco-Jimenez, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ríos-Marco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariotto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena-Guadix, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Cara, L. C.</span><span> </span><span class="NLM_article-title">New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.4155/fmc.15.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.4155%2Ffmc.15.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25875870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsV2lt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=417-436&author=F.+F.+Castro-Navasauthor=S.+Schiaffino-Ortegaauthor=M.+P.+Carrasco-Jimenezauthor=P.+R%C3%ADos-Marcoauthor=C.+Marcoauthor=A.+Espinosaauthor=M.+A.+Galloauthor=E.+Mariottoauthor=G.+Bassoauthor=G.+Violaauthor=A.+Entrena-Guadixauthor=L.+C.+L%C3%B3pez-Cara&title=New+more+polar+symmetrical+bipyridinic+compounds%3A+new+strategy+for+the+inhibition+of+choline+kinase+%CE%B11&doi=10.4155%2Ffmc.15.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1</span></div><div class="casAuthors">Castro-Navas, Francisco Fermin; Schiaffino-Ortega, Santiago; Carrasco-Jimenez, Maria Paz; Rios-Marco, Pablo; Marco, Carmen; Espinosa, Antonio; Gallo, Miguel Angel; Mariotto, Elena; Basso, Giuseppe; Viola, Giampietro; Entrena-Guadix, Antonio; Lopez-Cara, Luisa Carlota</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">417-436</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: Research of the antitumor properties of biscationic compds. has received significant attention over the last few years.  Results: A novel family of 1,1'-([2,2'-bipyridine]-5,5'-diylbis(methylene))bis-substituted bromide (9a-k), contg. two nitrogen atoms in the linker, considered as hypothetical hydrogen bond acceptors, were synthesized and evaluated as ChoK inhibitors and their antiproliferative activity against six cancer cell lines.  Conclusion: The most promising compds. in this series are 1,1'-([2,2'-bipyridine]-5,5'-diylbis(methylene))bis(4-(methyl(phenyl)amino)-quinolinium bromide derivs. 9g-i (analogs to RSM932A), that significantly inhibit cancer cell growth at even submicromolar concns., esp. against leukemia cells. Compds. 9g-i also inhibit the ChoKα1 with good or moderate values, as predicted by initial docking studies.  In addn., the most active compd. 9h remarkably induces apoptosis in two cell lines following the mitochondrial pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7kW4QSpq277Vg90H21EOLACvtfcHk0ljt9jWq-DvHOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsV2lt7g%253D&md5=6cb3e2a44c4c5cff5019886d6defb220</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.1%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Navas%26aufirst%3DF.%2BF.%26aulast%3DSchiaffino-Ortega%26aufirst%3DS.%26aulast%3DCarrasco-Jimenez%26aufirst%3DM.%2BP.%26aulast%3DR%25C3%25ADos-Marco%26aufirst%3DP.%26aulast%3DMarco%26aufirst%3DC.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DMariotto%26aufirst%3DE.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26aulast%3DEntrena-Guadix%26aufirst%3DA.%26aulast%3DL%25C3%25B3pez-Cara%26aufirst%3DL.%2BC.%26atitle%3DNew%2520more%2520polar%2520symmetrical%2520bipyridinic%2520compounds%253A%2520new%2520strategy%2520for%2520the%2520inhibition%2520of%2520choline%2520kinase%2520%25CE%25B11%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26spage%3D417%26epage%3D436%26doi%3D10.4155%2Ffmc.15.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Serrán-Aguilera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Cara, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo Mezo, M. Á.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchiarulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Guerrero, R.</span><span> </span><span class="NLM_article-title">Pharmacophore-based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1002/minf.201400140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1002%2Fminf.201400140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=458-466&author=L.+Serr%C3%A1n-Aguileraauthor=R.+Nutiauthor=L.+C.+L%C3%B3pez-Caraauthor=M.+%C3%81.+Gallo+Mezoauthor=A.+Macchiaruloauthor=A.+Entrenaauthor=R.+Hurtado-Guerrero&title=Pharmacophore-based+Virtual+Screening+to+Discover+New+Active+Compounds+for+Human+Choline+Kinase+%CE%B11&doi=10.1002%2Fminf.201400140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore-Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1</span></div><div class="casAuthors">Serran-Aguilera, Lucia; Nuti, Roberto; Lopez-Cara, Luisa C.; Mezo, Miguel A. Gallo; Macchiarulo, Antonio; Entrena, Antonio; Hurtado-Guerrero, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">458-466</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Choline kinase (CK) catalyzes the transfer of the ATP γ-phosphate to choline to generate phosphocholine and ADP in the presence of magnesium leading to the synthesis of phosphatidylcholine.  Of the three isoforms of CK described in humans, only the α isoforms (HsCKα) are strongly assocd. with cancer and have been validated as drug targets to treat this disease.  Over the years, a large no. of Hemicholinium-3 (HC-3)-based HsCKα biscationic inhibitors have been developed though the relevant common features important for the biol. function have not been defined.  Here, selecting a large no. of previous HC-3-based inhibitors, we discover through computational studies a pharmacophore model formed by five moieties that are included in the 1-benzyl-4-(N-methylaniline)pyridinium fragment.  Using a pharmacophore-guided virtual screening, we then identified 6 mols. that showed binding affinities in the low μM range to HsCKα1.  Finally, protein crystn. studies suggested that one of these mols. is bound to the choline and ATP-binding sites.  In conclusion, we have developed a pharmacophore model that not only allowed us to dissect the structural important features of the previous HC-3 derivs., but also enabled the identification of novel chem. tools with good ligand efficiencies to investigate the biol. functions of HsCKα1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf2JAwlyu3WrVg90H21EOLACvtfcHk0ljt9jWq-DvHOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWns7rN&md5=71a03f22eb62776360e0b29cc605f8f1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fminf.201400140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201400140%26sid%3Dliteratum%253Aachs%26aulast%3DSerr%25C3%25A1n-Aguilera%26aufirst%3DL.%26aulast%3DNuti%26aufirst%3DR.%26aulast%3DL%25C3%25B3pez-Cara%26aufirst%3DL.%2BC.%26aulast%3DGallo%2BMezo%26aufirst%3DM.%2B%25C3%2581.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DEntrena%26aufirst%3DA.%26aulast%3DHurtado-Guerrero%26aufirst%3DR.%26atitle%3DPharmacophore-based%2520Virtual%2520Screening%2520to%2520Discover%2520New%2520Active%2520Compounds%2520for%2520Human%2520Choline%2520Kinase%2520%25CE%25B11%26jtitle%3DMol.%2520Inf.%26date%3D2015%26volume%3D34%26spage%3D458%26epage%3D466%26doi%3D10.1002%2Fminf.201400140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rubio-Ruiz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figuerola-Conchas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos-Torrecillas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capitán-Cañadas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ríos-Marco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrasco, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. Á.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entrena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurtado-Guerrero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conejo-García, A.</span><span> </span><span class="NLM_article-title">Discovery of a New Binding Site on Human Choline Kinase α1: Design, Synthesis, Crystallographic Studies, and Biological Evaluation of Asymmetrical Bispyridinium Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1021/jm401665x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401665x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=507-515&author=B.+Rubio-Ruizauthor=A.+Figuerola-Conchasauthor=J.+Ramos-Torrecillasauthor=F.+Capit%C3%A1n-Ca%C3%B1adasauthor=P.+R%C3%ADos-Marcoauthor=M.+P.+Carrascoauthor=M.+%C3%81.+Galloauthor=A.+Espinosaauthor=C.+Marcoauthor=C.+Ruizauthor=A.+Entrenaauthor=R.+Hurtado-Guerreroauthor=A.+Conejo-Garc%C3%ADa&title=Discovery+of+a+New+Binding+Site+on+Human+Choline+Kinase+%CE%B11%3A+Design%2C+Synthesis%2C+Crystallographic+Studies%2C+and+Biological+Evaluation+of+Asymmetrical+Bispyridinium+Derivatives&doi=10.1021%2Fjm401665x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm401665x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401665x%26sid%3Dliteratum%253Aachs%26aulast%3DRubio-Ruiz%26aufirst%3DB.%26aulast%3DFiguerola-Conchas%26aufirst%3DA.%26aulast%3DRamos-Torrecillas%26aufirst%3DJ.%26aulast%3DCapit%25C3%25A1n-Ca%25C3%25B1adas%26aufirst%3DF.%26aulast%3DR%25C3%25ADos-Marco%26aufirst%3DP.%26aulast%3DCarrasco%26aufirst%3DM.%2BP.%26aulast%3DGallo%26aufirst%3DM.%2B%25C3%2581.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DMarco%26aufirst%3DC.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DEntrena%26aufirst%3DA.%26aulast%3DHurtado-Guerrero%26aufirst%3DR.%26aulast%3DConejo-Garc%25C3%25ADa%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520New%2520Binding%2520Site%2520on%2520Human%2520Choline%2520Kinase%2520%25CE%25B11%253A%2520Design%252C%2520Synthesis%252C%2520Crystallographic%2520Studies%252C%2520and%2520Biological%2520Evaluation%2520of%2520Asymmetrical%2520Bispyridinium%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D507%26epage%3D515%26doi%3D10.1021%2Fjm401665x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wittenberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornberg, A.</span><span> </span><span class="NLM_article-title">Choline Phosphokinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1953</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1953&pages=431-444&author=J.+Wittenbergauthor=A.+Kornberg&title=Choline+Phosphokinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittenberg%26aufirst%3DJ.%26aulast%3DKornberg%26aufirst%3DA.%26atitle%3DCholine%2520Phosphokinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1953%26volume%3D202%26spage%3D431%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1788</span><span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1784-1788&author=M.+Mayerauthor=B.+Meyer&title=Characterization+of+Ligand+Binding+by+Saturation+Transfer+Difference+NMR+Spectroscopy&doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of ligand binding by saturation transfer difference NMR spectroscopy</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1784-1788</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The difference between a satn. transfer spectrum and a normal NMR spectrum provides a new and fast method (satn. transfer difference (STD) NMR spectroscopy) to screen compd. libraries for binding activity to proteins.  STD NMR spectroscopy of mixts. of potential ligands with as little as 1 nmol of protein yields 1D and 2D NMR spectra that exclusively show signals from mols. with binding affinity.  In addn., the ligand's binding epitope is easily identified because ligand residues in direct contact to the protein show much stronger STD signals.  For example, the binding specificity of Lewisb-hexasaccharide to Aleulria aurantia agglutinin (AAA) can be mapped to the two fucosyl residues.  The efficiency of the STD NMR technique is shown by the binding of N-acetylglucosamine (GlcNAc) to wheat germ agglutinin (WGA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf8j8HiAqDArVg90H21EOLACvtfcHk0lg9IekLKVz8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVCntb0%253D&md5=03f825af40d22911062112dc6074cf46</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819990614%252938%253A12%253C1784%253A%253AAID-ANIE1784%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520Ligand%2520Binding%2520by%2520Saturation%2520Transfer%2520Difference%2520NMR%2520Spectroscopy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D1784%26epage%3D1788%26doi%3D10.1002%2F%28SICI%291521-3773%2819990614%2938%3A12%3C1784%3A%3AAID-ANIE1784%3E3.0.CO%3B2-Q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, B.</span><span> </span><span class="NLM_article-title">Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">6108</span><span class="NLM_x">–</span> <span class="NLM_lpage">6117</span><span class="refDoi"> DOI: 10.1021/ja0100120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0100120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFamsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=6108-6117&author=M.+Mayerauthor=B.+Meyer&title=Group+epitope+mapping+by+saturation+transfer+difference+NMR+to+identify+segments+of+a+ligand+in+direct+contact+with+a+protein+receptor&doi=10.1021%2Fja0100120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Group Epitope Mapping by Saturation Transfer Difference NMR To Identify Segments of a Ligand in Direct Contact with a Protein Receptor</span></div><div class="casAuthors">Mayer, Moriz; Meyer, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6108-6117</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A protocol based on satn. transfer difference (STD) NMR spectra was developed to characterize the binding interactions at an atom level, termed group epitope mapping (GEM).  As an example we chose the well-studied system of galactose binding to the 120-kDa lectin Ricinus communis agglutinin I (RCA120).  As ligands we used Me β-D-galactoside and a biantennary decasaccharide.  Anal. of the satn. transfer effects of Me β-D-galactoside showed that the H2, H3, and H4 protons are satd. to the highest degree, giving evidence of their close proximity to protons of the RCA120 lectin.  The direct interaction of the lectin with this region of the galactose is in excellent agreement with results obtained from the anal. of the binding specificities of many chem. modified galactose derivs. (Bhattacharyya, L.; Brewer, C. F., 1988).  This new NMR technique can identify the binding epitope of even complex ligands very quickly, which is a great improvement over time-consuming chem. modifications.  Efficient GEM benefits from a relatively high off rate of the ligand and a large excess of the ligand over the receptor.  Even for a ligand like the biantennary decasaccharide with micromolar binding affinity, the binding epitopes could easily be mapped to the terminal β-D-Gal-(1-4)-β-D-GlcNAc (β-D-GlcNAc = N-acetyl-D-glucosamine) residues located at the nonreducing end of the two carbohydrate chains.  The binding contribution of the terminal galactose residue is stronger than those of the penultimate GlcNAc residues.  We could show that the GlcNAc residues bind "edge-on" with the region from H2 to H4, making contact with the protein.  Anal. of STD NMR expts. performed under competitive conditions proved that the two saccharides studied bind at the same receptor site, thereby ruling out unspecific binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9BVgPNWHCsLVg90H21EOLACvtfcHk0lg9IekLKVz8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFamsbg%253D&md5=5fe9d7d46114ee1cc96a8a50f8da972c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja0100120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0100120%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DB.%26atitle%3DGroup%2520epitope%2520mapping%2520by%2520saturation%2520transfer%2520difference%2520NMR%2520to%2520identify%2520segments%2520of%2520a%2520ligand%2520in%2520direct%2520contact%2520with%2520a%2520protein%2520receptor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D6108%26epage%3D6117%26doi%3D10.1021%2Fja0100120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Dalvit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagerness, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadden, D. T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarver, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockman, B. J.</span><span> </span><span class="NLM_article-title">Fluorine-NMR Experiments for High-Throughput Screening: Theoretical Aspects, Practical Considerations, and Range of Applicability</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">7696</span><span class="NLM_x">–</span> <span class="NLM_lpage">7703</span><span class="refDoi"> DOI: 10.1021/ja034646d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja034646d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvFOitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=7696-7703&author=C.+Dalvitauthor=P.+E.+Fagernessauthor=D.+T.+A.+Haddenauthor=R.+W.+Sarverauthor=B.+J.+Stockman&title=Fluorine-NMR+Experiments+for+High-Throughput+Screening%3A+Theoretical+Aspects%2C+Practical+Considerations%2C+and+Range+of+Applicability&doi=10.1021%2Fja034646d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-NMR experiments for high-throughput screening: Theoretical aspects, practical considerations, and range of applicability</span></div><div class="casAuthors">Dalvit, Claudio; Fagerness, Paul E.; Hadden, Daneen T. A.; Sarver, Ronald W.; Stockman, Brian J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">7696-7703</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Competition ligand-based NMR screening expts. have recently been introduced to overcome most of the problems assocd. with traditional ligand-based NMR screening.  Mols. with marginal soly. and high affinity for a given target can be easily identified in a high-throughput manner by screening chem. mixts. against the target in the presence of a weak- to medium-affinity ligand of known binding const.  While the original competition-based approaches utilized 1H detection, significant advantages are obtained using 19F detection.  The absence of spectral overlap permits the screening of large chem. mixts. and allows for automated anal. of the spectra, even in the presence of protonated buffers, solvents, and detergents.  The large chem. shift anisotropy of fluorine and the significant exchange contribution allow for the selection of a weak-affinity spy mol., thus resulting in a lower binding affinity threshold for the identified NMR hits.  The method, labeled FAXS (fluorine chem. shift anisotropy and exchange for screening) is rapid and requires only a limited amt. of protein and, therefore, compares favorably with the other established non-NMR techniques used in high-throughput screening.  Herein the theor. aspects of this powerful 19F-based approach are presented and discussed in detail.  The exptl. conditions together with the detection limits and binding const. measurements are investigated using human serum albumin as the target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrluTqHSItDBLVg90H21EOLACvtfcHk0lg9IekLKVz8aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvFOitbs%253D&md5=58b7a2db41871c28e06873302d4a1ecb</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja034646d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja034646d%26sid%3Dliteratum%253Aachs%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DFagerness%26aufirst%3DP.%2BE.%26aulast%3DHadden%26aufirst%3DD.%2BT.%2BA.%26aulast%3DSarver%26aufirst%3DR.%2BW.%26aulast%3DStockman%26aufirst%3DB.%2BJ.%26atitle%3DFluorine-NMR%2520Experiments%2520for%2520High-Throughput%2520Screening%253A%2520Theoretical%2520Aspects%252C%2520Practical%2520Considerations%252C%2520and%2520Range%2520of%2520Applicability%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D7696%26epage%3D7703%26doi%3D10.1021%2Fja034646d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Shuker, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovering high-affinity ligands for proteins: SAR by NMR</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">1531</span><span class="NLM_x">–</span> <span class="NLM_lpage">1534</span><span class="refDoi"> DOI: 10.1126/science.274.5292.1531</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1126%2Fscience.274.5292.1531" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=8929414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1531-1534&author=S.+B.+Shukerauthor=P.+J.+Hajdukauthor=R.+P.+Meadowsauthor=S.+W.+Fesik&title=Discovering+high-affinity+ligands+for+proteins%3A+SAR+by+NMR&doi=10.1126%2Fscience.274.5292.1531"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands for proteins: SAR by NMR</span></div><div class="casAuthors">Shuker, Suzanne B.; Hajduk, Philip J.; Meadows, Robert P.; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5292</span>),
    <span class="NLM_cas:pages">1531-1534</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A NMR-based method is described in which small org. mols. that bind to proximal subsites of a protein are identified, optimized, and linked together to produce high-affinity ligands.  The approach is called "SAR by NMR" because structure-activity relationships (SAR) are obtained from NMR.  With this technique, compds. with nanomolar affinities for the FK506 binding protein were rapidly discovered by tethering two ligands with micromolar affinities.  The method reduces the amt. of chem. synthesis and time required for the discovery of high-affinity ligands and appears particularly useful in target-directed drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwkuE4EVU_yrVg90H21EOLACvtfcHk0ljDIXnnqfFIAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1ansLs%253D&md5=1b9a5a5e4f2d6ee4b1c249e3e1faf2ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5292.1531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5292.1531%26sid%3Dliteratum%253Aachs%26aulast%3DShuker%26aufirst%3DS.%2BB.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520for%2520proteins%253A%2520SAR%2520by%2520NMR%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1531%26epage%3D1534%26doi%3D10.1126%2Fscience.274.5292.1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M. F.</span><span> </span><span class="NLM_article-title">Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">574</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1021/jm700952v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm700952v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1entg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=574-580&author=A.+M.+Giannettiauthor=B.+D.+Kochauthor=M.+F.+Browner&title=Surface+plasmon+resonance+based+assay+for+the+detection+and+characterization+of+promiscuous+inhibitors&doi=10.1021%2Fjm700952v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Surface Plasmon Resonance Based Assay for the Detection and Characterization of Promiscuous Inhibitors</span></div><div class="casAuthors">Giannetti, Anthony M.; Koch, Bruce D.; Browner, Michelle F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">574-580</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Promiscuous binders achieve enzyme inhibition using a nonspecific aggregation-type binding mechanism to proteins.  These compds. are a source of false-pos. hits in biochem. inhibition assays and should be removed from screening hit lists because they are not good candidates to initiate medicinal chem. programs.  The authors introduce a robust approach to identify these mols. early in the lead generation process using real time surface plasmon resonance based biosensors to observe the behavior of the binding interactions between promiscuous compds. and proteins.  Furthermore, the time resoln. of the assay reveals a no. of distinct mechanisms that promiscuous compds. employ to inhibit enzyme function and indicate that the type of mechanism can vary depending on the protein target.  A classification scheme for these compds. is presented that can be used to rapidly characterize the hits from high-throughput screens and eliminate compds. with a nonspecific mechanism of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTh2kYyROf7Vg90H21EOLACvtfcHk0ljDIXnnqfFIAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1entg%253D%253D&md5=b2869c5be1cd6f455503f8e812ed6f23</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm700952v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700952v%26sid%3Dliteratum%253Aachs%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DKoch%26aufirst%3DB.%2BD.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26atitle%3DSurface%2520plasmon%2520resonance%2520based%2520assay%2520for%2520the%2520detection%2520and%2520characterization%2520of%2520promiscuous%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D574%26epage%3D580%26doi%3D10.1021%2Fjm700952v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Malito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekulic, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Too, W. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konrad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavie, A.</span><span> </span><span class="NLM_article-title">Elucidation of Human Choline Kinase Crystal Structures in Complex with the Products ADP or Phosphocholine</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1016/j.jmb.2006.08.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.jmb.2006.08.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=2006&pages=136-151&author=E.+Malitoauthor=N.+Sekulicauthor=W.+C.+S.+Tooauthor=M.+Konradauthor=A.+Lavie&title=Elucidation+of+Human+Choline+Kinase+Crystal+Structures+in+Complex+with+the+Products+ADP+or+Phosphocholine&doi=10.1016%2Fj.jmb.2006.08.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2006.08.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2006.08.084%26sid%3Dliteratum%253Aachs%26aulast%3DMalito%26aufirst%3DE.%26aulast%3DSekulic%26aufirst%3DN.%26aulast%3DToo%26aufirst%3DW.%2BC.%2BS.%26aulast%3DKonrad%26aufirst%3DM.%26aulast%3DLavie%26aufirst%3DA.%26atitle%3DElucidation%2520of%2520Human%2520Choline%2520Kinase%2520Crystal%2520Structures%2520in%2520Complex%2520with%2520the%2520Products%2520ADP%2520or%2520Phosphocholine%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D364%26spage%3D136%26epage%3D151%26doi%3D10.1016%2Fj.jmb.2006.08.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Aoyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishidate, K.</span><span> </span><span class="NLM_article-title">Structure and function of choline kinase isoforms in mammalian cells</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span><span class="refDoi"> DOI: 10.1016/j.plipres.2003.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.plipres.2003.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=15003397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs12js7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=266-281&author=C.+Aoyamaauthor=H.+Liaoauthor=K.+Ishidate&title=Structure+and+function+of+choline+kinase+isoforms+in+mammalian+cells&doi=10.1016%2Fj.plipres.2003.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of choline kinase isoforms in mammalian cells</span></div><div class="casAuthors">Aoyama, Chieko; Liao, Huanan; Ishidate, Kozo</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">266-281</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Choline kinase (CK) catalyzes the 1st phosphorylation reaction in the CDP-choline pathway for the biosynthesis of phosphatidylcholine (PC), yielding phosphocholine (P-Cho) from choline and ATP in the presence of Mg2+.  CK exists in mammalian cells as at least 3 isoforms that are encoded by 2 sep. genes termed ck-α and ck-β.  Each isoform is inactive in its monomeric form.  The active enzyme consists of either homo- or hetero-dimeric (or oligomeric) forms.  In recent years, the roles of CK in cell growth and cell stress/defense mechanisms have been intensely investigated.  These functions of CK do not seem to be directly related to net PC biosynthesis, but predict another important role of this enzyme in certain cell physiol.  This review summarizes briefly the recent progress of mammalian CK study which includes the gene structure of each isoform and its possible transcriptional regulation, the active configuration of the enzyme, induction of the particular isoform in chem. induced cell stress, and the possible role of this enzyme as well as of its reaction product, P-Cho, in cell growth and other cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLHF2RgVFzrVg90H21EOLACvtfcHk0lh4-lFdfcdnlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs12js7g%253D&md5=d20280a9cb9d4b987f10035ffd5b61bd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.plipres.2003.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plipres.2003.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DAoyama%26aufirst%3DC.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DIshidate%26aufirst%3DK.%26atitle%3DStructure%2520and%2520function%2520of%2520choline%2520kinase%2520isoforms%2520in%2520mammalian%2520cells%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2004%26volume%3D43%26spage%3D266%26epage%3D281%26doi%3D10.1016%2Fj.plipres.2003.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishidate, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teraoka, H.</span><span> </span><span class="NLM_article-title">Deletion and alanine mutation analyses for the formation of active homo-or hetero-dimer complexes of mouse choline kinase-α and-β</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1761</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.bbalip.2006.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.bbalip.2006.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=16490392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Ogsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1761&publication_year=2006&pages=111-120&author=H.+Liaoauthor=C.+Aoyamaauthor=K.+Ishidateauthor=H.+Teraoka&title=Deletion+and+alanine+mutation+analyses+for+the+formation+of+active+homo-or+hetero-dimer+complexes+of+mouse+choline+kinase-%CE%B1+and-%CE%B2&doi=10.1016%2Fj.bbalip.2006.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion and alanine mutation analyses for the formation of active homo- or hetero-dimer complexes of mouse choline kinase-α and -β</span></div><div class="casAuthors">Liao, Huanan; Aoyama, Chieko; Ishidate, Kozo; Teraoka, Hirobumi</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1761</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">111-120</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Choline kinase (CK) is the first-step regulatory enzyme for the biosynthesis of phosphatidylcholine in all mammalian cells.  It exists as at least three isoforms (α1, α2 and β) that are encoded by two sep. genes termed ck-α and ck-β.  The active enzyme has been proposed to consist of either their homo- or hetero-dimeric forms.  Here, we report on the identification of several essential domains and amino acid residues involved in their active dimer formation.  Full-length cDNAs or their truncated or alanine-mutated versions for mouse CK-α1 and CK-β tagged with either HA or Myc at their N-termini were expressed in COS-7 cells.  Each dimer formation was analyzed by immuno-pptn. followed by Western blotting.  Kinetic anal. for CK reaction was performed with different expression products.  Both the N-terminal domain-1 and C-terminal portions (E424-K430 for CK-α1 and Q379-K385 for CK-β) were shown to be crit. for the formation of active homo- or hetero-dimer complex.  Interestingly, D320 in the CK-motif of CK-α1 was found to be essential for α1/α1 homo-dimerization but not for α1/β hetero-dimerization.  A mutation of the corresponding D276 of CK-β to A276 did not show any effect on either its homo- or hetero-dimerization but it caused a strong inhibition of CK activity in either case.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NivcFHFUPLVg90H21EOLACvtfcHk0lh4-lFdfcdnlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Ogsr8%253D&md5=bc0b79fa5c2c62519df774ccade8bcc8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2006.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2006.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DAoyama%26aufirst%3DC.%26aulast%3DIshidate%26aufirst%3DK.%26aulast%3DTeraoka%26aufirst%3DH.%26atitle%3DDeletion%2520and%2520alanine%2520mutation%2520analyses%2520for%2520the%2520formation%2520of%2520active%2520homo-or%2520hetero-dimer%2520complexes%2520of%2520mouse%2520choline%2520kinase-%25CE%25B1%2520and-%25CE%25B2%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2006%26volume%3D1761%26spage%3D111%26epage%3D120%26doi%3D10.1016%2Fj.bbalip.2006.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hong, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allali-Hassani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finerty, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-W.</span><span> </span><span class="NLM_article-title">Crystal Structures of Human Choline Kinase Isoforms in Complex with Hemicholinium-3 Single Amino Acid near the Active Site Influences Inhibitor Sensitivity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">16330</span><span class="NLM_x">–</span> <span class="NLM_lpage">16340</span><span class="refDoi"> DOI: 10.1074/jbc.M109.039024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1074%2Fjbc.M109.039024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=16330-16340&author=B.+S.+Hongauthor=A.+Allali-Hassaniauthor=W.+Tempelauthor=P.+J.+Finertyauthor=F.+MacKenzieauthor=S.+Dimovauthor=M.+Vedadiauthor=H.-W.+Park&title=Crystal+Structures+of+Human+Choline+Kinase+Isoforms+in+Complex+with+Hemicholinium-3+Single+Amino+Acid+near+the+Active+Site+Influences+Inhibitor+Sensitivity&doi=10.1074%2Fjbc.M109.039024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.039024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.039024%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DB.%2BS.%26aulast%3DAllali-Hassani%26aufirst%3DA.%26aulast%3DTempel%26aufirst%3DW.%26aulast%3DFinerty%26aufirst%3DP.%2BJ.%26aulast%3DMacKenzie%26aufirst%3DF.%26aulast%3DDimov%26aufirst%3DS.%26aulast%3DVedadi%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DH.-W.%26atitle%3DCrystal%2520Structures%2520of%2520Human%2520Choline%2520Kinase%2520Isoforms%2520in%2520Complex%2520with%2520Hemicholinium-3%2520Single%2520Amino%2520Acid%2520near%2520the%2520Active%2520Site%2520Influences%2520Inhibitor%2520Sensitivity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D16330%26epage%3D16340%26doi%3D10.1074%2Fjbc.M109.039024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug–target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span><span class="refDoi"> DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug%E2%80%93target+residence+time+and+its+implications+for+lead+optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lgkVBZ59NAY3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug%25E2%2580%2593target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span> </span><span class="NLM_article-title">The role of binding kinetics in therapeutically useful drug action</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=19152211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt12ltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=31-39&author=D.+C.+Swinney&title=The+role+of+binding+kinetics+in+therapeutically+useful+drug+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The role of binding kinetics in therapeutically useful drug action</span></div><div class="casAuthors">Swinney, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-39</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Binding kinetics help define how a medicine will communicate with physiol. to produce a desired therapeutic response.  Clin. efficacy, duration of action, clin. differentiation and safety may all be influenced by binding kinetics.  The optimization of binding kinetics can be used to maximize a drug's therapeutic index and thereby decrease drug attrition.  The gap between basic scientific principles and the potential medical value of a drug is currently bridged by the use of empirical assays.  The value of binding kinetics to drug discovery will be increased through an improved ability to identify optimal kinetic mechanisms and define kinetic structure activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8IoReBfGAabVg90H21EOLACvtfcHk0lgkVBZ59NAY3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt12ltrk%253D&md5=129948a7fb0a60f3b9995e5aedb700a4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26atitle%3DThe%2520role%2520of%2520binding%2520kinetics%2520in%2520therapeutically%2520useful%2520drug%2520action%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D31%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsma, F.</span><span> </span><span class="NLM_article-title">The importance of drug-target residence time</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=19562645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=488-496&author=R.+Zhangauthor=F.+Monsma&title=The+importance+of+drug-target+residence+time"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of drug-target residence time</span></div><div class="casAuthors">Zhang, Rumin; Monsma, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of kinetics in drug-target interactions, and particularly the residence time of a drug with its target, is increasingly recognized to play a pivotal role in detg. both the efficacy and toxicity of a drug.  Drug residence time can often be demonstrated to be a key differentiating factor between drugs that act upon a common target.  Drug-target residence time can result in either favorable or unfavorable outcomes, and the use of such information could lead to the more efficient design of best-in-class drugs.  This review highlights several key concepts and observations related to drug-target residence time, and suggests the use of a kinetics-perceptive and energetics-informed approach to address the challenges facing current drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMGAUQvzpC3LVg90H21EOLACvtfcHk0liJEMw8CENDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClsbvF&md5=cf0982ae64a3b5e5294e033ffbd99ca0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DMonsma%26aufirst%3DF.%26atitle%3DThe%2520importance%2520of%2520drug-target%2520residence%2520time%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2009%26volume%3D12%26spage%3D488%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">Survey of the 2009 commercial optical biosensor literature</span> <span class="citation_source-journal">J. Mol. Recognit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span><span class="refDoi"> DOI: 10.1002/jmr.1138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1002%2Fjmr.1138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=22038797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=892-914&author=R.+L.+Richauthor=D.+G.+Myszka&title=Survey+of+the+2009+commercial+optical+biosensor+literature&doi=10.1002%2Fjmr.1138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Survey of the 2009 commercial optical biosensor literature</span></div><div class="casAuthors">Rich, Rebecca L.; Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-914</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  We took a different approach to reviewing the com. biosensor literature this year by inviting 22 biosensor users to serve as a review committee.  They set the criteria for what to expect in a publication and ultimately decided to use a pass/fail system for selecting which papers to include in this year's ref. list.  Of the 1514 publications in 2009 that reported using com. available optical biosensor technol., only 20% passed their cutoff.  The most common criticism the reviewers had with the literature was that "the biosensor expts. could have been done better.".  They selected 10 papers to highlight good exptl. technique, data presentation, and unique applications of the technol.  This communal review process was educational for everyone involved and one we will not soon forget.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVUTUDTLIbLbVg90H21EOLACvtfcHk0liJEMw8CENDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsL%252FI&md5=4a316816101a79565ddc287567eb2829</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjmr.1138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.1138%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DSurvey%2520of%2520the%25202009%2520commercial%2520optical%2520biosensor%2520literature%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2011%26volume%3D24%26spage%3D892%26epage%3D914%26doi%3D10.1002%2Fjmr.1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wilson, W. D.</span><span> </span><span class="NLM_article-title">Analyzing biomolecular interactions</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="refDoi"> DOI: 10.1126/science.295.5562.2103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1126%2Fscience.295.5562.2103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=11896282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1Ohurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=2103&author=W.+D.+Wilson&title=Analyzing+biomolecular+interactions&doi=10.1126%2Fscience.295.5562.2103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Tech sight: Analyzing biomolecular interactions</span></div><div class="casAuthors">Wilson, W. David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5562</span>),
    <span class="NLM_cas:pages">2103, 2105</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_MPii95I1LVg90H21EOLACvtfcHk0liJEMw8CENDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1Ohurg%253D&md5=1178b2938fde58488f9b4874cda13b06</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1126%2Fscience.295.5562.2103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.295.5562.2103%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DW.%2BD.%26atitle%3DAnalyzing%2520biomolecular%2520interactions%26jtitle%3DScience%26date%3D2002%26volume%3D295%26spage%3D2103%26doi%3D10.1126%2Fscience.295.5562.2103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonge, P. J.</span><span> </span><span class="NLM_article-title">Drug–target residence time: critical information for lead optimization</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2010.06.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.cbpa.2010.06.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=20663707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=467-474&author=H.+Luauthor=P.+J.+Tonge&title=Drug%E2%80%93target+residence+time%3A+critical+information+for+lead+optimization&doi=10.1016%2Fj.cbpa.2010.06.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time: Critical information for lead optimization</span></div><div class="casAuthors">Lu, Hao; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Failure due to poor in vivo efficacy is a primary contributor to attrition during the development of new chemotherapeutics.  Lead optimization programs that in their quest for efficacy focus solely on improving the affinity of drug-target binding are flawed, since this approach ignores the fluctuations in drug concn. that occur in vivo.  Instead the lifetime of the drug-target complex must also be considered, since drugs only act when they are bound to their targets.  Consequently, to improve the correlation between the in vitro and in vivo activity of drugs, measurements of drug-target residence time must be incorporated into the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodk2kN_txuMLVg90H21EOLACvtfcHk0liJEMw8CENDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D&md5=3189f56032106db858cfb4269d3fc11f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.06.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.06.176%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DDrug%25E2%2580%2593target%2520residence%2520time%253A%2520critical%2520information%2520for%2520lead%2520optimization%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D467%26epage%3D474%26doi%3D10.1016%2Fj.cbpa.2010.06.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Dahl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerud, T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and the drug–target residence time concept</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">707</span><span class="refDoi"> DOI: 10.1016/j.drudis.2013.02.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1016%2Fj.drudis.2013.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=23500610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVyqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=697-707&author=G.+Dahlauthor=T.+Akerud&title=Pharmacokinetics+and+the+drug%E2%80%93target+residence+time+concept&doi=10.1016%2Fj.drudis.2013.02.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and the drug-target residence time concept</span></div><div class="casAuthors">Dahl, Goeran; Akerud, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">697-707</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The concept of drug-target residence time has been in focus in recent drug discovery literature.  However, few studies consider the combined effect of pharmacokinetics (PK) and binding kinetics (BK) on the duration of effect of a drug.  Using a simple model that takes both PK and BK into account, we found that prolongation of binding owing to a long drug-target residence time can only occur when the binding dissocn. is slower than the PK elimination.  Data for several drugs and/or drug candidates in the literature indicate that the opposite is obsd., i.e., they have a slower elimination compared with dissocn.  These observations greatly reduce the usability of drug-target residence times for estg. the duration of effect of a drug in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon2xZ9fJkTybVg90H21EOLACvtfcHk0lhoUe2jSHan0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVyqtL0%253D&md5=73b190a44d359f55ee19af9099846505</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DAkerud%26aufirst%3DT.%26atitle%3DPharmacokinetics%2520and%2520the%2520drug%25E2%2580%2593target%2520residence%2520time%2520concept%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D697%26epage%3D707%26doi%3D10.1016%2Fj.drudis.2013.02.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Vilums, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wapenaar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollen, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barmare, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, J.</span><span> </span><span class="NLM_article-title">Structure–Kinetic Relationships: An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7706</span><span class="NLM_x">–</span> <span class="NLM_lpage">7714</span><span class="refDoi"> DOI: 10.1021/jm4011737</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011737" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7706-7714&author=M.+Vilumsauthor=A.+J.+Zweemerauthor=Z.+Yuauthor=H.+de+Vriesauthor=J.+M.+Hillgerauthor=H.+Wapenaarauthor=I.+A.+Bollenauthor=F.+Barmareauthor=R.+Grossauthor=J.+Clemens&title=Structure%E2%80%93Kinetic+Relationships%3A+An+Overlooked+Parameter+in+Hit-to-Lead+Optimization%3A+A+Case+of+Cyclopentylamines+as+Chemokine+Receptor+2+Antagonists&doi=10.1021%2Fjm4011737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm4011737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011737%26sid%3Dliteratum%253Aachs%26aulast%3DVilums%26aufirst%3DM.%26aulast%3DZweemer%26aufirst%3DA.%2BJ.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DHillger%26aufirst%3DJ.%2BM.%26aulast%3DWapenaar%26aufirst%3DH.%26aulast%3DBollen%26aufirst%3DI.%2BA.%26aulast%3DBarmare%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DR.%26aulast%3DClemens%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593Kinetic%2520Relationships%253A%2520An%2520Overlooked%2520Parameter%2520in%2520Hit-to-Lead%2520Optimization%253A%2520A%2520Case%2520of%2520Cyclopentylamines%2520as%2520Chemokine%2520Receptor%25202%2520Antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7706%26epage%3D7714%26doi%3D10.1021%2Fjm4011737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Al-Saffar, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judson, I. R.</span><span> </span><span class="NLM_article-title">Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-1338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1158%2F0008-5472.CAN-05-1338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=427-434&author=N.+M.+Al-Saffarauthor=H.+Troyauthor=A.+Ram%C3%ADrez+de+Molinaauthor=L.+E.+Jacksonauthor=B.+Madhuauthor=J.+R.+Griffithsauthor=M.+O.+Leachauthor=P.+Workmanauthor=J.+C.+Lacalauthor=I.+R.+Judson&title=Noninvasive+magnetic+resonance+spectroscopic+pharmacodynamic+markers+of+the+choline+kinase+inhibitor+MN58b+in+human+carcinoma+models&doi=10.1158%2F0008-5472.CAN-05-1338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-1338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-1338%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Saffar%26aufirst%3DN.%2BM.%26aulast%3DTroy%26aufirst%3DH.%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DL.%2BE.%26aulast%3DMadhu%26aufirst%3DB.%26aulast%3DGriffiths%26aufirst%3DJ.%2BR.%26aulast%3DLeach%26aufirst%3DM.%2BO.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DJudson%26aufirst%3DI.%2BR.%26atitle%3DNoninvasive%2520magnetic%2520resonance%2520spectroscopic%2520pharmacodynamic%2520markers%2520of%2520the%2520choline%2520kinase%2520inhibitor%2520MN58b%2520in%2520human%2520carcinoma%2520models%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D427%26epage%3D434%26doi%3D10.1158%2F0008-5472.CAN-05-1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Al-Saffar, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez de Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M. O.</span><span> </span><span class="NLM_article-title">The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase α leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5507</span><span class="NLM_x">–</span> <span class="NLM_lpage">5517</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-4476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1158%2F0008-5472.CAN-09-4476" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=5507-5517&author=N.+M.+Al-Saffarauthor=L.+E.+Jacksonauthor=F.+I.+Raynaudauthor=P.+A.+Clarkeauthor=A.+Ram%C3%ADrez+de+Molinaauthor=J.+C.+Lacalauthor=P.+Workmanauthor=M.+O.+Leach&title=The+phosphoinositide+3-kinase+inhibitor+PI-103+downregulates+choline+kinase+%CE%B1+leading+to+phosphocholine+and+total+choline+decrease+detected+by+magnetic+resonance+spectroscopy&doi=10.1158%2F0008-5472.CAN-09-4476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-4476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-4476%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Saffar%26aufirst%3DN.%2BM.%26aulast%3DJackson%26aufirst%3DL.%2BE.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DRam%25C3%25ADrez%2Bde%2BMolina%26aufirst%3DA.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DLeach%26aufirst%3DM.%2BO.%26atitle%3DThe%2520phosphoinositide%25203-kinase%2520inhibitor%2520PI-103%2520downregulates%2520choline%2520kinase%2520%25CE%25B1%2520leading%2520to%2520phosphocholine%2520and%2520total%2520choline%2520decrease%2520detected%2520by%2520magnetic%2520resonance%2520spectroscopy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D5507%26epage%3D5517%26doi%3D10.1158%2F0008-5472.CAN-09-4476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Guma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Lopez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Carbonell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiziani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacal, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">Choline kinase inhibition in rheumatoid arthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2014-205696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1136%2Fannrheumdis-2014-205696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25274633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A280%3ADC%252BC2M7msVWrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2015&pages=1399-1407&author=M.+Gumaauthor=E.+Sanchez-Lopezauthor=A.+Lodiauthor=R.+Garcia-Carbonellauthor=S.+Tizianiauthor=M.+Karinauthor=J.+C.+Lacalauthor=G.+S.+Firestein&title=Choline+kinase+inhibition+in+rheumatoid+arthritis&doi=10.1136%2Fannrheumdis-2014-205696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Choline kinase inhibition in rheumatoid arthritis</span></div><div class="casAuthors">Guma M; Firestein G S; Sanchez-Lopez E; Garcia-Carbonell R; Karin M; Lodi A; Tiziani S; Lacal J C</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the rheumatic diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-407</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Little is known about targeting the metabolome in non-cancer conditions.  Choline kinase (ChoKα), an essential enzyme for phosphatidylcholine biosynthesis, is required for cell proliferation and has been implicated in cancer invasiveness.  Aggressive behaviour of fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA) led us to evaluate whether this metabolic pathway could play a role in RA FLS function and joint damage.  METHODS:  Choline metabolic profile of FLS cells was determined by (1)H magnetic resonance spectroscopy ((1)HMRS) under conditions of ChoKα inhibition.  FLS function was evaluated using the ChoKα inhibitor MN58b (IC50=4.2 μM).  For arthritis experiments, mice were injected with K/BxN sera.  MN58b (3 mg/kg) was injected daily intraperitoneal beginning on day 0 or day 4 after serum administration.  RESULTS:  The enzyme is expressed in synovial tissue and in cultured RA FLS.  Tumour necrosis factor (TNF) and platelet-derived growth factor (PDGF) stimulation increased ChoKα expression and levels of phosphocholine in FLS measured by Western Blot (WB) and metabolomic studies of choline-containing compounds in cultured RA FLS extracts respectively, suggesting activation of this pathway in RA synovial environment.  A ChoKα inhibitor also suppressed the behaviour of cultured FLS, including cell migration and resistance to apoptosis, which might contribute to cartilage destruction in RA.  In a passive K/BxN arthritis model, pharmacologic ChoKα inhibition significantly decreased arthritis in pretreatment protocols as well as in established disease.  CONCLUSIONS:  These data suggest that ChoKα inhibition could be an effective strategy in inflammatory arthritis.  It also suggests that targeting the metabolome can be a new treatment strategy in non-cancer conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs3K3z7lK6Ol1C8OJBvdfbfW6udTcc2eZzy8zAxuvi3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7msVWrtA%253D%253D&md5=7fde813ebbc0f5642ed3843417416182</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2014-205696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2014-205696%26sid%3Dliteratum%253Aachs%26aulast%3DGuma%26aufirst%3DM.%26aulast%3DSanchez-Lopez%26aufirst%3DE.%26aulast%3DLodi%26aufirst%3DA.%26aulast%3DGarcia-Carbonell%26aufirst%3DR.%26aulast%3DTiziani%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DLacal%26aufirst%3DJ.%2BC.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DCholine%2520kinase%2520inhibition%2520in%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2015%26volume%3D74%26spage%3D1399%26epage%3D1407%26doi%3D10.1136%2Fannrheumdis-2014-205696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Bernard, N. J.</span><span> </span><span class="NLM_article-title">Rheumatoid arthritis: Choline kinase: more than a cancer therapy target?</span> <span class="citation_source-journal">Nat. Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span><span class="refDoi"> DOI: 10.1038/nrrheum.2014.180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=10.1038%2Fnrrheum.2014.180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=25330780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A280%3ADC%252BC2M3hvFeqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=699-699&author=N.+J.+Bernard&title=Rheumatoid+arthritis%3A+Choline+kinase%3A+more+than+a+cancer+therapy+target%3F&doi=10.1038%2Fnrrheum.2014.180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Rheumatoid arthritis: Choline kinase--more than a cancer therapy target?</span></div><div class="casAuthors">Bernard Nicholas J</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">699</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgc4UZLZDFNgvupmecNw_lfW6udTcc2eZzy8zAxuvi3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3hvFeqsg%253D%253D&md5=9804194be86e51e666018dd415f46169</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2014.180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2014.180%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DN.%2BJ.%26atitle%3DRheumatoid%2520arthritis%253A%2520Choline%2520kinase%253A%2520more%2520than%2520a%2520cancer%2520therapy%2520target%253F%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2014%26volume%3D10%26spage%3D699%26epage%3D699%26doi%3D10.1038%2Fnrrheum.2014.180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Identifying and characterizing binding sites and assessing druggability</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1021/ci800324m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci800324m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=377-389&author=T.+A.+Halgren&title=Identifying+and+characterizing+binding+sites+and+assessing+druggability&doi=10.1021%2Fci800324m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying and Characterizing Binding Sites and Assessing Druggability</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-389</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Identification and characterization of binding sites is key in the process of structure-based drug design.  In some cases there may not be any information about the binding site for a target of interest.  In other cases, a putative binding site has been identified by computational or exptl. means, but the druggability of the target is not known.  Even when a site for a given target is known, it may be desirable to find addnl. sites whose targeting could produce a desired biol. response.  A new program, called SiteMap, is presented for identifying and analyzing binding sites and for predicting target druggability.  In a large-scale validation, SiteMap correctly identifies the known binding site as the top-ranked site in 86% of the cases, with best results (>98%) coming for sites that bind ligands with subnanomolar affinity.  In addn., a modified version of the score employed for binding-site identification allows SiteMap to accurately classify the druggability of proteins as measured by their ability to bind passively absorbed small mols. tightly.  In characterizing binding sites, SiteMap provides quant. and graphical information that can help guide efforts to critically assess virtual hits in a lead-discovery application or to modify ligand structure to enhance potency or improve phys. properties in a lead-optimization context.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfAt0-gvcXDLVg90H21EOLACvtfcHk0lhb04FcMDNTlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1OhsA%253D%253D&md5=f03c7b27e30ae03d10e4127ed1f1ed3c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fci800324m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci800324m%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DIdentifying%2520and%2520characterizing%2520binding%2520sites%2520and%2520assessing%2520druggability%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D377%26epage%3D389%26doi%3D10.1021%2Fci800324m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span>SiteMap, version <span class="NLM_edition">2.4</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SiteMap%2C+version+2.4%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSiteMap%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>Glide, version <span class="NLM_edition">5.5</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.5%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>LigPrep, version <span class="NLM_edition">2.3</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LigPrep%2C+version+2.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DLigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>Prime, version <span class="NLM_edition">2.1</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Prime%2C+version+2.1%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+NY%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPrime%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQE','PDB','5EQE'); return false;">PDB: 5EQE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKQ','PDB','2CKQ'); return false;">PDB: 2CKQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQY','PDB','5EQY'); return false;">PDB: 5EQY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G15" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3G15','PDB','3G15'); return false;">PDB: 3G15</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQP','PDB','5EQP'); return false;">PDB: 5EQP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01552">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83055"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01552">10.1021/acs.jmedchem.5b01552</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional SAR tables, X-ray crystallography refinement data, structures of reference compounds, NMR spectra, and X-ray structures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_001.pdf">jm5b01552_si_001.pdf (1.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01552/suppl_file/jm5b01552_si_002.csv">jm5b01552_si_002.csv (3.46 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The following X-ray crystal structures have been deposited in the RCSB Protein Data Bank: codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQE">5EQE</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQP">5EQP</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EQY">5EQY</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01552&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-2%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01552%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01552" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677af6456fc2d1f3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
